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ABSTRACT 
 
The hemoparasite Cytauxzoon felis causes cytauxzoonosis, an emerging 
infectious disease of cats in the United States. Its life cycle involves sexual reproduction 
in the tick vector and asexual reproduction (schizogonous and erythrocyctic stages) in 
the felid. Cytauxzoon felis studies involve the use of infected cats, and in vitro 
cultivation would obviate this use as well as provide a continuous parasite source. 
Modeled after the microaerophilous stationary phase system used in cultures of Babesia 
bovis, a similar hemoparasite, 332 C. felis cultures were initiated to optimize the in vitro 
cultivation of the erythrocytic stage. Although no continuous cultivation was achieved, 
parasites were maintained short-term at a percentage of parasitized erythrocytes ranging 
from undetectable to 1.1% for two days to 140 days, with an average of 32 days. Five 
cultures underwent subculture four times, the maximum level achieved. 
Cytauxzoonosis can manifest itself as a recovered, chronic, or fatal infection. 
Historically, nearly all infected cats died, but as years passed, the number of cats that did 
survive increased, which may be attributed to different strains of Cytauxzoon felis. 
Internal transcribed spacer regions 1 and 2 (ITS1 and ITS2) were assessed for genetic 
variation and used for determining clinical outcome and spatial correlations.  Even 
though the ITS1 and ITS2 regions are genetically diverse, they do not aid in 
understanding differences in C. felis strains, as there was no association with clinical 
outcome or geography. 
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A potential C. felis coinfection with a hemoplasma was assessed for difference in 
clinical outcome. Polymerase chain reaction (PCR) and subsequent cloning showed 
clones of 11 of 41 C. felis-infected cats as positive for Candidatus Mycoplasma 
haemominutum with at least 99% identity and two other cats as positive for 
Rhodococcus spp. with at least a 97% identity. Clones of one of these two cats also 
matched Candidatus Mycoplasma kahanei with 99% identity.  
Based on prior molecular evidence of B. bovis and the sylvatic component of the 
C. felis life cycle, 161 ticks removed from white-tailed deer in south Texas were 
molecularly surveyed for hemoparasites. No ticks were positive for species of Babesia, 
Cytauxzoon, or Theileria.  
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
CYTAUXZOON FELIS 
Cytauxzoonosis is an emerging infectious disease of domestic cats in the United 
States and is caused by the tick-borne hemoparasite Cytauxzoon felis. The Cytauxzoon 
genus is classified as phylum Apicomplexa, class Aconoidasida, order Piroplasmida, and 
family Theileriidae. This genus was originally used to describe the causative agent of a 
fatal illness in an African grey duiker (Sylvicaprae grimmia) in 1948 (Neitz and Thomas, 
1948). Other African ungulates such as antelope (Thomas et al., 1982) and giraffe 
(Krecek et al., 1990) have shown to be infected with Cytauxzoon species.  
Cytauxzoon felis was first reported in the United States in 1976 in fatally infected 
domestic cats in Missouri (Wagner, 1976). Since Cytauxzoon species originally were 
only known to infect African ruminants, the finding of C. felis in cats in the U.S. raised 
concern for domestic food animals (Ferris, 1979; Kier et al., 1982). This warranted the 
early research conducted on infectivity and host range for this parasite. It was shown that 
C. felis only parasitized domestic and wild felids, especially bobcats. Results also 
revealed that the disease progression of this parasite varies considerably between 
domestic and wild felids.  
Within less than a decade after the first report of feline cytauxzoonosis in 
Missouri, this previously unrecognized disease was documented in additional 
southeastern states including Arkansas, Florida, Georgia, Louisiana, Mississippi, 
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Oklahoma, and Texas (Glenn et al., 1982). Cytauxzoon felis infections were 
subsequently identified in domestic cats in several other states such as Kansas, 
Kentucky, North Carolina, South Carolina, Tennessee, and Virginia (Meier and Moore, 
2000; Birkenheuer et al., 2006a; Jackson and Fisher, 2006; Haber et al., 2007). 
Cytauxzoon felis is frequently found infecting domestic cats in Arkansas, Missouri, and 
Oklahoma. The reported high prevalence affirms infected domestic cats as sources of 
infection for naïve felines and validates the use of acaricides on cats to prevent 
cytauxzoonosis (Rizzi et al., 2015).  
Cytauxzoon felis infection was reported in northern states of the U.S. as well. 
Cytauxzoonosis was diagnosed in domestic cats in southern Illinois (MacNeill et al., 
2015). Although not reported in domestic cats in North Dakota and Pennsylvania, 
C. felis infection has been found in bobcats in these states (Birkenheuer et al., 2008; 
Shock et al., 2011).  
All of the mentioned states lie within specific geographical regions that correlate 
with the range of the first identified tick vector, Dermacentor variabilis (American dog 
tick) (Birkenheuer et al., 2006a; Jackson and Fisher, 2006). 
Transmission  
Dermacentor variabilis is mainly found in U.S. states east of the Rocky 
Mountains. This tick can also be found in certain areas of Mexico, the Pacific Northwest 
of the U.S., and Canada, east of Saskatchewan (McNemee et al., 2003). Laboratory 
studies have shown that C. felis is capable of being experimentally transmitted by 
D. variabilis as well as Amblyomma americanum (lone star tick) (Blouin et al., 1984; 
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Kocan et al., 1992; Reichard et al., 2009; Reichard et al., 2010). Dermacentor variabilis 
has been experimentally shown as a transstadial vector for C. felis, but cytauxzoonosis 
cases better correlate geographically and epidemiologically with A. americanum 
(Reichard et al., 2009).  
An early study concluded that C. felis infection was unable to be transmitted via 
A. americanum adults that fed as nymphs on C. felis experimentally infected bobcats and 
domestic cats (Wightman et al., 1977). However, subsequent studies showed 
A. americanum as a more efficient vector for C. felis than D. variabilis (Bondy et al., 
2005; Reichard et al., 2009). Reichard et al., 2009 tested D. variabilis, Ixodes scapularis, 
Rhipicephalus sanguineus, and A. americanum for cat-to-cat tick transmission of C. felis, 
and only the A. americanum ticks were able to transmit C. felis from a cat that survived a 
natural C. felis infection to a recipient, susceptible cat. In addition, natural C. felis 
infection has been reported in unengorged A. americanum nymphs and adults that were 
caught outdoors (Reichard et al., 2010). Also, the prevalence of C. felis infection has 
been found to be higher in wild felids of states with known A. americanum populations 
(Shock et al., 2011; Shock et al., 2012).  
While C. felis is the only Cytauxzoon species identified in the U.S., infections 
with other Cytauxzoon spp. have been found in felids in other parts of the world. 
Cytauxzoon manul has been found to infect Pallas cats (Otocolobus manul) from 
Mongolia (Reichard et al., 2005). This Cytauxzoon sp. can infect domestic cats, but 
clinical signs are not observed with infection from this species as it does not cause 
disease. Cytauxzoon manul infection does not guarantee protection from a challenge 
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C. felis infection as well (Joyner et al., 2007). There was also a high prevalence of 62.5% 
of Cytauxzoon sp. in a Eurasian lynx and wild cats. Phylogenetic analysis showed two 
distinct clades of Cytauxzoon, in which all the sequences clustered to 
C. manul/Cytauxzoon sp. of Palaearctic felids (Jirsová et al., 2016). In Spain, infections 
of Cytauxzoon spp. have been reported in domestic cats (Criado-Fornelio et al., 2004) 
and an Iberian lynx (Lynx pardinus) (Millan et al., 2007). Domestic cats have been 
infected with Cytauxzoon spp. in France (Criado-Fornelio et al., 2009), northeastern Italy 
(Carli et al., 2012) , and South Africa (Allsopp et al., 1994). Cytauxzoon felis or a 
morphologically and genetically similar species of Cytauxzoon has been implicated in 
causing cytauxzoonosis in wild felids as well as feral domestic cats in Brazil (Peixoto et 
al., 2007; Andre et al., 2009). Cytauxzoon felis has also been detected in the serum and 
blood smear of a stray cat in Iran (Rassouli et al., 2015). A retrospective examination of 
organs from a Bengal tiger at a German zoo revealed a fatal infection resembling 
cytauxzoonosis after possibly coming in contact with bobcats (Lynx rufus) imported 
from North America (Jakob and Wesemeier, 1996).  
Originally, the accepted paradigm of the C. felis life cycle was a sylvatic cycle 
which included the transmission of C. felis from an infected bobcat (L. rufus) as the 
reservoir host (Glenn et al., 1983; Blouin et al., 1984) to a domestic, naïve cat as the 
aberrant or dead-end host (Greene et al., 2006). It was later shown that C. felis could be 
transmitted from a domestic cat to another domestic cat without the necessity of a wild 
felid host (Reichard et al., 2009). Iatrogenic transmission of C. felis was shown possible 
when a laboratory cat died of cytauxzoonosis 12 days after receiving an intraperitoneal 
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inoculation of blood mononuclear cells from an infected Florida panther (Felis concolor 
coryi [Puma concolor coryi]) (Butt et al., 1991). Ultrastructural and histologic features 
revealed an acute C. felis infection in the domestic cat. This would indicate that the 
Florida panther can serve as a carrier for C. felis.  
In addition to the bobcat and the Florida panther, subclinical C. felis infection has 
been demonstrated in Florida cougars (Puma concolor couguar) (Yabsley et al., 2006; 
Harvey et al., 2007) and in Texas cougars (Puma concolor stanleyana) (Rotstein et al., 
1999). A captive-reared white tiger (Panthera tigris) was diagnosed with fatal 
cytauxzoonosis in an enzootic part of northern Florida (Garner et al., 1996). The findings 
of C. felis infections in these wild felids identify them as hosts for C. felis as well.  
Life Cycle 
The C. felis life cycle begins as a naïve tick (usually a nymph) takes in a blood 
meal of circulating, piroplasm-containing erythrocytes from a felid host. Once engorged, 
the nymphal tick drops off and molts to the adult stage. At this time, the parasite is 
released into the tick’s gut and undergoes gametogenesis to develop into ray bodies that 
sexually reproduce by fusing into zygotes (Tarigo et al., 2013). These zygotes 
differentiate into kinetes that replicate and migrate to the salivary glands of the tick 
(Tarigo et al., 2013). In the salivary glands, these kinetes asexually reproduce by 
sporogony to form sporozoites, which infect as the adult tick feeds on a naïve domestic 
cat (Greene et al., 2006). These sporozoites infect host endothelial associated 
mononuclear phagocytes. This is followed by a prepatent period of approximately two to 
three weeks (Snider et al., 2010). During this time, schizonts are developing. The 
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schizonts in the cytoplasm of host cells start as indistinguishable vesicular structures, but 
as rounds of nuclear division take place, individual nuclei are more discernible within 
these enlarged schizonts. Widespread dissemination of occluded vessels with these 
schizont-infected cells results in formation of parasitic thrombi (Kier et al., 1987; Tarigo 
et al., 2013). This produces systemic disease leading to multi-organ failure and death 
(Tarigo et al., 2013). This part of the life cycle is known as the schizogonous or tissue 
phase (Meinkoth and Kocan, 2005).  
Schizonts undergo merogony, giving rise to merozoites (Kocan et al., 1992). 
Numerous merozoites rupture from schizonts to be released into the bloodstream and 
enter erythrocytes. Merozoites are identified in host erythrocytes one to three days after 
a schizont is found in mononuclear cells. Once identified within host erythrocytes, these 
merozoites are then termed piroplasms (Greene et al., 2006). These piroplasms continue 
to reproduce asexually. As piroplasms infect new erythrocytes, an erythroparasitemia 
results, and some feline hosts become carriers of C. felis. 
Disease Pathogenesis 
Cytauxzoonosis in most cats has a rapid onset of severe disease, which is due to 
the schizogonous phase of C. felis (Meinkoth and Kocan, 2005). Schizont-laden 
macrophages are found in almost any tissue in the body but are the most numerous in the 
liver, lungs, and spleen (Meinkoth and Kocan, 2005). Schizonts greatly distend 
mononuclear cells, and this has a profound effect on blood circulation. Schizont-laden 
monocytes become adherent to the endothelium and impede diapedesis (Susta et al., 
2009). The CD18 integrin, which after activation is present on most leukocytes  (Altieri 
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et al., 1992; Lynch et al., 1999; Willeke et al., 2000; Liebig et al., 2009), plays a role in 
this adherence (Frontera-Acevedo et al., 2013). The CD18 interaction with its ligands 
also causes an upregulation of proinflammatory cytokines (Frontera-Acevedo et al., 
2013). These parasitized mononuclear cells accumulate and totally occlude blood vessels 
(Wagner, 1976; Kier et al., 1987; Jackson and Fisher, 2006; Peixoto et al., 2007; Brown 
et al., 2009b; Susta et al., 2009). This vascular obstruction in conjunction with the 
release of inflammatory mediators causes severe vascular damage and leakage (Ma et 
al., 1991). This leads to disseminated intravascular coagulation (DIC) and multi-organ 
failure, which renders the cat in a shock-like state (Peri et al., 1990; Snider et al., 2010). 
The manifestations of disease generally vary between bobcats and domestic cats 
(Meinkoth and Kocan, 2005). The clinical presentation seems to correlate with the 
degree of the C. felis schizogonous phase (Blouin et al., 1987). Most domestic cats that 
are diagnosed with cytauxzoonosis experience an acute, short lived illness which 
culminates in death within approximately 19 to 21 days after the first appearance of 
clinical signs. Along with the massive numbers of schizonts in various tissues, these cats 
develop an erythroparasitemia as merozoites are released from enlarged monocytes 
(Meinkoth and Kocan, 2005). An immune-mediated erythrophagocytosis develops 
(Greene et al., 2006; Peixoto et al., 2007), and this triggers a sudden onset of 
nonregenerative anemia (Hoover et al., 1994). In bobcats, and in some domestic cats, 
C. felis infection is usually subclinical and leads to a long-lasting erythroparasitemia. In 
these felids, schizogonous forms are not observed (Glenn et al., 1983), and the 
erythroparasitemia is not accompanied by a hemolytic anemia (Bondy et al., 2005; 
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Mendes-de-Almeida et al., 2007; Millan et al., 2007). Occasionally, bobcats succumb to 
C. felis schizont tissue development and acute disease, similarly to acutely-ill domestic 
cats (Blouin et al., 1987; Nietfeld and Pollock, 2002).  
As discussed above, C. felis infection can either be subclinical or clinical, with 
the onset of clinical signs occurring soon after infection by tick transmission (Snider et 
al., 2010). A cat with cytauxzoonosis may show signs of depression, lethargy, anorexia, 
anemia, dyspnea, dehydration, icterus, dark urine, and pyrexia above 103°F (Wagner et 
al., 1980; Greene et al., 2006; Haber et al., 2007; Reichard et al., 2009; Susta et al., 
2009; Snider et al., 2010). Laboratory findings correlate with the DIC and inflammation 
associated with the disease. These findings include abnormalities in complete blood 
count (CBC), which could be in the form of any combination of cytopenias (Meinkoth 
and Kocan, 2005). Various combinations of normocytic, normochromic, non-
regenerative anemia, neutrophilia (Greene et al., 2006; Reichard et al., 2009), 
leukopenia, thrombocytopenia (Meinkoth and Kocan, 2005), and neutropenia may be 
seen. Biochemical findings such as hyperbilirubinemia, hypoalbuminemia (Hoover et al., 
1994; Greene et al., 1999), and elevations in liver enzyme activities, serum creatinine, 
and blood urea nitrogen (BUN) levels (Greene et al., 2006) may be observed as well.  
Diagnosis 
Since other diseases can produce similar clinical signs to cytauxzoonosis, a 
definitive diagnosis for C. felis infection can be made by direct observation of the 
organism in erythrocytes on blood smears, visualization of schizonts in affected tissues, 
and by polymerase chain reaction (PCR) assay. The most common diagnosis typically 
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was made using stained (Wright-Giemsa or Diff Quik) blood smears (Blouin et al., 1984; 
Meinkoth and Kocan, 2005) to observe piroplasms or schizonts. Piroplasms are 
pleomorphic and are morphologically described as tetrad, cocci-like chain, round “signet 
ring”, or bipolar oval “safety pin” (Greene et al., 2006). Although the detection of 
piroplasms in a blood smear is supportive in diagnosing C. felis infection, it has 
limitations. Depending on the stage of the disease, intraerythrocytic piroplasms may be 
missed. This is probable at initial presentation of clinical signs when a cat may not have 
a detectable erythroparasitemia. The schizogonous tissue phase is most responsible for 
clinical signs, and this point of the disease occurs prior to appearance of piroplasms. 
Although Theileria spp., C. manul, and small Babesia spp. (B. felis and B. leo) are 
difficult to distinguish from C. felis with light microscopy, there are no reports of 
Theileria spp. infecting cats in the U.S. Also, there has only been one report of feline 
babesiosis in Florida panthers (Yabsley et al., 2006) as well as a one report in a bobcat in 
the U.S. (Shock et al., 2013). Therefore, Mycoplasma haemofelis, stain precipitate, 
Howell-Jolly bodies, and water artifact would more likely lead to false positive 
identification of C. felis infection on blood smears. The presence of schizonts in 
mononuclear phagocytes in stained aspirates from the spleen, lungs, bone marrow, and 
lymph nodes can also aid in diagnosis (Greene et al., 2006; Reichard et al., 2009; Susta 
et al., 2009). Mononuclear phagocytes with tissue phase schizonts may be observed at 
edges of peripheral blood smears (Haber et al., 2007). 
A more thorough diagnosis is made with the detection of these pathognomonic 
schizonts in macrophages in blood vessels of various affected organs (Peixoto et al., 
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2007). Stained impression smears of many tissues can be used to identify the 
schizogonous phase of C. felis at different points of development in mononuclear 
phagocytes. The tissue stage of the organism can also be observed histopathologically 
with formalin-fixed tissues, particularly in the liver, lung, lymph node, and spleen 
(Greene et al., 2006), but this is not routinely conducted because as a confirmable 
diagnosis it can only be made at necropsy (Meier and Moore, 2000). Gross findings at 
necropsy usually consist of icterus, enlarged lymph nodes, hepatic and splenic mottling 
and enlargement, and non-collapsing lungs with petechial hemorrhages (Ferris, 1979; 
Kier et al., 1987; Hoover et al., 1994; Susta et al., 2009; Snider et al., 2010).  In some 
cats, a gelatinous, iteric fluid may accumulate in the pericardial sac, and petechial and 
ecchymotic hemorrhages on the epicardium may result (Kocan and Kocan, 1991).  
Molecular diagnostics can be used to detect C. felis. A PCR based assay was 
developed in 2006 that amplifies a 284-bp product of the C. felis 18S rRNA gene 
sequence (Birkenheuer et al., 2006b). This test has a sensitivity of 100% at a threshold of 
50 gene copies per reaction and is commercially available (North Carolina State 
University Vector Borne Disease Diagnostic Laboratory, Raleigh, NC; IDEXX 
Laboratories, Westbrook, ME). This test provides a more specific and sensitive means 
for detecting C. felis, but the rapid disease progression of C. felis may preclude its 
usefulness. Serologic methods have been utilized in order to test for antibody for C. felis 
but have not become commercially available. An indirect fluorescent antibody test was 
developed in 1978 (Shindel et al., 1978) and a microfluorometric immunoassay in 1988 
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(Cowell et al., 1988). Serological testing has been used only in prevalence studies and 
research to date.  
Treatments 
Different therapies have been evaluated for their effectiveness against 
cytauxzoonosis. Early on, antibiotics were utilized as therapy for cats with C. felis 
infection. Due to their lack of anti-protozoal activity, the outcome of C. felis infection 
did not solely depend on the use of antibiotics (Hoover et al., 1994; Walker and Cowell, 
1995). Two antiprotozoal agents, parvaquone and buparvaquone, are effective against 
Theileria spp., hemoparasites related to Cytauxzoon spp., in African cattle (Hawa et al., 
1988; Muraguri et al., 2006). However, neither was effective against cytauxzoonosis 
(Motzel and Wagner, 1990). Imidocarb dipropionate, a drug proven effective at treating 
Babesia spp. infections (Solano-Gallego and Baneth, 2011), and the drug diminazene 
aceturate have shown minimal success at treating C. felis infection (Greene et al., 1999). 
In a study involving seven cats, five cats survived acute cytauxzoonosis after being 
given diminazene aceturate and supportive therapy, and one other cat survived after the 
administration of imidocarb dipropionate and supportive therapy (Greene et al., 1999). 
Diminazine aceturate is not approved for therapeutic use in the U.S. Imidocarb is 
available for use in the U.S., but it is labeled for use in dogs only. It has also not 
consistently proven to be effective at treating C. felis infections (Meinkoth and Kocan, 
2005). In addition, erythroparasitemia was not eliminated from carrier cats with the 
administration of imidocarb or diminazene diaceturate (Lewis et al., 2014). In one study, 
imidocarb dipropionate was evaluated against azithromycin (antibacterial drug) co-
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administered with atovaquone (antimalarial drug) (Cohn et al., 2011). This clinical trial 
yielded the most promising results to date in which 60% of cats suffering from 
cytauxzoonosis survived to hospital discharge after combination of atovaquone and 
azithromycin (A&A) along with supportive care was administered versus 26% survival 
rate of those given imidocarb dipropionate and supportive care (Cohn et al., 2011). 
Atovaquone targets the C. felis cytochrome b (cytb). Thirty cytb genotypes have been 
identified, and the cytb1 genotype has been linked to higher chances of survival in cats 
administered A&A. Using a high-resolution melt analysis, a PCR panel was predicted to 
differentiate the cytb1 genotype from other cytb genotypes. With this panel, the C. felis 
cytb1 was identified with 100% sensitivity and 98.2% specificity (Schreeg et al., 2015).  
Glucosteroids or non-steroidal anti-inflammatory drugs (NSAIDs) can be used 
for their analgesic effects as well as suppression of pyrexia (Cohn et al., 2011). It has 
also been beneficial to provide intensive supportive therapy and heparin in order to 
prevent DIC (Greene et al., 1999; Greene et al., 2006; Cohn et al., 2011). In a recent 
study, an evaluation of the hemostatic status of five naturally C. felis-infected cats 
revealed that all five cats suffered from overt DIC (Conner et al., 2015). Despite having 
coagulation abnormalities, the cats had neither an antithrombin deficiency nor clinical 
signs of hemorrhage. These findings have shed light on conducting further research on 
the utility of therapies against thrombotic DIC, which could improve the survival of a cat 
against cytauxzoonosis.  
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Genetic Variation 
Cytauxzoon felis infection was once considered uniformly fatal in domestic cats, 
but over the years there has been an increasing number of reports of cats surviving 
infection (Motzel and Wagner, 1990; Greene et al., 1999; Meinkoth et al., 2000; Haber 
et al., 2007; Brown et al., 2008; Brown et al., 2009a; Brown et al., 2010; Cohn et al., 
2011). Some cats’ survival could be attributed to treatment (supportive care and/or 
antiprotozoal therapy), while others received no treatment and survived. Along with the 
inconsistent findings with therapies against C. felis infection, there was speculation that 
cats surviving infection may be due to a less virulent C. felis strain. Furthermore, early 
reports of C. felis infection survival cases in domestic cats appeared to be more limited 
to certain areas such as western Arkansas (Brown et al., 2009a) and eastern Oklahoma 
(Meinkoth and Kocan, 2005). This led to the hypothesis that less virulent strains were 
associated with certain geographical locations, which could further indicate a possible 
emergence of genetically variable C. felis strains.  
In order to test this hypothesis, a population of C. felis isolates would be assessed 
for strain variation. This would entail selection of a locus to be used as a genetic marker 
(Brown et al., 2009a). Polymerase chain reaction amplified DNA sequence analysis of 
such genetic markers has provided a very sensitive and reproducible means in which to 
identify and type various microorganisms (Williams et al., 1999). This is also a method 
for discerning genetic polymorphisms (Williams et al., 1999).  
An ideal genetic marker would be one that is a multicopy gene, which would be 
highly sensitive to a given detection method, and ever-present in the same genus. These 
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criteria make the ribosomal genes suitable candidates (Ferrer et al., 2001), which led to 
the 18S ribosomal RNA (18S rRNA) gene being commonly used as a taxonomic marker 
(Aktas et al., 2007). Initial C. felis molecular work involved sequencing the ribosomal 
genes, with more emphasis on comparing the structural 18S rRNA genes. In an early 
study, sequencing fragments of the C. felis 18S rRNA gene from a cat that survived 
infection revealed a >99% homology to a previously reported C. felis 18S rRNA gene 
from a fatal infection (Meinkoth et al., 2000). In another study, almost full-length 
(approximately 1,700 base pairs out of 1,774 base pairs) C. felis 18S rRNA gene 
sequences of four mid-Atlantic cats that either died or were euthanized due to C. felis 
infection had a ≤ 99.9% sequence identity to C. felis 18S rRNA sequences reported for 
cats that either died or survived infection from other U.S. regions (Birkenheuer et al., 
2006a). These findings are not surprising since the 18S region is highly conserved. The 
studying of this area for variation may not lead to distinguishing between very similar 
species (Aktas et al., 2007), and therefore may not be useful at the strain level.  
Genes associated with antigenic variation and pathogenicity also have been used 
for detection and molecular characterization of closely related apicomplexans, such as 
Babesia spp. (Yamasaki et al., 2007; Jia et al., 2009). The phylogenetic analysis of the 
heat shock protein 70 (hsp70) gene sequences of the canine Babesia spp. revealed the 
close relation amongst these species, as if evolved from the same ancestor. Using the 
phylogenetic analysis of hsp70 gene sequences could be useful in classifying Babesia 
and Theileria spp. (Yamasaki et al., 2007). 
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Identification of virulence genes is not an easy feat and can limit molecular 
studies (Brown et al., 2009a). Genomic studies commonly use the internal transcribed 
spacer (ITS) regions of the ribosomal RNA operon in order to detect genetic variation 
between very similar species. The ITS regions are composed of noncoding sequences 
and do not follow the same functional constraints of the rRNA genes (Brown et al., 
2009a). The ITS regions are distinguishing and divergent (Lott et al., 1993; Williams et 
al., 1995; Lott et al., 1998) as they are usually homogeneous amongst strains but evolve 
at a higher rate than the structural rRNAs  (Windsor et al., 2006). In eukaryotes, the 
rDNA unit is tandemly organized with the internal transcribed spacer 1 (ITS1) and 
internal transcribed spacer 2 (ITS2) regions separated by the 5.8S rRNA gene and 
flanked by the 18S and 28S rRNA genes (Kibe et al., 1994). Genetic variability within 
the ITS regions has been reported with other similar protozoal parasites, such as 
Theileria spp. (Kibe et al., 1994; Aktas et al., 2007), Babesia canis (Zahler et al., 1998), 
Cyclospora cayetanensis (Olivier et al., 2001), and Eimeria spp. (Barta et al., 1998). In 
the study with B. canis, ITS variability resulted in division of B. canis isolates of varying 
vector specificity, geographical location, and pathogenicity into three separate groups, 
approximately at species level, which was reflective of proposed subspecies 
(B. canis canis, B. canis rossi, and B. canis vogeli) (Zahler et al., 1998). 
Genetic analysis of the C. felis ITS regions was pursued in order to divulge any 
distinct parasite populations that could possibly be inferred in the variable outcomes of 
cytauxzoonosis as well as any differences in geography and hosts (wild and domestic 
cats). The first study compared C. felis ITS1 sequence data for three samples (two 
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infected ticks and one infected feline blood), in which all the bases were nearly identical 
except for two ambiguous bases found in one sample (Bondy et al., 2005). In a 2009 
study, C. felis ITS1 and ITS2 sequences from 88 acutely-ill cats from Arkansas and 
Georgia were evaluated for genetic variability as well as a positive association with 
clinical outcome (Brown et al., 2009a).Within the C. felis ITS1 sequences, there were 
eight single nucleotide polymorphisms (SNPs) and one nucleotide insertion, and ITS2 
sequences revealed four SNPs and a single 40 bp insertion. The combination of ITS1 and 
ITS2 sequences yielded 11 different ITS sequences and three unique genotypes.  
Gentoypes ITSA and ITSB were found only in Georgia samples, and ITSC was found 
only in Arkansas samples. Fourteen samples revealed the incorporation of two 
nucleotides at one given position within either the C. felis ITS1 or ITS2 sequence. This 
was understood as either a co-infection in a cat with multiple genotypes or there are 
multiple copies of the rRNA genes with polymorphic units in the C. felis genome, as 
described with a similar protozoan, Theileria parva (Kibe et al., 1994). Brown et al., 
2009a also reported survival rates of 79.2% (38/48) for genotype ITSA, 19% (4/21), for 
genotype ITSB, and 0% (0/5) for genotype ITSC. This led to a conclusion of a strong 
association of ITS genotype with C. felis pathogenicity.  
Brown et al., 2009b, analyzed 48 archived tissues of infected domestic cats in 
GA from 1995-2007 for C. felis ITS genetic variation as well as temporal analysis. There 
were six SNPs in ITS1 sequences and five SNPs in ITS2 sequences. The most common 
genotype, designated ITSa in this particular study, was found in 27/48 (56.3%) samples, 
and each of the 27 samples contained two nucleotides at a single position. ITSb was 
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detected in 8/48 (16.7%) samples, and ITSc was found in 3/48 (6.3%) samples. ITSb and 
ITSc genotypes only differed from the ITSa genotype at the same polymorphic position 
(position 180) of ITS2. Each genotype contained one of the two nucleotides of ITSa. The 
remaining ITS sequences were labeled in this study as ITSe, ITSf, ITSi, ITSj, and ITSk 
and were all detected in a single sample each. Chronologically, ITSa and ITSb were 
found in C. felis-infected cats over the course of many years. Also, ITSc was only 
detected in three samples in this study. During the 1995-2007 period, this sequence was 
not found in samples archived since 2001 (Brown et al., 2009b); whereas, it was the 
most common genotype (previously designated as ITSA) in samples from 2005-2007 in 
the earlier study (Brown et al., 2009a).  
Brown et al., 2009b suggested that the significant difference in the most common 
ITS genotypes found may be attributed to changes in the C. felis population over the 
periods of time for this current study and the previous one (Brown et al., 2009a).  
In a 2010 study, blood samples of high-risk, subclinical cats and bobcat tissue 
samples were evaluated for ITS genotype variation within the C. felis population (Brown 
et al., 2010). Out of the 27 C. felis positive domestic cats, all ITS1 sequences were 
identical, with the exception of four SNPs and a single insertion in one sample, and only 
one SNP within the ITS2 sequence of eight other samples. Together, the sequence data 
revealed three distinct ITS sequence types. Within the C. felis ITS1 sequence from 
bobcats, five SNPs and one single nucleotide insertion were found as well as three SNPs 
in the ITS2 region. When combined, 11 ITS sequence types were revealed (three 
previously reported as infecting domestic cats and eight that were not). Cytauxzoon felis 
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from the bobcats showed some SNPs in the ITS1 and most of SNPs in ITS2 as having 
two nucleotide bases at a single position. The ITS  sequence types of the C. felis 
subclinically infected cats were also detected in clinically infected cats (Brown et al., 
2009a). This led to conclusion that ITS sequences may be useful for observing genetic 
diversity within a given C. felis population but not as suitable for distinguishing amongst 
variably virulent C. felis strains.  
In 2011, the effectiveness of the co-administration of azithromycin and 
atovaquone as treatment for C. felis was evaluated as well as ITS genotyping and 
geographic association with outcome (Cohn et al., 2011). Out of 36 genotypes found, 15 
were unique. The remaining 21 genotypes matched those previously described (Brown et 
al., 2009a; Brown et al., 2009b; Brown et al., 2010). Although certain genotypes 
(ITSa/ITSc) were correlated with less virulence than other genotypes (ITSC) in other 
studies, this was not found in the 2011 study. And led to the conclusion that ITS 
genotyping is not ideal for predicting virulence in C. felis. Also, the distribution of ITS 
genotypes of the cats that died versus those that survived was proportional amongst the 
five states used in the study. This would suggest that survival may not necessarily be 
based on geographic region (Cohn et al., 2011).  
A 2012 study assessed the genetic variability within the C. felis ITS1 and ITS2 
regions from bobcats and pumas (Shock et al., 2012). For ITS1, 65/144 sequences were 
identical to those previously reported in domestic cats. The other 79/144 ITS1 sequences 
were unique. For ITS2, 49/112 sequences were identical to previously reported ITS2 
sequences of C. felis in domestic cats. The remaining 63 ITS2 sequences were unique. 
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There were 111 samples in which both ITS1 and ITS2 were obtained. Of those samples, 
25 wild felids had five C. felis genotypes that had been previously reported. Due to the 
greater diversity in the ITS1 and ITS2 of C. felis from pumas and bobcats found in this 
study, more C. felis strains may possibly circulate amongst wild felids (Shock et al., 
2012).  
Previous studies analyzing the intraspecific variation of the C. felis ITS1 and 
ITS2 rRNA regions did not utilize cell-based cloning of PCR-amplified DNA (Bondy et 
al., 2005; Brown et al., 2009a; Brown et al., 2009b; Brown et al., 2010; Cohn et al., 
2011; Shock et al., 2012). However, it was reported that there was an incorporation of 
two nucleotides at a single position in the sequences of C. felis ITS1 and/or ITS2. This 
led to difficulty in sequence analysis as well as some unusable data (Wright, 1984; 
Brown et al., 2009a; Brown et al., 2009b; Brown et al., 2010; Cohn et al., 2011; Shock et 
al., 2012). It was speculated that this incorporation was due to either a co-infection with 
multiple C. felis strains or presence of multiple rRNA gene copies which contained 
polymorphic units. Southern blot analysis could be conducted in order to identify the 
presence of any heterogeneous copies of the rRNA genes (Brown et al., 2009b). Cloning 
results in a single sequence of bases, and prior to sequencing, it could be used to 
alleviate an incorporation of mixed nucleotides at a single position.  
Authenticity of a sequence could be compromised as a result of direct sequencing 
of a highly heterogenic sample (as seen with double peaks in chromatogram) (Winters et 
al., 2011). Cloning has this drawback too in that a composition of mixed PCR reaction 
(whether heterogeneity was from adulteration of sample or damage) can be seen when 
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obtaining sequences (Winters et al., 2011). Carr et al., 2007 stated that with bisulphite 
genomic sequencing, using direct sequencing could lead to superimposed ‘staggered’ 
electropherograms due to dissimilar electrophoretic movement of bisulphite PCR 
product containing two varying template sequences (two divergent methylation states).  
One way to alleviate the presence of more than one nucleotide at a single 
position would be to clone prior to sequencing. Since a clone contains a single sequence, 
the differences in movement during bisulfite sequencing do not show, and any 
spuriously amplified DNA can be quickly recognized and removed (Carr et al., 2007). 
The majority of strands present during PCR contribute to the bases that are incorporated 
into strands of the PCR product (Strachan and Read, 1999), and a low-frequency 
sequence variation is overwhelmed by the sequence in abundance in a given sample 
(Ruecker et al., 2011). Cell-based cloning is the better way to detect polymorphisms 
(whether caused by Taq DNA polymerase error or a heterogeneous sequence mixture) at 
a low frequency. Despite cloning being a great candidate for detecting more 
polymorphisms, it is also more likely to contribute to greater sequence diversity 
(Ruecker et al., 2011). With any highly heterogenetic pool of molecules, amplification 
used for both direct sequencing of PCR products and sequencing of clones should be 
repeated, and their respective resulting sequences should be compared to each other in 
order to obtain the correct consensus sequence.  
FELINE HEMOTROPIC MYCOPLASMA (HEMOPLASMA) 
Due to the icterus, anemia, and erythroparasites, some of the first cases of 
cytauxzoonosis initially suggested Haemobartonella felis infection. As a result of DNA 
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studies, H. felis was officially reclassified as a mycoplasma in 2001 (Tasker, 2006), 
which led to the renaming of the feline hemotropic mycoplasmas (hemoplasmas) as M. 
haemofelis, “Candidatus Mycoplasma turicensis,” and “Candidatus Mycoplasma 
haemominutum (Sykes, 2010).” The Candidatus distinction is used for newly described 
prokaryotic species in which more than a sequence is available, but additional evidence 
needed for classification according to the International Code of Nomenclature of 
Bacteria is lacking (Murray and Stackebrandt, 1995). Occasionally a fourth species of 
Mycoplasma, a Candidatus Mycoplasma haematoparvum-like organism, can be found 
infecting felines as well (Sykes et al., 2007).  
Mycoplasma haemofelis 
Feline infectious anemia is caused by M. haemofelis (Willi et al., 2005; Sykes, 
2010). Pathogenicity ranges from subclinical to severe hemolytic anemia, and this differs 
between hemoplasma species (Willi et al., 2007b). This also may be due to strain 
variation within species, in which some strains induce anemia more than others (Sykes, 
2010). Mycoplasma haemofelis is an epierythrocytic hemoplasma capable of causing 
hemolytic anemia (Allison et al., 2010) and is difficult to cultivate in vitro (Sykes, 
2010).  
In experimentally infected cats, M. haemofelis infection resulted in severe 
hemolytic anemia. An association with anemia in naturally M. haemofelis-infected cats 
was not always demonstrated (Tasker, 2006). This could be attributed to the differences 
in population of cats sampled. A population of cats showing clinical signs consistent for 
hemoplasma infection in a study would have a higher prevalence of M. haemofelis 
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infection with an acute disease than a study including any healthy cats as well as cats 
with any sign of ill health (Tasker, 2006). Despite this, M. haemofelis is still considered 
the most pathogenic species (Sykes, 2010), and one third of untreated cats with acute 
M. haemofelis infection succumb to the severe anemia (Tasker, 2006).  
Five naïve cats and five cats that recovered Candidatus M. turicensis infection 
were exposed to M. haemofelis. No cross-protection was witnessed, but differences in 
infection kinetics were observed (Baumann et al., 2015). In a similar study, five naïve 
cats (Group A) and five cats that recovered from M. haemofelis infection (Group B) 
were compared. Bacterial loads by quantitative PCR, antibody response to hsp70 by 
enzyme-linked immunosorbent assay (ELISA), quantitative reverse transcriptase PCR, 
and blood lymphocyte cell subtypes by flow cytometry were measured. It was observed 
that all the cats of Group A were parasitized with high bacterial loads and seroconverted, 
and Group B were protected against reinfection (Hicks et al., 2015). 
Candidatus Mycoplasma haemominutum 
Candidatus M. haemominutum is also difficult to culture in vitro, and infections 
with Candidatus M. haemominutum are chronic and subclinical (Sykes, 2010). Anemia, 
if present, is often mild, but in some cases, it can be moderate. A co-infection with 
Candidatus M. haemominutum and other diseases, such as feline leukemia virus (FeLV), 
can lead to significant anemia (Tasker, 2006). Most prevalence studies have not shown 
an association between natural Candidatus M. haemominutum infection and anemia. 
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Candidatus Mycoplasma turicensis 
 Candidatus M. turicensis was first identified in Switzerland (Willi et al., 2005) 
and subsequently has been reported in the U.S., Italy, Japan, United Kingdom, Australia, 
South Africa, and Canada (Sykes, 2010). This hemoplasma was first discovered by PCR 
and has not been detected on blood smear or cultivated in the laboratory (Sykes, 2010). 
The pathogenicity of Candidatus M. turicensis can range from moderate to severe 
anemia. Concurrent infections, such as with FeLV, and immunosuppression are 
associated with increasing its pathogenic potential (Tasker, 2006). 
These mycoplasmas are transmitted by hematophagous ectoparasites, especially 
fleas (Willi et al., 2007a). The more time cats spend outdoors in temperate and tropical 
regions, the more they may be exposed to infected ectoparasites, such as fleas and ticks 
(Loyd et al., 2013). Coincidence of exposure to infected fleas and ticks could potentially 
lead to a coinfection in cats with a feline hemoplasma and a hemoparasite, such as 
C. felis (Allison et al., 2010).  
A coinfection could be implicated in causing a difference in pathogenicity, 
clinical manifestations, or response to treatment (Shaw et al., 2001). A mycoplasma and 
Plasmodium falciparum coinfection was evaluated in squirrel monkeys (Saimiri 
sciureus) (Contamin and Michel, 1999). It was observed that if a P. falciparum infection 
followed a latent mycoplasma infection, then the mycoplasma infection stayed latent and 
did not affect the course of the P. falciparum infection. If the P. falciparum infection 
was initiated first before the development of patent mycoplasma infection, then the 
P. falciparum infection persisted longer as the host resisted longer or was able to 
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eliminate P. falciparum infection. When intact monkeys with P. falciparum infection 
had a splenectomy performed at different times, then the patent mycoplasma infection 
was delayed. It was observed that a mycoplasma infection activated after splenectomy 
may have an impact on the progress of P. falciparum parasitemia (Contamin and Michel, 
1999). In another P. falciparum study using splenectomized squirrel monkeys as hosts, 
the splenectomy activated a patent infection caused by a wall-less bacterium. The 16S 
rRNA gene sequence analysis revealed the bacterium as a hemoplasma (Neimark et al., 
2002). 
With exposure to fleas that harbor a feline hemoplasma and ticks that harbor 
C. felis, cats may naturally acquire these organisms, which could lead to a feline 
hemoplasma and C. felis coinfection. During an evaluation for hemoparasites in a 
domestic shorthair cat, the diagnosis was M. haemofelis and C. felis coinfection (Allison 
et al., 2010). It was suggested that the manifestations of the C. felis present might have 
reactivated a latent M. haemofelis infection (Allison et al., 2010). Since C. felis 
undergoes both an erythrocytic and tissue phase, the presence of the tissue phase during 
postmortem examination helps differentiate between C. felis and M. haemofelis 
infections (Meinkoth and Kocan, 2005).  
IN VITRO CULTIVATION OF PROTOZOAL HEMOPARASITES 
The in vitro cultivation of parasitic protozoa has been beneficial at understanding 
the disease potential and biology of these organisms. This continued supply of viable 
parasite stock has led to better understanding of the host-pathogen interaction along with 
producing quantities of parasitic nucleic acids in order to conduct phylogenetic studies, 
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improve diagnostics (esp. with subclinical infections), produce attenuated strains and 
parasitic antigen for potential vaccine development (Schuster, 2002a). In vitro 
cultivation of these parasites has also enhanced the assessment in parasite triggered 
immune factors and drug screening (Visvesvara and Garcia, 2002). 
In vitro cultivation of protozoan parasites entails multifaceted techniques that 
must accommodate numerous factors. Protozoan parasites have complex life cycles, and 
culture parameters must take the stage of the life cycle into consideration (Visvesvara 
and Garcia, 2002). The first attempts of cultivating protozoa in vitro were with 
P. falciparum and Plasmodium vivax (Bass and Johns, 1912). Plasmodium spp. undergo 
sexual reproduction in the invertebrate, mosquito host. As a mosquito feeds, it injects 
sporozoites into the bloodstream, where these sporozoites travel to the liver and invade 
the hepatocytes. Here, the sporozoites grow and divide, which results in merozoites. The 
merozoites exit hepatocytes and re-enter the bloodstream. The asexual reproduction in 
the vertebrate host (Trager, 1986) occurs as the parasite begins a cycle of invading 
erythrocytes. In the erythrocytes, they develop into mature schizonts. These schizonts 
rupture and release numerous merozoites, and the merozoites enter new erythrocytes 
(Schuster, 2002b). Some merozoite-infected cells continue replicating; while others 
develop into male and female gametocytes. As a mosquito bites, it ingests the 
gametocytes, and the cycle repeats. 
Due to its involvement in the pathogenesis of malaria as well as potential in 
vaccine development, the erythrocytic stages of the Plasmodium life cycle are the most 
widely used in cultivation (Schuster, 2002b). Cultivation of these parasites without the 
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use of animal models or humans dates back as early as 1912 (Bass and Johns, 1912). As 
the years progressed, more work on improving culture conditions of the erythrocytic 
stages of malarial parasites of experimental animals as well as human malaria was being 
conducted (Butcher and Cohen, 1971; Diggs et al., 1971; Trager, 1971; Trigg, 1975). In 
1976, Trager and Jensen established the first continuous culture of human malaria 
parasites (Trager and Jensen, 1976). This entailed maintaining cultures in RPMI-1640 
medium with human serum at 38°C under atmospheric conditions of low O2 (1% or 5%) 
and 7% CO2 using a candle jar (Trager and Jensen, 1976). These atmospheric conditions 
produced by a candle jar were used in cultivating other similar parasites, such as Babesia 
and Cryptosporidia spp. (Timms 1980; Upton et al., 1994).  
A study to develop an indirect fluorescent antibody (IFA) against C. felis was the 
first attempt at cultivating this parasite in vitro (Shindel et al., 1978). The origins of the 
cultures began with the suspension of spleen and bone marrow cells of a moribund, 
C. felis-infected cat into Medium 199 with Hank’s salts supplemented with 20% fetal 
bovine serum (FBS; v/v), penicillin (200 units/ml), kanamycin (100 µg/ml), mycostatin 
(60 units/ml), and dihydrostreptomycin (200 µg/ml) in 50 ml Falcon flasks. Five days 
post initiation, the infected spleen and bone marrow cells were removed and mixed 1:4 
with African green monkey kidney (Vero) cells (American Type Culture Collection, 
Rockville, MD). The co-culture was maintained to a third passage, at which time a cat 
was inoculated with the cultured material. This successfully immunized the cat against 
challenges of C. felis and serum from this cat was harvested and used as the antiserum in 
the IFA (Shindel et al., 1978). However, the propagation of the parasite was not verified 
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through the cultures (Shindel et al., 1978), and there have been no additional reports of 
in vitro cultivation of C. felis.  
The method developed by Trager and Jensen, 1976 was utilized for short-term 
culture of B. bovis in bovine erythrocytes incubated at 37°C in a candle jar using RPMI-
1640 with 10% fetal calf serum (FCS) buffered with 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) (Erp et al., 1978). The cultivation resulted in 
percentage of parasitized erythrocytes (PPE) that reached 2.85% and did not increase 
beyond this point (Erp et al., 1978). Erp et al., 1978 also evaluated B. bovis cultivation 
using the spinner flask (SF) method. The SF method entailed using magnetic stirrers to 
keep the cultures constantly agitated and centrifugation to collect cells each time for 
subculture. The medium used was 50% Medium 199 supplemented with 50% bovine 
serum (Erp et al., 1978; Erp et al., 1980). With this exact protocol in addition to lowering 
the pH to 7, Erp et al. (1980) were able to support the continuous cultivation of B. bovis. 
Short-term cultivation of B. canis was also supported using the SF method with HEPES-
buffered RPMI-1640 medium and 20% normal dog serum (Molinar et al., 1982). 
However, this method was not very practical because it required a large quantity of 
culture that resulted in low numbers of parasites (Levy and Ristic, 1980). The continuous 
cultivation of B. bovis also was made possible at a higher parasitemia in a settled layer of 
erythrocytes (Levy and Ristic, 1980). This microaerophilous stationary phase (MASP) 
technique allowed the parasites to proliferate in this settled layer of cells at low oxygen 
tension similar to the candle jar environment, while being incubated at 37°C to 38°C in 
an atmosphere of 5% CO2 and 95% humidified air. The medium consisted of Medium 
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199 (60%) and bovine serum (40%), which was supplemented with 15 mM HEPES, 100 
units/ml of penicillin G, and 100 µg of streptomycin. The cultures were initiated with an 
inoculum of both normal and infected bovine erythrocytes (Levy and Ristic, 1980). This 
application is regarded as more suitable for Babesia growth (Canning and Winger, 1987; 
Goff and Yunker, 1988).  
Timms (1980) cultivated B. bovis, B. bigemina, and Babesia rodhaini in their 
host erythrocytes for up to 96 hours in vitro using the candle jar technique (Trager and 
Jensen, 1976) with some modifications. It was shown that 40% erythrocyte suspension 
yielded better results than 10-12% suspension of red blood cells (RBC) as shown by 
Trager and Jensen (1976) for P. falciparum. Based on the culture parameters used by 
Timms (1980) a continuous culture system for B. bigemina was developed (Vega et al., 
1985). This system included washing erythrocytes used in culture with a special 
solution. The culture medium consisted 5-10% (v/v) of erythrocytes suspended in 
Medium 199 supplemented with 20-50% fresh normal bovine serum under atmospheric 
conditions of 5% CO2, 2% O2, and 93% N2. The inoculation of a susceptible calf also 
demonstrated that in vitro propagation for 36 days and nine subcultures did not 
negatively affect the pathogenicity or morphology of B. bigemina (Vega et al., 1985). 
Rodriguez et al. (1983) evaluated different culture conditions and subsequently 
developed a B. bovis cloning procedure using in vitro cultivation. It was shown that a 
low-O2 environment best supports growth of B. bovis with a low initial PPE (<0.1%), 
and a PPE of ≥ 0.1% of B. bovis grows better in a high-O2 environment. It was also 
shown that oxygen consumption in B. bovis infected erythrocytes as well as increased 
 29 
 
depth of overlaying culture medium restricted O2 concentration at the settled layer of 
erythrocytes. A PPE of approximately 30% was the highest parasitemia attained in this 
study. With the development of this cloning procedure, avirulent B. bovis was able to be 
isolated from carrier animals, and homogeneous B. bovis populations were established 
and cultivated. This cloning procedure resulted in establishing three different B. bovis 
clonal lines (fast-, intermediate-, and slow growing) as indicated by the three different 
growth rates (Rodriguez et al., 1983).  
Goff and Yunker (1986) cultivated B. bovis continuously using a modified 
MASP method with Medium 199 with Earle’s salts without NaHCO3 or ʟ-glutamine 
(60%) and normal adult bovine serum (40%) supplemented with 50 mM TES, 10 µg/ml 
glucose, 0.25 µg/ml amphotericin B, and 50 µg/ml gentamycin. The complete medium 
was adjusted to a pH of 7.35. This study evaluated conditions that were essential for 
obtaining the maximum PPE as well as developed an improved method to assess the 
growth of B. bovis in vitro (Goff and Yunker, 1986). As the PPE was calculated, the 
observed parasitic forms were also classified as either trophozoites (visible cytoplasm 
and nucleus within a single parasite), dense forms (no visible cytoplasm), or merozoites 
(pair of pear-shaped bodies). It was shown that exponential growth varied inversely to 
the starting PPE and ceased when a threshold was reached (Goff and Yunker, 1986). 
Even when this peak was reached, individual parasites continued to grow. This 
culminated in a greater proportion of mature merozoite-infected RBC. Reducing the total 
number of erythrocytes also elevated the PPE. Besides PPE, the incorporation of [3H] 
hypoxanthine was used to assess parasite growth in vitro. There was a correlation with 
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uptake of [3H] hypoxanthine and PPE, with trophozoites exhibiting the greatest uptake 
(Goff and Yunker, 1986). 
The variables (pH, buffers, and media storage) were evaluated for their effects on 
the in vitro growth of B. bovis (Goff and Yunker, 1988). It was demonstrated that 
parasitic growth occurred in an alkaline pH range of 7.02-7.79. Optimal growth occurred 
at a pH range of 7.31 to 7.39. The parasite seemed to be intolerant of acidic pH medium 
(pH 6.86). The zwitterion buffer 3-(N-tris-[hydroxymethyl] methylamino)-
hydroxypropane sulfonic acid (TAPSO) at a concentration of 10 mM served as a better 
buffer than 2-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]amino]ethanesulfonic acid 
(TES). Exponential growth proceeded through four days in the presence of TAPSO, but 
for only three days with TES. Although cold medium storage has been reported as 
leading to less-than-optimal results, refrigeration and/or freezing before use had no 
profound effect on parasitic growth (Goff and Yunker, 1988). 
Babesia divergens is a parasite mainly of cattle but has caused babesiosis in 
humans throughout Europe (Schuster, 2002a). Adapting the MASP method, a strain 
isolated from Finland was cultivated continuously. This strain sustained 27 subcultures 
over the course of 85 days (Vayrynen and Tuomi, 1982). Medium 199 (60%) and bovine 
serum (40%) were used, and an average of 5-10% PPE was observed (Vayrynen and 
Tuomi, 1982). A French isolate of B. divergens was successfully cultivated in serum-free 
medium (Grande et al., 1997). The culture was originally initiated with RPMI-1640 (25 
mM HEPES) supplemented with 10% human serum (HS) and produced ≥ 40% PPE. 
Serum was gradually eliminated from the medium and was accompanied with a drop in 
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PPE. After a period of adaption, the culture remained continuous at a 3% PPE. Neither 
the addition of vitamins nor reduced glutathione increased the low PPE, but replacement 
of the serum with either Albumax I or bovine serum albumin (BSA) (Cohn’s Factor V) 
promoted growth with a high PPE (>30%). Neither lipid nor protein fractions alone were 
enough to promote parasite growth and led to cell lysis. Addition of whole lipid fraction 
from serum or Albumax I to lipid-free albumin produced a PPE of 7%. This could have 
indicated that parasitic growth was dependent upon certain lipids with a carrier, such as 
BSA. These findings showed that Albumax I could replace HS in medium. The 
replacement of HS could alleviate any issues that could arise from using this serum 
(Grande et al., 1997).  
Konrad et al., 1985 demonstrated that cultures of B. divergens and Babesia major 
could be maintained at low temperatures. These lower temperatures could prolong time 
between subculturing. After giving cultures time to develop, the medium was removed 
and replaced, and the cultures were switched from a temperature of 38°C to 4°C. This 
lower temperature delayed the need to subculture for up to 1 week. A lower PPE was 
observed during this period of lower temperature, but there was an increase in free extra-
erythrocytic merozoites. Parasitic growth was restored in cultures stored this way upon 
returning the temperature to 38°C (Grande et al., 1997).  
Novel developments in biotechnology have led to new media for cell culture. 
Using a chemically defined medium, HL-1 (Ventrex Laboratories, Inc., Portland, Maine) 
supplemented with 20% normal adult horse serum, 2 mM ʟ-glutamine, 25 µg/ml 
amphotericin B (Fungizone), 100 U/ml penicillin, and 100 µg/ml streptomycin, Babesia 
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caballi was cultivated in vitro (Holman et al., 1993). HL-1 medium contains  transferrin, 
saturated and unsaturated fatty acids, and insulin (Holman et al., 1994a), which are not 
commonly found in tissue culture media (Schuster, 2002a). This medium was developed 
for hybridomas and lymphoid cells (Ishikawa et al., 1987). In the first report of an isolate 
of Babesia sp. infective to North American elk (Cervus elaphus), the parasite was 
established in continuous cultures using HL-1 medium  supplemented with ʟ-glutamine 
(2 mM), 20% normal adult bovine serum, 500 U/ml penicillin, 500 μg/ml streptomycin, 
125 μg/ml Fungizone, and 100 μg/ml gentamicin (Holman et al., 1994b).  Parasitemias 
ranging from 3-19% were reported (Holman et al., 1994b). Using HL-1 medium 
supplemented with Albumax I (1 mg/ml), 2% HB101, 20% FBS, 100 µg/ml gentamycin 
and 2 mM ʟ-glutamine, Holman et al.(1994) were able to establish and maintain the 
continuous cultivation of the erythrocytic stage of Babesia equi (Theileria equi). After 
establishment, normal adult horse serum could replace FBS in culturing later passages of 
B. equi (T. equi).  Initially, the cultures were maintained in 5% CO2 and 95% air, but 
they were later switched to 2% O2, 5% CO2, and 93% N2 in order to improve condition 
of the cells. A PPE in excess of 15% was commonly seen in the established cultures 
(Holman et al., 1994a).  
Zweygarth et al. (1999) cultivated B. caballi in serum-free conditions. HEPES-
buffered HL-1 medium (80%) supplemented with NaHCO3 (2 g/l), 2 mM ʟ-glutamine, 
0.2 mM hypoxanthine, streptomycin (100 µg/ml), penicillin 100 IU, and 20% horse 
serum was initially used in cultures of two strains of B. caballi. In order to replace 
serum, BSA (5, 10, and 20 mg/ml), Albumax I (5, 10, and 20 mg/ml), and chemically 
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defined lipids (CDL; 0.25%, 0.5%, 0.75%, and 1%) alone or in combinations were 
tested. Adaptation to serum-free conditions was reached by gradually reducing serum in 
media at subculture. B. caballi was propagated in vitro for over six months in media 
containing either all concentrations of Albumax I or Albumax I (10 mg/ml) with CDL in 
various amounts. Bovine serum albumin or CDL alone or in combination could not 
support B. caballi in vitro. Neither RPMI-1640 nor Dulbecco’s modified Eagle medium-
F-12 in replacement of HL-1 as the basal medium supported growth of the parasite 
(Zweygarth et al., 1999). 
Even with the success of established MASP culture techniques, some attempts at 
in vitro cultivation proved difficult, as seen with the merozoite stage of Theileria spp. 
(Miranda et al., 2006) and with certain isolates of B. bovis (Jackson et al., 2001). 
Therefore, modifications were warranted in order to achieve optimization for in vitro 
cultivation. Miranda et al.( 2006) were the first to report the successful cultivation of the 
erythrocytic stage of Theileria uilenbergi. After testing numerous combinations of 
conditions, HL-1 was shown to be the best culture medium. Best growth was achieved 
with HL-1 supplemented with 25 mM HEPES, 2 mM ʟ-glutamine, 200 µM 
hypoxanthine, 0.02 mM bathocuproinedisulfonic acid disodium salt, 1 mM ʟ-cysteine, 
24 mM sodium bicarbonate, amphotericin B (2.5 µg/ml), gentamicin (50 µg/ml), 0.75% 
CDL and 20% sheep serum and incubation at 37°C under a humidified atmosphere of 
2% O2, 5% CO2, and 93% N2. The cultivation had a duration for over a year with a PPE 
of 3%, and with further optimization a higher PPE could possibly be obtained (Miranda 
et al., 2006).  
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Field isolates and laboratory-adapted parasite lines of B. bovis were cultured in 
vitro using a chemically defined medium (RPMI-1640) and Albumax II (1% w/v) in 
place of bovine serum. Additional supplements were 25 mM HEPES, 25 mM NaHCO3, 
penicillin 100 IU/ml, streptomycin 100 µg/ml, and amphotericin B 0.25 µg/ml. With 
these conditions, some B. bovis isolates directly from cattle that were unable to be 
cultivated in traditional serum-containing medium were able to be propagated. 
Modifications in culture volume as well as gas composition showed that a 600 µl culture 
in 24-well plate in atmosphere of 5% O2, 5% CO2, and 90% NO2 resulted in a higher 
PPE than other tested combinations, and supplementation with hypoxanthine led to 
improved parasitic growth as well (Jackson et al., 2001).  
It was recently observed that a low oxygen environment may not be required to 
continuously cultivate T. equi, a hemoparasite closely related to C. felis. Zweygarth and 
Josemans (2014) speculated that low oxygen tension at culture initiation may cause 
ʟ-cysteine to be liberated from an erythrocytic source, such as glutathione (GSH). This 
would suggest that culture initiation and cultivation of T. equi may rely more on the 
availability of ʟ-cysteine than the microaerophilic culture conditions (Zweygarth and 
Josemans, 2014).   
The continuous in vitro cultivation of C. felis has yet to be achieved. This has 
slowed the progress with the development of immunological assays (Snider et al., 2010) 
and vaccines against the parasite. The only way to study C. felis is through the use of 
naturally or experimentally infected cats. The establishment of C. felis in vitro cultures 
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would provide an unlimited source of the parasite for research as well as eliminate the 
dependence on animal use.  
ROLES OF VECTORS IN TRANSMISSION 
Ixodid ticks (Acari: Ixodidae) parasitize a broad range of vertebrate hosts 
worldwide (Bursali et al., 2010) and have been implicated in transmitting pathogens 
threatening to human and animal health (Sonenshine, 1991). These ticks feed a single 
time at each active stage of their life cycle. This feeding could occur on any vertebrate 
hosts from diverse habitats (Sonenshine, 1991).  
One common vertebrate host that has been implicated for being a reservoir of 
certain bacterial and protozoal pathogens is the white-tailed deer (WTD; Odocoileus 
virginianus) (Yabsley et al., 2002; Cantu et al., 2007; Allan et al., 2010; Nair et al., 
2014). They may not only potentially harbor certain pathogens, but they can also 
maintain tick populations (Lane et al., 1991). The most common ticks to parasitize WTD 
are of the genera Ixodes, Amblyomma, and Dermacentor (Davidson, 2006). Ticks of 
these genera are three-host ticks, in which they require a blood-meal from a different 
host to complete each stage of the life cycle (Allan, 2001). Ticks of Boophilus, now 
Rhipicephalus, were also commonly found across the range of white-tailed deer. These 
one-host ticks, however, have been eradicated from the U.S. but can be found in Texas 
and California within the quarantine zone along the Mexican border (Allan, 2001). 
These ticks of WTD also commonly infect other wildlife and livestock.  
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As with many species of birds, reptiles, and mammals, WTD participate in 
continuing the wildlife-tick cycle (Davidson and Nettles, 1997). White-tailed deer are 
the primary reproductive hosts of adult Ixodes scapularis (black-legged deer ticks). 
These ticks spread the Lyme disease bacterium, Borrelia burgdorferi (Tillett, 2010). 
Despite their presence in the I. scapularis cycle, WTD seem to have a larger role in the 
maintenance and transportation of infected ticks than serving as a reservoir for Lyme 
disease (Lane et al., 1991). 
Rhipicephalus (Boophilus) spp. ticks primarily feed on and infect cattle with 
B. bovis and B.  bigemina, the causative agents of Cattle Fever. It has been shown that 
other ungulates, such as WTD, can be additional hosts of infection (Pound et al., 2010).  
This could pose a challenge with maintaining the Cattle Tick Fever-free status in the 
U.S. (Holman et al., 2011). 
 Data from molecular and serological studies have indicated the presence of 
Babesia spp. in WTD in counties of south Texas (LaSalle and Webb) (Ramos et al., 
2010), central Texas (Tom Green) (Holman et al., 2011) and northern states of Mexico 
that border Texas (Cantu et al., 2007; Cantu et al., 2009). Cantu et al., 2007 studied the 
presence of B. bovis and B. bigemina in WTD in the states of Nuevo Leon and 
Tamaulipas, Mexico by specific nested PCR and indirect fluorescence antibody tests 
(IFAT) on 20 WTD blood samples. Nested PCR revealed 11 samples as B. bigemina 
positive, and four were positive for B. bovis. Subsequent sequences of amplicons were 
identical to B. bigemina and B. bovis (Rap 1) sequences in Genbank. Results of the IFAT 
showed antibodies formed against both pathogens in serum samples (Cantu et al., 2007).  
 37 
 
In another study, 457 WTD whole blood and serum samples were tested for 
B. bigemina and B. bovis using nested PCR and IFAT. A survey was also issued to each 
WTD ranch used in the study to gather information about management practices. Nested 
PCR revealed that 19 were B. bigemina positive, and six were B. bovis positive. The 
IFAT results were that 274 samples showed antibodies to B. bovis and 25 for 
B. bigemina. Statistical analysis of survey information varied with dependent variables, 
but three management factors (grazing system, habitat, and tick treatment) were 
associated with positive nested PCR for B. bigemina. Findings would suggest that WTD 
could serve as a reservoir for bovine babesiosis (Cantu et al., 2009).  
Ramos et al. (2010) found eight of 49 WTD samples from LaSalle County and 
two of 47 WTD samples from Webb County, Texas were PCR positive for B. bovis. 
Sequence analysis of subsequent cloning showed 99% identity with B. bovis 18S rRNA 
gene. However, the IFAT showed a poor seroreactivity to B. bovis (Ramos et al., 2010).  
In a following study, 25 WTD blood samples from Tom Green County, Texas 
were tested for B. bigemina and B. bovis (Holman et al., 2011). Three samples were PCR 
positive for B. bovis, as confirmed by ITS sequence analysis. Three samples were PCR 
positive for B. bigemina, but subsequent sequencing of cloned amplicons revealed only 
one WTD sample as B. bigemina positive. The neighbor-joining phylogenetic tree for 
18S rDNA sequences revealed a cluster of the WTD B. bovis sequences with two bovine 
B. bovis sequences and the WTD B. bigemina sequences with bovine B. bigemina 
sequences. The neighbor-joining phylogenetic tree for the rRNA ITS1-5.8S gene-ITS2 
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genomic region showed no separation between bovine and cervine B. bovis sequences 
(Holman et al., 2011).  
 It has been shown that A. americanum feed on WTD, and these WTD serve as 
reservoirs of pathogens carried by this tick (Kollars et al., 2000; Childs and Paddock, 
2003; Allan et al., 2010). Ehrlichia chaffeensis is transmitted by A. americanum, and 
WTD are thought to be the main reservoir responsible for this organism’s enzootic cycle 
(Allan et al., 2010). White-tailed deer naturally infected with Ehrlichia ewingii have 
been documented in several locations that correlate with the distribution of 
A. americanum (Yabsley et al., 2002). In addition, natural infections of Borrelia 
lonestari, vectored by A. americanum, has been reported in WTD in the southeastern 
U.S. (Moore et al., 2003). Amblyomma americanum is the primary vector of C. felis. 
With wild felids serving as reservoirs for C. felis and A. americanum being a 3-host tick, 
this could possibly lead to WTD as additional hosts in the sylvatic cycle of C. felis.  
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CHAPTER II  
EVALUATION OF CULTURE CONDITIONS FOR IN VITRO CULTIVATION 
OF THE ERYTHROCYTIC STAGE OF CYTAUXZOON FELIS 
 
INTRODUCTION 
 Cytauxzoon felis, a tick-borne protozoan hemoparasite, is harbored by wild 
felids, and its infection in domestic cats causes cytauxzoonosis. High fever, dehydration, 
anorexia, lethargy, anemia, and dyspnea may be manifestations of cytauxzoonosis 
(Greene et al., 2006; Meinkoth and Kocan, 2005), which often in the past culminated in 
death in nearly 100% of C. felis-infected cats (Brown et al., 2009). Some cats, however, 
survive this peracute infection,  while others may have a subclinical C. felis infection 
(Reichard et al., 2010).  
The pathophysiology of the disease is due to the schizogonous (tissue) phase of 
the parasite’s life cycle (Meinkoth and Kocan, 2005), in which schizonts of C. felis 
distend mononuclear phagocytes and occlude vessels (Snider et al., 2010). The 
widespread dissemination of vessels occluded by these schizont-infected cells can result 
in the formation of parasitic thrombi (Kier et al., 1987; Tarigo et al., 2013), which leads 
to multi-organ failure and death (Tarigo et al., 2013).  
The erythrocytic phase occurs when merozoites are released from the schizonts 
into the bloodstream and enter erythrocytes (Kocan et al., 1992), where they are referred 
to as piroplasms (Greene et al., 2006). Piroplasms asexually divide and infect new 
erythrocytes, resulting in erythroparasitemia. This merozoite stage is most exposed to the 
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host immune system (Miranda et al., 2006), which is advantageous for studies 
identifying antigenic proteins for diagnostics and vaccine development.  
Acquiring parasites for these types of studies involves using either naturally or 
experimentally infected cats. Ability to cultivate C. felis in vitro would eliminate the 
necessity of infecting cats and lead to a continual source of the parasite. The first 
reported C. felis cultures were used in producing antiserum needed to develop an indirect 
fluorescent antibody (IFA) test against the parasite (Shindel et al., 1978). Spleen and 
bone marrow cell suspensions from a moribund C. felis-infected cat were used to initiate 
the cultures. After five days in culture, the infected spleen and bone marrow cells were 
mixed with African green monkey kidney (Vero) cells and maintained for several 
passages. The cultures were then used to successfully immunize a cat against challenges 
of C. felis. Serum from this cat was collected and used as the antiserum for developing 
the IFA test (Shindel et al., 1978). However, Shindel et al. (1978) did not verify 
propagation of the organism through the subcultures, and there have been no subsequent 
reports of in vitro cultivation of C. felis. As a result, the conditions for continuous 
propagation of the erythrocytic phase of C. felis are yet to be described.  
However, the erythrocytic stage of a related hemoparasite, Babesia bovis, is 
cultivated in vitro using the microaerophilous stationary phase (MASP) system (Levy 
and Ristic, 1980).  In this technique a stationary layer of erythrocytes is overlaid with a 
buffered cell culture medium containing  25-55% adult bovine serum (Ristic and Levy, 
1981). Incubation in a sufficient depth of overlaying medium in an environment of 
enhanced carbon dioxide content, such as 5% CO2 and 95% humidified air, results in 
 41 
 
reduced oxygen tension in the erythrocyte layer (Levy and Ristic, 1980; Ristic and Levy, 
1981). Cultures supporting parasitic growth darken in color due to the oxygen 
consumption of the parasites as well as the maintenance of the erythrocytic hemoglobin 
in a deoxygenated state in the reduced oxygen tension (Ristic and Levy, 1981; Schuster, 
2002).  
A continuous C. felis culture system would be advantageous in further 
developing immunological assays and vaccines, as well as assaying potential therapeutic 
agents against the parasite (Snider et al., 2010). The objective of this study was to 
determine the optimal conditions for in vitro cultivation of the erythrocytic stage of 
C. felis based on a MASP system. 
MATERIALS AND METHODS 
Blood Samples 
 Cytauxzoon felis-infected blood and uninfected donor blood from domestic cats 
for this study were provided under institutionally approved animal use protocols (Mason 
Reichard, Department of Veterinary Pathobiology, Oklahoma State University, 
Stillwater, OK; Animal Care and Use Protocol, “Feline cytauxzoonosis: Establishment 
of continuous parasites cultures” Protocol Number: VM1121; Leah A. Cohn, 
Department of Small Animal Internal Medicine, Veterinary Medicine Teaching Hospital, 
University of Missouri, Columbia, MO;  Animal Care and Use Protocol, “C. felis source 
cats” Protocol Number 7301). Normal adult guinea pig, individual male feline, and 
hamster blood were obtained from a commercial source (BioChemed Services, Inc., 
Winchester, VA).  
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Upon receipt, the blood samples were centrifuged at 330 × g for 15 min. The 
supernatant and buffy coat were removed and discarded. If the resulting packed red 
blood cells (RBC) volume was ≥ 5 ml, then the RBC were washed 3 times in 5 volumes 
of Minimum Essential Medium (MEM; Mediatech, Inc., Manassas, VA) or RPMI-1640 
medium (Mediatech, Inc.) by centrifugation at 330 × g for 10 minutes. If the volume was 
< 5 ml, then the cells were similarly washed 3 times by centrifugation at 870 × g for 3 
min in a microfuge. After the final wash, the supernatant was removed. Washed RBC 
(both infected and uninfected) were either used immediately or stored at 4°C in an equal 
volume of Puck’s saline glucose with 10% extra glucose (W/V) (PSG+G) until use for a 
maximum period of 4 weeks. The percentage of parasitized erythrocytes (PPE) was 
determined in the washed C. felis infected RBC (iRBC) by counting at least 1,000 total 
RBC on Giemsa-stained smears.   
Initiation and Maintenance of Cultures 
Cultures were initiated in duplicate wells of 24-, 48-, or 96-well plates in final 
volumes of 1.1 ml, 800 µl, and 200 µl, respectively, with 10% iRBC (V/V) in various 
media (Tables 1-4). The initial PPE of the cultures ranged from undetectable to 10%. 
Some cultures were initiated with a varying initial PPE in 48-well plate (Table 5). The 
iRBC with approximately 40% PPE were diluted with normal uninfected cat RBC 
(donor RBC) to yield final PPE of 10%, 5%, and 1% in the cultures. 
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Table 1. Hl-1 medium and various sera and supplement combinations with inclusion of 
antibiotic/antimycotic (Ab/Am)a tested for in vitro cultivation of Cytauxzoon felis. The number of cultures 
initiated (N) are shown. Sera tested were fetal bovine serum (FBS), feline serum (FS), calf serum with iron 
(CaSI), and others as indicated.  Supplements tested include sodium hypoxanthine (Hypo), thymidine 
(Thym), AlbuMAX I® (Alb), HB 101 supplement (2% V/V prepared according to manufacturer’s 
recommendation) (HB 101), 2 mM ʟ-glutamine (ʟ-glut), bovine serum albumin (BSA), and chemically 
defined lipids (CDL at 0.375 or 0.75% V/V).   
 
N Serum Supplements 
Hypo 
(mM) 
Thym 
(mM) 
ʟ-glut 
(mM) 
Alb 
(mg/ml) 
HB101 
(%) 
BSA 
(mg/ml) 
CDL 
(%) 
3 40% FBS 0.2 0.032 2 1 2 - - 
26 20% FBS 0.2 0.032 2 1 2 - - 
6 20% FBSb 0.2 0.032 2 1 2 - - 
1 20% FBS 0.2 0.032 2 - 2 - - 
1 10% FS/10% FBS - - 2 - - - - 
1 30% FS - - 2 - - - - 
1 40% FS - - 2 - - - - 
1 10% FS/10% FBS 0.2 0.032 2 1 2 - - 
1 10% FS/10% FBS - - - - - - - 
8 20% FS/20% FBSc 0.2 0.032 2 1 2 - - 
1 30% FS 0.2 0.032 2 1 2 - - 
2 20% CaSI 0.2 0.032 2 1 2 - - 
2 40% CaSI 0.2 0.032 2 1 2 - - 
4 40% FS 0.2 0.032 2 1 2 - - 
1 40% FS 0.2 0.032 2 1 2 - 0.75 
1 40% FS 0.2 0.032 2 - 2 - - 
3 40% FS 0.2 0.032 2 0.5 2 - - 
1 40% FS 0.2 0.032 2 1 2 12.5 - 
1 40% FS 0.2 0.032 2 1 2 - 0.375 
4 40% FS 0.2 0.032 2 0.5 2 - 0.375 
1 40% FS 0.2 0.032 2 0.5 2 12.5 - 
15 20% rabbit serumd 0.2 0.032 2 1 2 - - 
1 20% FS 0.2 0.032 2 1 2 - - 
1 20% hamster serum 0.2 0.032 2 1 2 - - 
1 20% rat serum 0.2 0.032 2 1 2 - - 
2 20% mouse serum 0.2 0.032 2 1 2 - - 
1 20% guinea pig serum 0.2 0.032 2 1 2 - - 
3 20% FS 0.2 0.032 2 1 2 - - 
1 10% FS/10% FBS 0.2 0.032 2 - 2 25 - 
1 10% FS/10% FBS 0.2 0.032 2 - 2 - - 
1 10% FS/10% FBS 0.2 0.032 2 - 2 25 0.75 
2 10% FBSe 0.2 0.032 2 1 2 - - 
2 10% FBS f 0.2 0.032 2 1 2 - - 
1 20% FBS 0.2 0.032 2 1 2 - 0.75 
a Final concentration of 200 µg/ml streptomycin, 200 U/ml penicillin, 0.5 µg/ml Fungizone  
b Histopaque purified. 
c Two different lots of feline serum were tested. 
d Four different lots of rabbit serum were tested.  
e Cultured with a feeder cell layer of baby hamster kidney cells. 
f Utilized conditioned media from cultured baby hamster kidney cells. 
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Table 2. HL-1 media combinations tested with no antibiotic/antimycotic added.  The number of 
cultures initiated (N) are shown.  Unless stated otherwise, the medium included 2 mM ʟ-glutamine 
(ʟ-glut), 1 mg/ml AlbuMAX I® (Alb), 0.2 mM sodium hypoxanthine (Hypo) and 0.032 mM 
thymidine (Thym), and 2% HB101 (V/V) in a total volume of 800 µl in 48-well plates. Sera tested 
were fetal bovine (FBS), feline (FS), equine (ES), and calf serum with iron (CaSI). Bovine serum 
albumin (BSA), chemically defined lipids (CDL), Nutridoma-CS (Nutri), and ʟ-glutathione (GSH) 
were tested as indicated. 
 
N Serum Supplements  
Hypo 
(mM) 
Thym 
(mM) 
ʟ-glut 
(mM) 
Alb 
(mg/ml) 
HB 101 
(%) 
BSA 
(mg/ml) 
CDL 
(%) 
Nutri 
(%) 
GSH 
(µg) 
2 20% FS 0.2 0.032 2 1 2 - - - - 
2 20% CaSI 0.2 0.032 2 1 2 - - - - 
21 20% FBSa 0.2 0.032 2 1 2 - - - - 
2 20% FBS 0.2 0.032 2 - 2 25 - - - 
1 20% equine 
serum 
0.2 0.032 2 1 2 - - - - 
1 40% FBS 0.2 0.032 2 - 2 25 0.75 - - 
2 20% FBS 0.2 0.032 2 - 2 25 0.75 - - 
3 20% FBS a,b 0.2 0.032 2 1 2 - - - - 
3 20% FBS a,c 0.2 0.032 2 1 2 - - - - 
3 20% FBS a,d 0.2 0.032 2 1 2 - - - - 
3 20% FBS 0.2 0.032 - 1 2 - - - - 
3 20% FBS 0.3 0.048 - 1 2 - - - - 
1 20% FBS e 0.3 0.048 2 1 2 - - - - 
1 20% FBS 0.2 0.032 2 1 2 - - 1 - 
3 20% FBS 0.2 0.032 2 1 2 - - 2 - 
1 None 0.2 0.032 2 1 2 - - 2 - 
2 20% FBS 0.2 0.032 2 1 2 - - - 300 
1 20% FBS 0.2 0.032 2 1 2 - - - 600 
1 20% FBS 0.2 0.032 2 1 2 - - - 900 
4 20% FBSf - - - - - - - - - 
a Two different lots of fetal bovine serum were tested. 
b 1.2 ml culture volume in 48-well plate. 
c 0.9 ml culture volume in 48-well plate. 
d 0.6 ml culture volume in 48-well plate. 
e Erythrocytes underwent a hypotonic lysis.  
f  Supplemented with additional 5 mg/ml glucose. 
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Table 3. Various combinations of medium, sera, and supplements tested for in vitro cultivation of Cytauxzoon felis. The number of cultures 
initiated (N) are shown. Media tested were HEPES-buffered Ultradoma (UltraD) without ʟ-glutamine (ʟ-glut) (Lonza, Walkersville, MD), 
RPMI-1640 (RPMI) with HEPES (Mediatech, Inc.,Manassas, VA) and without HEPES (Lonza), Minimal Essential Medium (MEM) without 
HEPES (Mediatech), and BSK-II (Millipore, Kankakee, IL). HEPES buffer was added to all media not containing this buffer in the formulation, 
as indicated. Sera included fetal bovine serum (FBS), feline serum (FS), calf serum with iron (CaSI), or rabbit serum (RS). Supplements 
included sodium hypoxanthine (Hypo), thymidine (Thym), 1 mg/ml AlbuMAX I® (Alb), HB 101 supplement (HB 101) (2% V/V prepared 
according to manufacturer’s recommendation), 2 mM ʟ-glut, bovine serum albumin (BSA), chemically defined lipids (CDL at 0.375 or 0.75% 
V/V), 1X MEM Non-essential amino acids (NEAA), Nutridoma-CS (Nutri), and ʟ-glutathione (GSH). BSK-II media consisted of 50 µg/ml of 
rifampicin, 100 µg/ml of phosphomycin, and 0.25 µg/ml of Amphotericin B (Fungizone). No antibiotic/antimycotic was used in the other 
media.  
 
N Medium Serum Supplements 
Hypo 
(mM) 
Thym 
(mM) 
ʟ-glut 
(mM) 
Alb 
(mg/ml) 
HB 101 
(%) 
BSA 
(mg/ml) 
Ab/Am CDL 
(%) 
NEAA Nutri 
(%) 
GSH 
(µg) 
6 UltraD 20% FBSa 0.2 0.032 2 1 2 - - - - - - 
2 RPMIb 40% FS - - - - - - - - - - - 
2 RPMIb 40% FBS - - - - - - - - - - - 
2 RPMIb 40% CaSI - - - - - - - - - - - 
2 RPMI 40% FBS 0.2 0.032 2 1 - - - - - - - 
2 RPMI 40% FS 0.2 0.032 2 1 - - - - - - - 
2 RPMI 20% CaSI - - - - - - - - - - - 
4 RPMI 20% FBS - - - - - - - - - - - 
1 RPMIc 20% FBS 0.28 - - - - 40 - - - - - 
1 RPMIc 20% FBS 0.28 - - - - 40 - - - - 300 
1 RPMIc 20% FBS 0.28 - - - - 40 - - - - 600 
1 RPMIc 20% FBS 0.28 - - - - 40 - - - - 900 
1 RPMI 20% FBS 0.2 0.032 2 1 - - - - - 2 - 
1 RPMI 10% FBS 0.2 0.032 2 1 - - - - - 2 - 
2 RPMI 20% FBS 0.2 0.032 2 1 - - - - - 1 - 
1 RPMIc None 0.2 - - 1 - - - - - - - 
1 RPMIc 20% FBS 0.2 - - 1 - - - - - - - 
1 RPMIc 40% FBS 0.2 - - 1 - - - - - - - 
1 RPMIc 10% 
equine 
serum 
0.1 - - - - - - - - - - 
3 RPMIc 10% FBSd - - - - - - - - - - - 
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Table 3. Continued 
 
N Medium Serum Supplements 
Hypo 
(mM) 
Thym 
(mM) 
ʟ-glut 
(mM) 
Alb 
(mg/ml) 
HB 101 
(%) 
BSA 
(mg/ml) 
Ab/Am CDL 
(%) 
NEAA Nutri 
(%) 
GSH 
(µg) 
2 MEM None - - - - - - - - - - - 
2 MEM None - - - - - - - - 1X - - 
1 MEM 20% FBS 0.2 0.032 - 1 2 - - - 1X - - 
2 MEMb 40% FBS 0.2 0.032 - 1 2 - - - 1X - - 
2 MEM 20% FS - - - - - - - - - - - 
2 MEM 20% FBS - - - - - - - - - - - 
2 MEM 20% CaSI - - - - - - - - - - - 
8 BSK-II 20% FBS - - - - - 50 + - - - - 
8 BSK-II 20% RS - - - - - 50 + - - - - 
a Two lots tested. 
b 20mM HEPES added. 
c 25mM HEPES added. 
d Contained 20mg/ml glucose. 
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Table 4. HL-1 medium supplemented with 2 mM ʟ-glutamine (ʟ-glut), 20% fetal bovine serum 
(FBS), 1 mg/ml AlbuMAX I® (Alb) or feline serum albumin, 2% HB101 (V/V), and varying 
concentrations of hypoxanthine (Hypo) and thymidine (Thym) were tested for the in vitro 
cultivation of Cytauxzoon felis . A 1:2 or 1:4 initial subculture ratio was employed in some 
cultures. The media contained no antibiotic/antimycotic. The number of cultures initiated (N) are 
shown.  
N Serum Supplements 1:2 Ratio 1:4 
Ratio 
Hypo 
(mM) 
Thym 
(mM) 
ʟ-glut 
(mM) 
Alb 
(mg/ml) 
HB 
101 
(%) 
1 20% FBS 0.1 - 2 1 2 - + 
1 20% FBS 0.2 - 2 1 2 - + 
1 20% FBS 0.3 - 2 1 2 - + 
1 20% FBS 0.4 - 2 1 2 - + 
1 20% FBS 0.2 0.032 2 1 2 - + 
1 20% FBS - - 2 1 2 - + 
2 20% FBS 0.1 - 2 1 2 - - 
2 20% FBS 0.2 - 2 1 2 - - 
2 20% FBS 0.3 - 2 1 2 - - 
3 20% FBS 0.4 - 2 1 2 - - 
1 20% FBS 0.1 - 2 1 2 + - 
1 20% FBS 0.2 - 2 1 2 + - 
1 20% FBS 0.3 - 2 1 2 + - 
1 20% FBS 0.4 - 2 1 2 + - 
1 20% FBS 0.2 0.032 2 1 2 + - 
1 20% FBS - - 2 1 2 + - 
1 20% FBS 0.5 - 2 1 2 - - 
11 20% FBSa 0.3 0.048 2 1 2 - - 
1 20% FBS 0.4 0.064 2 1 2 - - 
1 20% FBS 0.3 0.048 2 1b 2 - - 
1 20% FBS 0.3c 0.048 2 1 2 - - 
a Used in both cat and cat/horse mixed erythrocytes cultures.  
b 1 mg/ml feline serum albumin replaced Albumax I. 
c HT increased from 0.2mM, 0.032 mM to 0.3mM, 0.048 mM seven days post initiation.  
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Table 5. Varying initial percentage of parasitized erythrocytes (PPE) and/or 1:2 weekly subcultures 
evaluated in Cytauxzoon felis cultures. Media used were HL-1, RPMI-1640 (RPMI) with 25 mM 
HEPES (Mediatech, Inc.,Manassas, VA), and Minimal Essential Medium (MEM) without HEPES 
(Mediatech), and all were supplemented with 1 mg/ml AlbuMAX I®, 0.2 mM sodium hypoxanthine 
and 0.032 mM thymidine, and either fetal bovine serum (FBS) or feline serum (FS). Additional 
supplements consisted of HB 101 supplement (HB 101) (2% V/V prepared according to 
manufacturer’s recommendation), 2 mM ʟ-glut, chemically defined lipids (CDL at 0.75% V/V), and 
1X MEM Non-essential amino acids (NEAA). An amount of 20mM HEPES was added to MEM 
medium. Some media included 200 µg/ml streptomycin, 200 U/ml penicillin, 0.5 µg/ml Fungizone 
(antibiotic/antimycotic, Ab/Am), and other media contained no Ab/Am. The number of cultures 
initiated (N) are shown.  
N Medium Serum Supplements  Ab/
Am 
Weekly 
Subculture    HB 
101(%) 
NEAA ʟ-glut 
(mM) 
CDL 
(%) 
4 HL-1 40% FS 2 - 2 - +  + 
2 HL-1 40% FBS 2 - 2 - +  + 
4 HL-1 40% FBS 2 - 2 0.75 +  + 
2 HL-1a 20% FBS 2 - 2 - -  + 
1 HL-1b 20% FBS 2 - 2 - -  + 
1 HL-1c 20% FBS 2 - 2 - -  + 
1 HL-1 40% FS 2 - 2 0.75 +  + 
1 HL-1a 20% FBS 2 - 2 - -  - 
1 HL-1c 20% FBS 2 - 2 - -  - 
1 RPMIa,d 40% FBS - - 2 - -  - 
1 RPMIc 40% FBS - - 2 - -  - 
1 HL-1c 20% FBS 2 - 2 - -  - 
3 HL-1b,d 20% FBS 2 - 2 - -  - 
1 RPMIb,d 40% FBS - - 2 - -  - 
1 MEMb,d 40% FBS 2 1X - - -  - 
1 MEMc 40% FBS 2 1X - - -  - 
1 HL-1a,d 20% FBS 2 - 2 - -  - 
1 RPMIa,d 40% FBS - - 2 - -  - 
1 MEMa,d 40% FBS 2 1X - - -  - 
1 MEMa 40% FBS 2 1X - - -  - 
a Used 1% initial PPE. 
b Used 5% initial PPE. 
c Used 10% initial PPE. 
d Contained no hypoxanthine and thymidine. 
  
 
 
 
 
 49 
 
The culture medium was replenished daily by removing 900 µl, 700 µl, or 140 µl 
spent media from wells of 24-, 48-, or 96-well plates, respectively, without disturbing 
the layer of settled RBC, and then replacing with an equivalent measure of fresh 
medium. Subcultures were performed at a 1:2 or 1:4 split ratio as needed. The medium 
was replaced as described above and the cells gently resuspended. The appropriate 
aliquot was transferred to a new well and fresh medium and donor RBC were added to 
achieve the final volume (10% RBC). If the PPE was insufficient to subculture, fresh 
RBC (50 µl, 40 µl, and 10 µl per well in 24-, 48-, or 96-well plates, respectively) were 
added weekly. Trials of blind passages at a 1:2 split ratio at weekly intervals were 
performed (Table 5). The cultures were incubated in a  humidified gas atmosphere of 5% 
CO2, 2% oxygen, and 93% nitrogen at 37°C in a modular incubator chamber (Billups-
Rothenberg, Inc., Del Mar, CA), except for trials at 39°C or a gas atmosphere of 5% 
CO2, 5% O2, and 90% N2 (Table 6). 
HL-1 medium (Lonza Walkersville, Inc., Walkersville, MD) supplemented with 
a final concentration of 2 mM ʟ-glutamine, 20% FBS (V/V), 1 mg/ml AlbuMAX I®  
(Invitrogen, Carlsbad, CA), 0.2 mM sodium hypoxanthine and 0.032 mM thymidine 
(HT), 2% HB101 (V/V) with or without 200 µg/ml streptomycin, 200 U/ml penicillin, 
and 50 µg/ml Fungizone (Antibiotic/Antimycotic [Ab/Am]; Gibco BRL, Grand Island, 
NY), served as the reference medium for comparative studies (Tables 1 and 2).  
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Table 6. Gas mixtures (5% CO2, 2% O2, 93% N2 and 5% CO2, 2% O2, 90% N2), incubation 
temperatures (37°C and 39°C), and varying culture volumes (0.6ml, 0.8ml, 0.9ml, and 1.2 ml) in 48-
well plates were evaluated in Cytauxzoon felis cultures. HL-1 medium and RPMI-1640 without 
HEPES (Lonza, Walkersville, MD) supplemented with varying concentrations of hypoxanthine 
(Hypo) and thymidine (Thym), 2 mM ʟ-glutamine (ʟ-glut), fetal bovine serum (FBS), 1 mg/ml 
AlbuMAX I® (Alb), and 2% HB101 (V/V) were used in the cultures. The media contained no 
antibiotic/antimycotic. The number of cultures initiated (N) are shown.  
 
N Medium Serum Supplements O2 
(%) 
Temp. 
(°C) 
Volume 
(ml) Hypo 
(mM) 
Thym 
(mM) 
ʟ-glut 
(mM) 
Alb 
(mg/ml) 
HB 
101 
(%) 
1 HL-1 20% FBS 0.2 0.032 2 1 2 5 37 0.8 
1 HL-1 20% FBS 0.3 0.048 2 1 2 5 37 0.8 
1 HL-1 20% FBSa - - - - - 5 37 0.8 
2 RPMIb 40% FBSc 0.2 - - 1 - 2 37 1.2 
2 RPMIb 40% FBSc 0.2 - - 1 - 2 37 0.9 
2 RPMIb 40% FBSc 0.2 - - 1 - 2 37 0.6 
2 RPMIb 40% FBSc 0.2 - - 1 - 5 37 1.2 
2 RPMIb 40% FBSc 0.2 - - 1 - 5 37 0.9 
2 RPMIb 40% FBSc 0.2 - - 1 - 5 37 0.6 
3 HL-1 20% FBSc 0.2 0.032 2 1 2 5 37 1.2 
3 HL-1 20% FBSc 0.2 0.032 2 1 2 5 37 0.9 
3 HL-1 20% FBSc 0.2 0.032 2 1 2 5 37 0.6 
1 RPMIb None 0.2 - - 1 - 5 37 0.8 
1 RPMIb 20% FBS 0.2 - - 1 - 5 37 0.8 
1 RPMIb 40% FBS 0.2 - - 1 - 5 37 0.8 
1 HL-1 20% FBS 0.2 0.032 2 1 2 2 39 0.8 
1 HL-1 20% FBS 0.3 0.048 2 1 2 2 39 0.8 
1 HL-1 20% FBSd 0.2 0.032 2 1 2 2 39 0.8 
1 HL-1 20% FBSe 0.2 0.032 2 1 2 2 39 0.8 
a Supplemented with additional 5 mg/ml glucose. 
b 25 mM HEPES added. 
c Two different lots of fetal bovine serum were tested. 
d Contained 300µg ʟ-glutathione. 
e Contained 2% Nutridoma-CS. 
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Feeder layers of baby hamster kidney (BHK) cells and conditioned medium from 
the cultures were evaluated for their ability to support the propagation of C. felis (Table 
1). Cryopreserved BHK cells were thawed at 37°C and transferred to 25-cm2 culture 
flasks containing 6 ml of HL-1 medium supplemented with 10% FBS (V/V), 2 mM ʟ-
glutamine and Ab/Am (HL10) and incubated at 37°C in a humidified atmosphere of 5% 
CO2 in air. When a confluent monolayer was reached, the medium was removed and the 
cell layer rinsed twice with 2 ml Dulbecco’s phosphate-buffered saline (PBS). The cells 
layer was trypsinized at 37°C to facilitate detachment. After detachment, 4 ml HL10 was 
added, and the cells resuspended. The cell suspension (3 ml) was added to duplicate 
wells of a 6-well plate. The BHK cells were allowed to adhere for 1 h, and the medium 
was removed and replaced. Cell culture inserts (Falcon Translucent Polyethylene 
Terephthalate Cell Culture Insert, Becton Dickinson Labware, Franklin Lakes, NJ) were 
placed in each well and 2 ml of fresh HL10 and 100 µl of packed iRBC were added 
inside the insert. At 48 h intervals, 4 ml medium was removed and replaced. The 
cultures were incubated at 37°C in a humidified 5% CO2 in air atmosphere. 
Conditioned HL10 medium was collected daily from monolayer cultures of BHK 
cells and centrifuged at 870 × g for 3 min to remove any BHK cells. Conditioned 
medium was tested on C. felis cultured in 96-well plates. Each well received 140 µl of 
conditioned medium daily as described above for culture maintenance.  
Density gradient cell separation with Histopaque®-1077 (Sigma Chemical Co., 
St. Louis, MO) was evaluated in a few cultures as a means of more efficiently 
eliminating white blood cells from erythrocyte preparations (Table 1). Three milliliters 
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of C. felis-infected whole blood was layered onto 3 ml of 25°C Histopaque-1077 and 
centrifuged at 330 × g for 30 min. After centrifugation, the resultant layers were 
removed, and the RBC were washed as described above.  
Since iRBC (such as B. bovis iRBC) were more resistant to hypotonic saline 
solution, a differential lysis resulted in a higher concentration of iRBC (Wright, 1990). 
In order to increase the percentage of C. felis iRBC, a hypotonic lysis technique prior to 
initiation was implemented prior to culture initiation (Table 2). The iRBC were washed 
as described above. Five milliliters of 0.475% (W/V) NaCl solution was added to 1 ml of 
iRBC, mixed gently, and allowed to sit at 25°C for 5 min. The mixture was centrifuged 
at 330 × g for 5 min followed by removal of supernatant. The resultant iRBC were 
subsequently used in culture.  
Erythrocytes from different species (cat, rabbit, or hamster) were tested as donor 
cells for C. felis in vitro as shown in Table 7. The RBC were washed using the wash 
protocol stated above and introduced to the cultures at the time of subculture and/or 
RBC replenishment.  
Thin smears of cultured RBC were used to monitor parasitic growth and evaluate 
the culture conditions daily. The smears were stained 1:20 with Giemsa (Accustain, 
Sigma, St. Louis, MO) and examined by microscopy under oil immersion at 1000X.  
RBC containing C. felis piriforms (tetrads, singles, and multiples) in a total of 1000 RBC 
were counted to calculate the PPE. 
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Table 7. Cat, rabbit, or hamster donor normal erythrocytes were tested in Cytauxzoon felis 
cultures (total volume of 800 µl in 48-well plates) as shown. The medium was HL1 with 2 mM 
ʟ-glutamine, 20% serum (RS, rabbit serum; FS, feline serum; FBS, fetal bovine serum), 1 mg/ml 
AlbuMAX I® (Alb), and 2% HB101 (V/V)) supplemented with hypoxanthine (Hypo) and 
thymidine (Thym) as shown, with no antibiotic/antimycotic. 
 
Donor  Supplements  
Erythrocytes Serum Hypo 
(mM) 
Thym 
(mM) 
ʟ-glutamine 
(mM) 
Albumax 
(mg/ml) 
HB 101 
(%) 
Rabbit 20% FBS 0.2 0.032 2 1 2 
Hamster 20% FBS 0.2 0.032 2 1 2 
Rabbit 20% RS 0.2 0.032 2 1 2 
Rabbit 20% FBS 0.3 0.048 2 1 2 
Hamster 20% FBS 0.3 0.048 2 1 2 
Cat 20% FS 0.3 0.048 2 1 2 
Rabbit 20% RS 0.3 0.048 2 1 2 
 
 
 
RESULTS 
A total of 332 C. felis erythrocytic stage cultures were initiated during this study. 
The minimum and maximum duration of cultures were 2 and 140 days, respectively, 
with an average of 32 days. Five cultures were subcultured 4 times, the maximum level 
achieved. The PPE maintained in the cultures ranged from undetectable to 1.1%.  
One hundred two cultures were initiated using HL-1 medium with inclusion of 
antibiotic/antimycotic (Ab/Am) and various sera and supplement combinations. One 
culture was maintained for 140 days, which was the longest duration achieved. Fifteen 
cultures underwent a subculture. The PPE maintained in the cultures ranged from 
undetectable to 0.02% (Table 8). 
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Table 8. Results of the representative Cytauxzoon felis culture of the cultures of HL-1 medium with antibiotic/antimycotic (Ab/Am)a and 
various sera and supplement combinations tested. Duration of the culture (Days), the PPE at initiation (Initial PPE), average PPE during 
maintenance (Maintained PPE) (cultures with undetectable parasitemias for most of culture duration are indicated as low), and subculture 
level attained are shown. Sera tested were fetal bovine serum (FBS), feline serum (FS), calf serum with iron (CaSI), and others as 
indicated. Supplements tested include sodium hypoxanthine (Hypo), thymidine (Thym), AlbuMAX I® (Alb), HB 101 supplement (2% 
V/V prepared according to manufacturer’s recommendation) (HB 101), 2 mM ʟ-glutamine (ʟ-glut), bovine serum albumin (BSA), and 
chemically defined lipids (CDL at 0.375 or 0.75% V/V).  
 
Days Initial 
PPE (%) 
Maintained 
PPE (%) 
Subculture 
Level 
Serum Supplements 
Hypo 
(mM) 
Thym 
(mM) 
ʟ-glut 
(mM) 
Alb 
(mg/ml) 
HB101 
(%) 
18 0.2 0.006 - 40% FBS 0.2 0.032 2 1 2 
108 0.5 0.01 1 20% FBS 0.2 0.032 2 1 2 
94 0.3 0.007 1 20% FBSb 0.2 0.032 2 1 2 
84 0.2 0.005 - 20% FBS 0.2 0.032 2 - 2 
59 0.2 0.003 - 10% FS/10% FBSc - - 2 - - 
59 0.2 0.005 - 30% FSc - - 2 - - 
59 0.2 0.003 - 40% FSc - - 2 - - 
59 0.2 0.005 - 10% FS/10% FBS 0.2 0.032 2 1 2 
82 0.3 0.004 - 10% FS/10% FBSc,d - - - - - 
63 0.4 0.008 1 20% FS/20% FBSe 0.2 0.032 2 1 2 
84 0.2 0.006 - 30% FS 0.2 0.032 2 1 2 
32 0.2 0.006 - 20% CaSI 0.2 0.032 2 1 2 
11 low low - 40% CaSI 0.2 0.032 2 1 2 
140 0.2 0.02 1 40% FS 0.2 0.032 2 1 2 
18 0.2 0.006 - 40% FS 0.2 0.032 2 1 2 
18 low low - 40% FS 0.2 0.032 2 - 2 
31 0.2 0.006 - 40% FS 0.2 0.032 2 0.5 2 
18 0.2 0.006 - 40% FS 0.2 0.032 2 1 2 
18 0.2 0.006 - 40% FS 0.2 0.032 2 1 2 
28 0.2 0.01 - 40% FS 0.2 0.032 2 0.5 2 
18 0.2 0.006 - 40% FS 0.2 0.032 2 0.5 2 
84 0.5 0.007 - 20% rabbit serumf 0.2 0.032 2 1 2 
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Table 8. Continued.  
 
Days Initial 
PPE (%) 
Maintained 
PPE (%) 
Subculture 
Level 
Serum Supplements 
 Hypo 
(mM) 
Thym 
(mM) 
ʟ-glut 
(mM) 
Alb 
(mg/ml) 
HB101 
(%) 
 
113 0.2 0.01 1 20% FSe 0.2 0.032 2 1 2 
33 0.2 0.006 - 20% hamster serum 0.2 0.032 2 1 2 
100 0.6 0.01 1 20% rat serum 0.2 0.032 2 1 2 
80 0.2 0.004 - 20% mouse serum 0.2 0.032 2 1 2 
33 0.2 0.006 - 20% guinea pig serum 0.2 0.032 2 1 2 
82 0.4 0.006 - 10% FS/10% FBS 0.2 0.032 2 1 2 
84 0.2 0.006 - 10% FS/10% FBS 0.2 0.032 2 - 2 
84 0.2 0.006 - 10% FS/10% FBS 0.2 0.032 2 - 2 
14 low low - 10% FBSg 0.2 0.032 2 - 2 
24 0.5 0.04 - 10% FBSh 0.2 0.032 2 1 2 
73 0.6 0.08 - 20% FBS 0.2 0.032 2 1 2 
a Final concentration of 200 µg/ml streptomycin, 200 U/ml penicillin, 0.5 µg/ml Fungizone. 
b Histopaque purified. 
c Contained no 2% HB101. 
d Contained no added 2mM ʟ-glut. 
e Two different lots of feline serum were tested. 
f Four different lots of rabbit serum were tested. 
g Cultured with a feeder cell layer of baby hamster kidney cells. 
h Utilized conditioned media from cultured baby hamster kidney cells.
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Sixty cultures were initiated using HL-1 medium with various sera and 
supplements in the absence of Ab/Am. One culture was maintained for 103 days. Of 
these cultures, 31 were subcultured, and the maximum subculture level achieved was 
four. The PPE maintained in the cultures ranged from undetectable to 0.02% (Table 9). 
Sixty-six cultures were initiated with various sera, supplement combinations, and 
various media, which excluded the HL-1 medium. A maximum duration of 50 days was 
achieved with one culture. Nineteen cultures were subcultured, and the maximum 
subculture level achieved was two. The PPE maintained in the cultures ranged from 
undetectable to 0.01% (Table 10). 
Thirty-six cultures were initiated using supplemented HL-1 medium without 
Ab/Am and varying concentrations of hypoxanthine and thymidine. One culture was 
maintained for 70 days. A subculture was attained in 29 cultures, and the maximum 
subculture level achieved was four. The PPE maintained in the cultures ranged from 
undetectable to 0.02% (Table 11).  
Using a varying initial PPE and/or 1:2 weekly subculture, 30 cultures were 
initiated with various media, either FBS or FS, and various other supplements. One 
culture was maintained for 84 days. Blind, 1:2 weekly subculture were performed on 15 
cultures, and passage 10 was the highest attained. The remaining 15 cultures all 
underwent at least one subculture, in which a 4th subculture passage was the highest 
reached. The PPE maintained in the cultures ranged from undetectable to 1.1% (Table 
12).
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Table 9. Results of the representative Cytauxzoon felis culture of the cultures of HL-1 medium without antibiotic/antimycotic (Ab/Am) and various sera and 
supplement combinations tested. Duration of the culture (Days), the PPE at initiation (Initial PPE), average PPE during maintenance (Maintained PPE) 
(cultures with undetectable parasitemias for most of culture duration are indicated as low), and subculture level attained are shown. Unless stated otherwise, the 
medium included 2 mM ʟ-glutamine (ʟ-glut), 1 mg/ml AlbuMAX I® (Alb), 0.2 mM sodium hypoxanthine (Hypo) and 0.032 mM thymidine (Thym), and 2% 
HB101 (V/V) in a total volume of 800 µl in 48-well plates. Sera tested were fetal bovine (FBS), feline (FS), equine (ES), and calf serum with iron (CaSI). 
Bovine serum albumin (BSA), chemically defined lipids (CDL), Nutridoma-CS (Nutri), and ʟ-glutathione (GSH) were tested as indicated. 
 
Days Initial PPE 
(%) 
Maintained 
PPE (%) 
Subculture 
Level 
Serum  Supplements  
Hypo 
(mM) 
Thym 
(mM) 
ʟ-glut 
(mM) 
Alb 
(mg/ml) 
CDL 
(%) 
Nutri 
(%) 
GSH 
(µg) 
39 0.2 0.01 1 20% FS 0.2 0.032 2 1 - - - 
10 low low - 20% CaSI 0.2 0.032 2 1 - - - 
103 0.5 0.02 4 20% FBSa 0.2 0.032 2 1 - - - 
53 0.5 0.02 1 20% FBSb 0.2 0.032 2 - - - - 
10 low low - 20% equine serum 0.2 0.032 2 1 - - - 
32 0.2 0.01 - 40% FBSb 0.2 0.032 2 - 0.75 - - 
36 0.1 0.01 1 20% FBSb 0.2 0.032 2 - 0.75 - - 
38 0.2 0.01 2 20% FBS a,c 0.2 0.032 2 1 - - - 
27 0.2 0.01 2 20% FBS a,d 0.2 0.032 2 1 - - - 
35 0.2 0.01 1 20% FBS a,e 0.2 0.032 2 1 - - - 
31 0.1 0.006 - 20% FBS 0.2 0.032 - 1 - - - 
57 0.2 0.007 - 20% FBS 0.3 0.048 - 1 - - - 
24 low low - 20% FBSf 0.3 0.048 2 1 - - - 
14 low low - 20% FBS 0.2 0.032 2 1 - 1 - 
49 0.5 0.006 1 20% FBS 0.2 0.032 2 1 - 2 - 
13 low low - None 0.2 0.032 2 1 - 2 - 
44 0.2 0.01 3 20% FBS 0.2 0.032 2 1 - - 300 
30 0.3 0.01 2 20% FBS 0.2 0.032 2 1 - - 600 
39 0.2 0.005 1 20% FBS 0.2 0.032 2 1 - - 900 
63 0.1 0.008 1 20% FBSg,h - - - - - - - 
a Two different lots of fetal bovine serum were tested. 
b Contained 25mg/ml BSA. 
c 1.2 ml culture volume in 48-well plate. 
d 0.9 ml culture volume in 48-well plate. 
e 0.6 ml culture volume in 48-well plate. 
f Erythrocytes underwent a hypotonic lysis. 
g Supplemented with additional 5 mg/ml glucose.  
h Contained no 2% HB101.
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Table 10. Results of the representative Cytauxzoon felis culture of the cultures of various combinations of medium, sera, and supplements tested. Duration of the culture (Days), the PPE at initiation (Initial PPE), average PPE during maintenance (Maintained 
PPE) (cultures with undetectable parasitemias for most of culture duration are indicated as low), and subculture level attained are shown. Media tested were HEPES-buffered Ultradoma (UltraD) without ʟ-glutamine (ʟ-glut) (Lonza, Walkersville, MD), RPMI-
1640 (RPMI) with HEPES (Mediatech, Inc.,Manassas, VA) and without HEPES (Lonza), Minimal Essential Medium (MEM) without HEPES (Mediatech), and BSK-II (Millipore, Kankakee, IL). HEPES buffer was added to all media not containing this buffer 
in the formulation, as indicated. Sera included fetal bovine serum (FBS), feline serum (FS), calf serum with iron (CaSI), or rabbit serum (RS). Supplements included sodium hypoxanthine (Hypo), thymidine (Thym), 1 mg/ml AlbuMAXI® (Alb), HB 101 
supplement (HB 101) (2% V/V prepared according to manufacturer's recommendation), 2 mM ʟ-glut, bovine serum albumin (BSA), 1X MEM Non-essential amino acids (NEAA), Nutridoma-CS (Nutri), and ʟ-glutathione (GSH). BSK-II media consisted of 50 
µg/ml of rifampicin, 100 µg/ml of phosphomycin, and 0.25 µg/ml of Amphotericin B (Fungizone). No antibiotic/antimycotic was used in the other media.  
 
Days Initial 
PPE (%) 
Maintained PPE 
(%) 
Sub- 
culture 
Level 
Medium Serum Supplements 
Hypo 
(mM) 
Thym 
(mM) 
ʟ-glut (mM) Alb 
(mg/ml) 
HB 101 (%) BSA (mg/ml) Ab/ 
Am 
CDL 
(%) 
NEAA Nutri (%) 
29 0.1 0.01 2 UltraD 20% FBSa 0.2 0.032 2 1 2 - - - - - 
37 0.2 0.005 1 RPMIb 40% FS - - - - - - - - - - 
27 0.2 0.007 1 RPMIb 40% FBS - - - - - - - - - - 
10 low low - RPMIb 40% CaSI - - - - - - - - - - 
25 0.3 0.008 - RPMI 40% FBS 0.2 0.032 2 1 - - - - - - 
21 0.2 0.01 - RPMI 40% FS 0.2 0.032 2 1 - - - - - - 
30 0.2 0.007 - RPMI 20% CaSI - - - - - - - - - - 
50 0.2 0.008 2 RPMI 20% FBS - - - - - - - - - - 
33 0.1 0.009 2 RPMIc 20% FBS 0.28 - - - - 40 - - - - 
28 0.1 0.01 1 RPMIc 20% FBS 0.28 - - - - 40 - - - - 
25 0.2 0.008 1 RPMIc 20% FBS 0.28 - - - - 40 - - - - 
15 0.2 0.007 - RPMIc 20% FBS 0.28 - - - - 40 - - - - 
25 0.2 0.01 1 RPMI 20% FBS 0.2 0.032 2 1 - - - - - 2 
32 0.2 0.009 1 RPMI 10% FBS 0.2 0.032 2 1 - - - - - 2 
49 0.2 0.006 1 RPMI 20% FBS 0.2 0.032 2 1 - - - - - 1 
19 0.1 0.005 1 RPMIc None 0.2 - - 1 - - - - - - 
40 0.4 0.008 1 RPMIc 20% FBS 0.2 - - 1 - - - - - - 
20 0.5 0.01 1 RPMIc 40% FBS 0.2 - - 1 - - - - - - 
40 0.2 0.008 2 RPMIc 10% equine serum 0.1 - - - - - - - - - 
14 low low - RPMIc 10% FBSd - - - - - - - - - - 
12 low low - MEM None - - - - - - - - 1X - 
12 low low - MEM None - - - - - - - - - - 
19 0.1 0.005 - MEM 20% FBS 0.2 0.032 - 1 2 - - - 1X - 
29 0.2 0.01 1 MEMb 40% FBS 0.2 0.032 - 1 2 - - - 1X - 
17 0.2 0.006 1 MEM 20% FS - - - - - - - - - - 
17 0.2 0.01 1 MEM 20% FBS - - - - - - - - - - 
10 low low - MEM 20% CaSI - - - - - - - - - - 
48 0.3 0.008 - BSK-II 20% FBS - - - - - 50 + - - - 
41 0.4 0.01 - BSK-II 20% RS - - - - - 50 + - - - 
a Two lots tested. 
b 20mM HEPES added. 
c 25mM HEPES added. 
d Contained 20mg/ml glucose.
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Table 11. Results of the representative Cytauxzoon felis culture of the cultures of HL-1 medium 
supplemented with 2 mM ʟ-glutamine, 20% fetal bovine serum (FBS), 1 mg/ml AlbuMAX I® or feline 
serum albumin, 2% HB101 (V/V), and varying concentrations of hypoxanthine (Hypo) and thymidine 
(Thym) tested. A 1:2 or 1:4 initial subculture ratio was employed in some cultures. The media contained 
no antibiotic/antimycotic. Duration of the culture (Days), the PPE at initiation (Initial PPE), average PPE 
during maintenance (Maintained PPE) (cultures with undetectable parasitemias for most of culture 
duration are indicated as low), and subculture level attained are shown. 
 
Days Initial 
PPE 
(%) 
Maintained 
PPE (%) 
Sub-
culture 
Level 
Serum Supplements  1:2 
Ratio 
1:4 
Ratio Hypo 
(mM) 
Thym 
(mM) 
ʟ-glut 
(mM) 
10 low low - 20% FBS 0.1 - 2 - + 
10 low low - 20% FBS 0.2 - 2 - + 
10 low low - 20% FBS 0.3 - 2 - + 
50 0.2 0.01 1 20% FBS 0.4 - 2 - + 
10 low low - 20% FBS 0.2 0.032 2 - + 
10 low low - 20% FBS - - 2 - + 
39 0.1 0.008 1 20% FBS 0.1 - 2 - - 
45 0.2 0.01 3 20% FBS 0.2 - 2 - - 
36 0.2 0.01 2 20% FBS 0.3 - 2 - - 
70 0.5 0.01 4 20% FBS 0.4 - 2 - - 
35 0.2 0.01 2 20% FBS 0.1 - 2 + - 
46 0.2 0.01 2 20% FBS 0.2 - 2 + - 
46 0.2 0.01 2 20% FBS 0.3 - 2 + - 
46 0.2 0.02 3 20% FBS 0.4 - 2 + - 
50 0.5 0.02 2 20% FBS 0.2 0.032 2 + - 
30 0.2 0.01 2 20% FBS - - 2 + - 
33 0.2 0.01 2 20% FBS 0.5 - 2 - - 
63 0.2 0.01 4 20% FBSa 0.3 0.048 2 - - 
28 0.2 0.01 2 20% FBS 0.4 0.064 2 - - 
11 0.1 0.009 1 20% FBS 0.3 0.048 2 - - 
31 0.2 0.01 2 20% FBS 0.3c 0.048 2 - - 
a Used in both cat and cat/horse mixed erythrocytes cultures.  
b 1 mg/ml feline serum albumin replaced Albumax I. 
c HT increased from 0.2mM, 0.032 mM to 0.3mM, 0.048 mM seven days post initiation.  
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Table 12. Results of the representative Cytauxzoon felis culture of the cultures of varying initial percentage of parasitized erythrocytes (PPE) and/or 1:2 
weekly subcultures evaluated. Duration of the culture (Days), the PPE at initiation (Initial PPE), average PPE during maintenance (Maintained PPE) 
(cultures with undetectable parasitemias for most of culture duration are indicated as low), and subculture level attained are shown. Media used were 
HL-1, RPMI-1640 (RPMI) with 25 mM HEPES (Mediatech, Inc.,Manassas, VA), and Minimal Essential Medium (MEM) without HEPES 
(Mediatech), and all were supplemented with 1 mg/ml AlbuMAX I®, 0.2 mM sodium hypoxanthine and 0.032 mM thymidine, and either fetal bovine 
serum (FBS) or feline serum (FS). Additional supplements consisted of HB 101 supplement (HB 101) (2% V/V prepared according to manufacturer's 
recommendation), 2 mM ʟ-glut, chemically defined lipids (CDL at 0.75% V/V), and 1X MEM Non-essential amino acids (NEAA). An amount of 
20mM HEPES was added to MEM medium. Some media included 200 µg/ml streptomycin, 200 U/ml penicillin, 0.5 µg/ml Fungizone 
(antibiotic/antimycotic, Ab/Am), and other media contained no Ab/Am.  
 
Days Initial 
PPE 
(%) 
Maintained 
PPE (%) 
Subculture 
Level 
Medium Serum Supplements  Ab/Am Weekly 
Subculture HB 101 
(%) 
NEAA ʟ-glut 
(mM) 
CDL (%) 
63 0.2 0.01 9 HL-1 40% FS 2 - 2 - +  + 
11 low low 1 HL-1 40% FBS 2 - 2 - +  + 
42 0.2 0.02 6 HL-1 40% FBS 2 - 2 0.75 +  + 
49 1.0 0.06 7 HL-1 20% FBS 2 - 2 - -  + 
61 5.0 0.2 8 HL-1 20% FBS 2 - 2 - -  + 
84 10.0 0.5 10 HL-1 20% FBS 2 - 2 - -  + 
7 low low 1 HL-1 40% FS 2 - 2 0.75 +  + 
52 1.0 0.04 3 HL-1 20% FBS 2 - 2 - -  - 
50 10.0 0.7 3 HL-1 20% FBS 2 - 2 - -  - 
49 1.0 0.004 1 RPMIa 40% FBS - - 2 - -  - 
14 10.0 1.1 2 RPMI 40% FBS - - 2 - -  - 
50 10.0 0.6 4 HL-1 20% FBS 2 - 2 - -  - 
30 5.0 0.05 2 HL-1a 20% FBS 2 - 2 - -  - 
49 5.0 0.2 3 RPMIa 40% FBS - - 2 - -  - 
50 5.0 0.3 3 MEMa 40% FBS 2 1X - - -  - 
25 10.0 0.9 4 MEM 40% FBS 2 1X - - -  - 
30 1.0 0.01 2 HL-1a 20% FBS 2 - 2 - -  - 
28 1.0 0.01 3 RPMIa 40% FBS - - 2 - -  - 
20 1.0 0.01 1 MEMa 40% FBS 2 1X - - -  - 
39 1.0 0.01 3 MEM 40% FBS 2 1X - - -  - 
a Contained no hypoxanthine or thymidine.
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Thirty-one cultures were initiated using supplemented HL-1 or RPMI media 
without Ab/Am and incubated in varying gas mixtures (5% CO2, 5% O2, 90% N2 and 
5% CO2, 2% O2, 93% N2), incubation temperatures (37°C and 39°C), and varying 
culture volumes (0.6ml, 0.8ml, 0.9ml, and 1.2 ml). One culture was maintained for 44 
days. A subculture was attained in 21 cultures, and the maximum subculture level 
achieved was three. The PPE maintained in the cultures ranged from undetectable to 
0.01% (Table 13). 
Seven cultures were initiated using donor erythrocytes from different animal 
species in HL-1 supplemented medium without Ab/Am. Six of the seven cultures were 
maintained for 31 days. A subculture was attained in all seven cultures, and the 
maximum subculture level achieved was two. The PPE maintained in the cultures ranged 
from undetectable to 0.01% (Table 14). 
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Table 13. Results of the representative Cytauxzoon felis culture of the cultures incubated in varying gas mixtures (5% CO2, 5% O2, 90% 
N2 and 5% CO2, 2% O2, 93% N2), incubation temperatures (37°C and 39°C), and varying culture volumes (0.6 ml, 0.8 ml, 0.9 ml, and 1.2 
ml) in 48-well plates tested. HL-1 medium and RPMI-1640 without HEPES (Lonza, Walkersville, MD) supplemented with varying 
concentrations of hypoxanthine (Hypo) and thymidine (Thym), 2 mM ʟ-glutamine, fetal bovine serum (FBS), 1 mg/ml AlbuMAX I®, 
and 2% HB101 (V/V) were used in the cultures. The media contained no antibiotic/antimycotic. Duration of the culture (Days), the PPE 
at initiation (Initial PPE), average PPE during maintenance (Maintained PPE) (cultures with undetectable parasitemias for most of culture 
duration are indicated as low), and subculture level attained are shown.  
 
Days Initial 
PPE 
(%) 
Maintained 
PPE (%) 
Subculture 
Level 
Medium Serum Supplements O2 
(%) 
Temp. 
(°C) 
Volume 
(ml) Hypo 
(mM) 
Thym(mM) HB 101 
(%) 
40 0.3 0.01 3 HL-1 20% FBSa 0.2 0.032 2 5 37 0.8 
37 0.3 0.005 1 HL-1 20% FBSa 0.3 0.048 2 5 37 0.8 
43 0.3 0.007 3 HL-1 20% FBSb,c - - - 5 37 0.8 
42 0.4 0.007 1 RPMId 40% FBSe 0.2 - - 2 37 1.2 
16 low low 1 RPMId 40% FBSe 0.2 - - 2 37 0.9 
26 0.3 0.01 2 RPMId 40% FBSe 0.2 - - 2 37 0.6 
44 0.3 0.009 1 RPMId 40% FBSe 0.2 - - 5 37 1.2 
26 0.3 0.01 1 RPMId 40% FBSe 0.2 - - 5 37 0.9 
26 0.3 0.01 1 RPMId 40% FBSe 0.2 - - 5 37 0.6 
29 0.3 0.01 2 HL-1 20% FBSa,e 0.2 0.032 2 5 37 1.2 
29 0.3 0.01 2 HL-1 20% FBSa,e 0.2 0.032 2 5 37 0.9 
26 0.3 0.01 1 HL-1 20% FBSa,e 0.2 0.032 2 5 37 0.6 
19 low low 1 RPMId None 0.2 - - 5 37 0.8 
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Table 13. Continued.  
Days Initial 
PPE 
(%) 
Maintained 
PPE (%) 
Subculture 
Level 
Medium Serum Supplements O2 
(%) 
Temp. 
(°C) 
Volume 
(ml) Hypo 
(mM) 
Thym(mM) HB 101 
(%) 
28 0.4 0.01 1 RPMId 20% FBS 0.2 - - 5 37 0.8 
40 0.3 0.008 1 RPMId 40% FBS 0.2 - - 5 37 0.8 
40 0.3 0.01 2 HL-1 20% FBSa 0.2 0.032 2 2 39 0.8 
39 0.3 0.008 1 HL-1 20% FBSa 0.3 0.048 2 2 39 0.8 
34 0.3 0.01 1 HL-1 20% FBSa,f 0.2 0.032 2 2 39 0.8 
12 low low - HL-1 20% FBSa,g 0.2 0.032 2 2 39 0.8 
a Contained 2 mM ʟ-glutamine.  
b Supplemented with additional 5 mg/ml glucose.  
c Contained no 1mg/ml Albumax I.  
d 25 mM HEPES added. 
e Two different lots of fetal bovine serum were tested. 
f Contained 300µg ʟ-glutathione. 
g Contained 2% Nutridoma-CS.
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Table 14. Results of the representative Cytauxzoon felis culture of the cultures of cat, rabbit, or 
hamster donor normal eryrhrocytes tested in total volume of 800 µl in 48-well plates as shown. 
The medium was HL-1 with 2 mM ʟ-glutamine, 20% serum (RS, rabbit serum; FS, feline serum; 
FBS, fetal bovine serum), 1 mg/ml AlbuMAX I® (Alb), and 2% HB101 (V/V) supplemented 
with hypoxanthine (Hypo) and thymidine (Thym) as shown, with no antibiotic/antimycotic. 
Duration of the culture (Days), the PPE at initiation (Initial PPE), average PPE during 
maintenance (Maintained PPE) (cultures with undetectable parasitemias for most of culture 
duration are indicated as low), and subculture level attained are shown. 
 
Days Initial 
PPE 
(%) 
Maintained 
PPE (%) 
Sub-
culture 
Level 
Donor 
Erythrocytes 
Serum Supplements 
Hypo 
(mM) 
Thym 
(mM) 
HB 
101 
(%) 
31 0.2 0.009 1 Rabbit 20% FBS 0.2 0.032 2 
17 0.2 0.006 1 Hamster 20% FBS 0.2 0.032 2 
31 0.2 0.006 1 Rabbit 20% RS 0.2 0.032 2 
31 0.2 0.006 1 Rabbit 20% FBS 0.3 0.048 2 
31 0.2 0.006 1 Hamster 20% FBS 0.3 0.048 2 
31 0.2 0.01 1 Cat 20% FS 0.3 0.048 2 
31 0.2 0.006 2 Rabbit 20% RS 0.3 0.048 2 
 
 
 
DISCUSSION 
 
This study evaluated in vitro cultivation parameters for the erythrocytic stage of 
Cytauxzoon felis in a microaerophilous stationary phase (MASP) culture system (Levy 
and Ristic, 1980). Numerous hemoparasites have been cultured using various 
adaptations of this methodology, including both Babesia and Theileria species (reviewed 
by Schuster, 2002).  Specifically, the successful establishment of continuous cultures of 
Theileria equi and Theileria uilenbergi (Holman et al., 1994; Zweygarth et al., 1995a; 
Miranda et al., 2006), which are closely related to the genus Cytauxzoon, suggested the 
suitability of MASP for establishing continuous cultures of C. felis.   
Successful continuous cultivation of T. uilenbergi required a PPE greater than 
0.1% at culture initiation (Miranda et al., 2006). In the current study, a range of initial 
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PPE from cats with different clinical presentations of cytauxzoonosis was investigated to 
determine the effects on in vitro propagation of C. felis.  Those cultures with an initial 
PPE of approximately 0.2% from subclinical, chronic cytauxzoonosis cases were 
maintained for the longest periods, while the cultures initiated from acute, recovered 
cases had the greatest mean length in culture overall. Cultures initiated with these RBC 
of acute, fatal cases had the highest PPEs maintained in the cultures. However, the 
parasites in these cultures became undetectable at a fast rate, which likely indicates the 
high maintained PPEs are attributable to the high initial PPEs. It was also observed that 
cultures started with an initial PPE greater than 0.2% from acute, fatal cases underwent 
more subculture passages than others. Inasmuch as continuous cultures were not attained 
in this study, the impact of a high or low initial PPE is difficult to assess.   
Medium and serum selection have long been recognized as critically important 
factors in continuous in vitro cultivation of hemoparasitic protozoa (reviewed by 
Canning and Winger 1987). In this study, C. felis cultures initially propagated in all six 
media tested, which included HL-1, conditioned HL-1, RPMI-1640, Ultradoma, BSK-II, 
and MEM. However, only formulations of HL-1 medium were able to support growth 
for an extended period of time. HL-1 medium is a chemically defined medium that is 
formulated with known amounts of insulin, transferrin, sodium selenite, testosterone, 
ethanolamine, proprietary stabilizing proteins, unsaturated, and saturated fatty acids. 
This medium was developed for of hybridomas and cells of lymphoid origin (Ishikawa et 
al., 1987). HL-1 medium was first used to culture Babesia (Theileria) equi (Holman et 
al., 1994), and has been shown to support cultures of related hemoparasites (Holman et 
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al., 1993; Zweygarth et al., 1999; Miranda et al., 2006). In one study comparing HL-1, 
Medium 199, and RPMI-1640 media for culturing T. uilenbergi, only HL-1 supported 
long term cultivation of the parasite (Miranda et al., 2006).  Also, Babesia caballi is 
supported by HL-1 medium in the presence of serum and in the absence of serum 
(Holman et al., 1993; Zweygarth et al., 1999).  Another hybridoma medium, Ultradoma, 
contains insulin, transferrin and albumin, and C. felis cultures with this medium did not 
last beyond 29 days. Of the different sera tested in this study, fetal bovine serum and 
feline serum produced the best results. Serum supplementation at less than 20% was not 
as suitable for cultivating C. felis in vitro.  
Antibiotics and antimycotics are routinely used in cell cultures to prevent 
microbial contamination. In this study, the antibiotic and antimycotic combination used 
was penicillin, streptomycin, and amphotericin B. Penicillin works by targeting the cell 
wall biosynthesis in bacteria. Streptomycin acts by binding to the 30S subunit of the 
bacterial ribosome, and this subsequently inhibits the protein synthesis in bacteria 
(Waksman, 1953). Amphotericin B works by binding to the sterol component in the cell 
membrane and increases its permeability (Wiehart et al., 2006).  
Cytauxzoon felis cultivated in the absence of the antibiotic-antimycotic 
combination underwent a greater number of subculture levels than those in its presence. 
This might be due to the amphotericin B component. Amphotericin B more readily binds 
to the ergosterol in fungal cell membranes, but it can also bind the cholesterol 
component of mammalian cell membranes, albeit with lower affinity, and lead to 
cytotoxicity (Wiehart et al., 2006). Erythrocytes parasitized by the trophozoite stage of 
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Plasmodium falciparum were more susceptible to lysis in the presence of amphotericin 
B (Wiehart et al., 2006). Amphotericin B also showed effects against Babesia gibsoni in 
normal canine erythrocytes 12 hours after culture initiation (Yamasaki et al., 2014). 
However, the utilization of the amphotericin B along with penicillin and streptomycin 
did not the affect the continuous cultivation of B. caballi established from blood of 
horses in a carrier state (Holman et al., 1993). It could be speculated that amphotericin B 
may play a role in the decreased invasion thus subsequent lowered PPE and number of 
subculture passages in C. felis cultures, but further studies are needed to determine 
whether this drug impedes cellular invasion by this hemoparasite.   
This study demonstrated that hypoxanthine-supplemented cultures maintained a 
higher PPE for a longer period of time than cultures without this purine derivative. In 
earlier studies with Plasmodium spp., infected erythrocytes incorporated exogenously 
supplied purines into nucleic acids (Bungener and Nielsen, 1967, 1968; Gutteridge and 
Trigg, 1970). Just as with Plasmodium spp., C. felis may require purine from the 
medium in order to synthesize nucleic acids. When initiated from animals with a very 
low parasitemia or from liquid nitrogen storage, hypoxanthine seemed to enhance the 
growth of T. (B.) equi and an unknown Babesia sp. in cultures (Zweygarth et al., 1995a; 
Zweygarth et al., 1995b). Hypoxanthine was also vital for in vitro growth of 
P. falciparum in serum-free conditions (Asahi et al., 1996). RPMI-1640 medium 
contains no purine precursors, and when this basal medium was supplemented with 
hypoxanthine, Babesia bigemina was able to grow in every serum condition tested 
(Neves et al., 2001). 
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One C. felis culture persisted for an extended period without being provided a 
source of hypoxanthine in the medium. This culture, however, was supplied additional 
glucose (5 mg/ml). Glucose is metabolized during the pentose phosphate pathway (PPP). 
During PPP, ribose 5-phosphate is produced from glucose 6-phosphate and used in the 
synthesis of nucleic acids and nucleotides (Barrett, 1997). Alternatively, glucose is also 
metabolized for cellular energy to lactate via anaerobic glycolysis. By this means, most, 
if not all, of the energy of hemoparasites, such as Babesia spp., is derived (Rickard, 
1969; Yamasaki et al., 2003).  
Some cultures were initiated using density gradient cell separation to purify the 
erythrocytes from lymphocytes and other mononuclear cells. One such culture was 
maintained for 94 days, but it required a frequent addition of uninfected donor cat 
erythrocytes due to the loss of RBC integrity occurring at a faster rate compared to 
washed RBC.  Thus, there did not appear to be an advantage to using RBC prepared for 
culture by this method. 
Although continuous cultivation of C. felis was not achieved during this study, it 
has provided insight for further modifications to optimize conditions for parasite growth. 
In addition to further investigation into culture medium and supplementation, various 
culture conditions should be evaluated in future studies. Different gas mixtures, 
particularly with emphasis on the O2 concentration, as well as the incubation temperature 
should be investigated.  
Based on the work of Rodriguez and others (1983), hemoparasites with a low 
PPE (generally 0.1%) at culture initiation are often propagated in an oxygen-reduced gas 
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atmosphere. It was recently shown that T. equi cultures initiated from horses with 
undetectable parasitemias initiation could be propagated in a 5% CO2-in-air atmosphere 
with ʟ-cysteine-supplemented culture medium. In comparing an oxygen-reduced 
environment and 5% CO2-in-air atmosphere in conjunction with ʟ-cysteine 
supplementation it was four days before parasites were seen under the oxygen-reduced 
conditions, whereas six days elapsed before parasites were detected in a 5% CO2-in-air 
atmosphere (Zweygarth and Josemans, 2014). Thus, low oxygen tension may not be the 
requirement for culture initiation. Zweygarth and Josemans (2014) speculated that the 
low oxygen environment at culture initiation may cause ʟ-cysteine to be released from 
an erythrocytic source, such as glutathione (GSH). This would suggest that the 
availability of ʟ-cysteine is the prerequisite for in vitro initiation and cultivation of 
T. equi more than the microaerophilic culture conditions (Zweygarth and Josemans, 
2014). This is an avenue that certainly might be explored for C. felis cultures.  
With the successful establishment of continuous cultures of C. felis, there would 
be an unlimited supply of biological materials of this pathogen. This would aid in 
improving diagnostics and enhance the current state of knowledge regarding the 
biochemistry behind its nutritional requirements and metabolic pathways. An established 
culture system would also provide antigens for vaccine development as well as provide a 
platform for studying drug susceptibility. Perhaps most importantly, C. felis cultures 
would eliminate the need to infect live animals to carry out relevant studies.   
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CHAPTER III  
GENETIC VARIABILITY OF CYTAUXZOON FELIS RIBOSOMAL RNA ITS1 
AND ITS2 GENOMIC REGIONS FROM DOMESTIC CATS OF VARIED 
GEOGRAPHIC REGIONS AND CLINICAL OUTCOMES 
 
INTRODUCTION 
 Cytauxzoon felis, a tick-borne protozoan parasite, is the causative agent of 
cytauxzoonosis in domestic cats in the United States. The first report described a fatal 
infection in domestic cats in southwestern Missouri (Wagner, 1976). Since then, C. felis 
infections in domestic cats have been found in south central, southeastern, mid-western, 
and mid-Atlantic states (Wagner, 1976; Ferris, 1979; Kier et al., 1982; Birkenheuer et 
al., 2006). Bobcats (Lynx rufus) are considered to be the primary reservoir host (Glenn et 
al., 1983; Blouin et al., 1984), and they typically do not exhibit clinical signs. 
Subclinical infection is reported in other wild felids in the United States such as Florida 
panthers (Felis concolor coryii [Puma concolor coryi]) (Butt et al., 1991), Florida 
cougars (Puma concolor couguar) (Yabsley et al., 2006; Harvey et al., 2007), and Texas 
cougars (Puma concolor stanleyana) (Rotstein et al., 1999).  
In contrast to the common subclinical infection of wild felids, C. felis infection of 
domestic cats often leads to rapid disease progression, and most infected cats die within 
one week of the onset of clinical signs (Hoover et al., 1994; Greene et al., 2006). This is 
due to the schizogonous phase, in which the lumen of blood vessels in the liver, lungs, 
lymph nodes, and spleen are occluded by schizont-laden mononuclear phagocytes. Upon 
maturation the schizonts rupture and release numerous merozoites, which invade 
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erythrocytes as piroplasms (erythrocytic phase) and cause hemolysis (Kier et al., 1987; 
Kocan and Kocan, 1991; Kocan et al., 1992, Cohn et al., 2011). The historic high 
fatality, sporadic incidence, and rapid disease progression of cytauxzoonosis in domestic 
cats suggest that they may be aberrant hosts (Kier et al., 1987; Greene et al., 2006).  
 An increasing number of cats that have survived infection are documented 
(Motzel and Wagner, 1990; Walker and Cowell, 1995; Greene et al., 1999; Meinkoth et 
al., 2000; Rizzi et al., 2015). Cytauxzoonosis survivors may range from animals that 
were ill and recovered from the acute infection to cats that never exhibited clinical signs 
of the infection. Some cats remain detectably parasitemic as long as a year after clinical 
signs have resolved, and PCR testing has revealed C. felis DNA in the blood of clinically 
healthy cats with microscopically undetectable parasitemias (Meinkoth et al., 2000; 
Brown et al., 2008; Haber et al., 2007). Piroplasms could persist in erythrocytes of 
survivors for possibly the life span of the cat, rendering the animal a subclinical chronic 
carrier (Birkenheuer et al., 2006; Haber et al., 2007; Brown et al., 2008; Lewis et al., 
2014). Reichard and others (2009) demonstrated that a natural survivor transmitted 
C. felis via the Amblyomma americanum tick vector to a naïve domestic cat resulting in 
clinical cytauxzoonosis, thus indicating that chronic carriers may serve as reservoirs and 
increasing the risk of C. felis exposure to other domestic cats.  
 In a previous study examining the intraspecific variation of the internal 
transcribed spacer (ITS) regions of the C. felis ribosomal RNA genes, specific genotypes 
were associated with clinical outcome and geographic regions (Brown et al., 2009a).  
However, such an association was not confirmed in subsequent studies (Brown et al., 
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2009b; Brown et al., 2010; Cohn et al., 2011; Shock et al., 2012). The previous studies 
employed direct sequencing of the target regions.  Thus, the objectives of this study were 
to clone and further analyze the C. felis 18S rRNA gene, ITS1, and ITS2 regions, and to 
assess the ITS genotypes for any spatial or clinical outcome associations.  
MATERIALS AND METHODS 
Fresh or frozen blood samples from 41 Cytauxzoon felis-infected blood from 
domestic cats for this study were provided under institutionally approved animal use 
protocols (Mason Reichard, Department of Veterinary Pathobiology, Oklahoma State 
University, Stillwater, OK; Animal Care and Use Protocol, “Feline cytauxzoonosis: 
Establishment of continuous parasites cultures” Protocol Number: VM1121; Leah A. 
Cohn, Department of Small Animal Internal Medicine, Veterinary Medicine Teaching 
Hospital, University of Missouri, Columbia, MO;  Animal Care and Use Protocol, 
“C. felis source cats” Protocol Number 7301). The samples originated from Texas, 
Oklahoma, Arkansas, Kansas, and Missouri from cats with various clinical presentations 
(Table 15).  
 
 
 
Table 15. State of origin and clinical outcomes of Cytauxzoon felis-infected cats.  The number 
of isolates for each cytauxzoonosis presentation and the geographic origin are indicated.  
 
Clinical Outcome No. of isolates State of Origin  
  OK KS AR MO TX 
acute, fatal 30 26 0 0 3 1 
chronic, subclinical 9 2 0 6 1 0 
acute, recovered 2 0 1 0 0 1 
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The C. felis-infected cats were categorized for clinical outcome based upon the 
provided history of the cat. If the history was not known, such as with feral cats and 
other opportunistic samples, then the provided clinical status of the cat at time of blood 
draw was used. Cytauxzoon felis-infected cats that died were denoted as acute, fatal 
cases. Ill cats that showed clinical signs but survived were considered acute, recovered. 
The time period for the acute status for a majority of the cats was not known. Cats that 
were known to have a persistent C. felis infection but never showed clinical signs were 
considered chronic, subclinical.  
The samples were shipped on ice overnight to Texas A&M University and either 
used upon arrival or stored at -80°C until use. Genomic DNA was extracted (FlexiGene 
DNA Kit, Qiagen, Valencia, CA) from each blood sample, and the concentration was 
determined by spectrophotometry (NanoDrop ND-1000 Spectrophotometer, NanoDrop 
Technologies, Wilmington, DE). The full-length C. felis 18S rRNA gene was amplified 
in a primary PCR with primers A and B (Sogin, 1990) (Table 16) and 50-100 ng DNA 
according to manufacturer’s instructions (High Fidelity Platinum ® Taq, Invitrogen™). 
Molecular biology grade water served as a negative control and a cloned plasmid with a 
full-length C. felis 18S rRNA gene insert served as a positive control. The reactions 
underwent a 30 s denaturation at 94°C followed by 45 cycles of 94°C for 15 s, 60°C for 
15 s, 68°C for 2 min, with a final extension at 68°C for 7 min, and then were held at 4°C 
(Labnet MultiGene™ Thermal Cycler, Labnet International, Inc., Woodbridge, NJ). The 
PCR products were resolved by agarose gel electrophoresis alongside a 100-bp DNA 
marker (Invitrogen), stained with ethidium bromide, and visualized by ultraviolet light 
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transillumination (FluorChem 8000, Alpha Innotech Corporation, San Leandro, CA). If a 
band was not visualized, the primary product was diluted and used in a nested reaction 
with primers AN50 and BN1700 (Schoelkopf et al., 2005) (Table 16). The cycling 
parameters were as above, except that the reactions underwent 30 cycles. The PCR 
products were visualized as above. 
 
 
 
a Designated primer after primer adjustments were made. 
 
 
 
The genomic region spanning partial 18S rRNA gene, rRNA internal transcribed 
spacer 1, 5.8S rRNA gene, ITS2, and partial 28S rRNA gene (ITS) was amplified as 
above using primers ITSF and LSU50R (Table 16) at an annealing temperature of 55°C 
and extension time of 2 min. A primary amplification using primers 1055F (Elwood et 
al., 1985) and LSU50R (Table 16) and a Pyrococcus-like polymerase according to 
Table 16.  Oligonucleotide primers used in amplifying the 18S rRNA gene and ITS1-5.8S gene-ITS2 
region of Cytauxzoon felis. 
 
Primer Name, sense PCR Sequence 5'→3' 
A, forward Primary 18S AACCTGGTTGATCCTGCCAG 
B, reverse Primary 18S GATCCTTCTGCAGGTTCACCTAC 
AN50, forward Nested 18S GCTTGTCTTAAAGATTAAGCCATGC 
BN1700, reverse Nested 18S CGACTTCTCCTTCCTTTAAG 
ITSF, forward Primary and Nested ITSa GAGAAGTCGTAACAAGGTTTCCG 
LSU50R, reverse Primary ITS GCTTCACTCGCCGTTACTAGG 
1055F, forward Primary ITSa GGTGGTGCATGGCCG 
LSURN30, reverse Nested ITSa AATTCAGCGGGTAGTCTCAC 
m13F, forward Colony 18S and ITS, plasmid 
(pDNA) 
GTAAAACGACGGCCAG 
m13R, reverse Colony 18S and ITS, plasmid 
(pDNA) 
CAGGAAACAGCTATGAC 
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manufacturer’s instructions (Phusion High-Fidelity DNA Polymerase, Thermo 
Scientific, Pittsburgh, PA) was employed for C. felis isolates that yielded no amplicons 
with ITSF and LSUR50. The cycling parameters were a 2 min denaturation at 98°C 
followed by 45 cycles of 98°C for 10 s, 55°C for 30 s, 72°C for 1 min, a final extension 
of 72°C for 7 min, and a hold at 4°C. The PCR products were resolved and visualized as 
above. If a band was not visualized, the primary product was diluted and used in a nested 
reaction with primers ITSF and LSURN30 (Table 16). The cycling parameters were as 
above, but with a 30 s initial denaturation, 30 s extension time, and 30 cycles for 
amplification. The PCR products were resolved by agarose gel electrophoresis as above. 
 Appropriately-sized 18S rDNA and ITS1-5.8S-ITS2 amplicons synthesized by 
High Fidelity Platinum® Taq DNA Polymerase were ligated into pCR®2.1-TOPO® 
(Invitrogen, Life Technologies, Grand Island, NY) or pPrime (5 PRIME, Gaithersburg, 
MD) cloning vector. Amplicons synthesized with Phusion High-Fidelity DNA 
Polymerase were ligated into the pJET1.2/blunt cloning vector (Thermo Fisher Scientific 
Inc., Waltham, MA). When multiple bands resulted in PCR, the appropriately-sized 
bands were gel purified (QIAQuick Gel Extraction Kit, Qiagen, Valencia, CA) prior to 
cloning. TOP10 E. coli were transformed according to manufacturer’s instructions. 
Colonies were verified to contain the cloned insert by colony PCR using primers 
appropriate for the plasmid vector (Table 16). Verified colonies were expanded 
overnight in broth cultures, and plasmid DNA was prepared (Promega or Bio Basic, 
Inc.). The plasmid DNA concentration was determined using spectrophotometry. 
Bidirectional sequencing of the inserts was conducted by Davis Sequencing (Davis, CA). 
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Sequence and chromatogram data were analyzed, and forward and reverse sequence data 
were trimmed to exclude primer sequences and unreadable data, aligned, and analyzed 
for contiguous sequences using Sequencher 4.2 software (Gene Codes Corporation, Inc., 
Ann Arbor, MI).  The obtained sequences were compared to sequences in GenBank 
using the NCBI Basic Local Alignment Search Tool (BLAST) (Altschul et al., 1990). 
The 18S rDNA sequence data served to confirm C. felis infection. Using previous 
C. felis ITS1 and ITS2 sequences from GenBank as template, the ITS1 and ITS2 region 
sequences were identified in the cloned sequences, then aligned and analyzed separately 
(Clustal Omega, http://www.ebi.ac.uk/Tools/msa/clustalo/). The ITS1 and ITS2 
sequences were assigned GenBank accession numbers and combined GenBank 
accession numbers were designated specific genotypes as previously described (Brown 
et al., 2009a, 2009b, 2010; Shock et al., 2012). With the chi-square test for 
independence, genotypes found in this study were evaluated for associations with 
clinical outcome (fatal, recovered, or chronic) and state of origin (Oklahoma, Kansas, 
Arkansas, Missouri, or Texas) (JMP®, Version Pro 11. SAS Institute Inc., Cary, NC, 
1989-2007).  A chi-square test for independence was also employed to evaluate single 
and multiple variance(s) (SNP[s] and/or single random substitutions) in the delineated 
ITS1 and ITS2 sequence combinations for a correlation with PCR amplification (primary 
or nested) and polymerase (High Fidelity Platinum® Taq or Phusion) used. 
RESULTS 
Forty of 41 (98%) samples yielded 18S rRNA cloned amplicons, and subsequent 
sequencing revealed 1,774-bp inserts sharing 99% identity with C. felis 18S rRNA 
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cloned amplicons of approximately 1,000-bp (KR817922-KR818036 and KT783518-
The partial 18S-ITS1-5.8S-ITS2-partial 28S rDNA sequence for all C. felis 
cloned amplicons from this study were submitted to GenBank. The ITS sequence data 
were extracted from each of these sequences and used for the analysis of the ITS1 and 
ITS2 regions, respectively. An alignment of the sequence data from the 122 C. felis ITS1 
region clones obtained revealed ITS sequences with 21 single nucleotide polymorphisms 
(SNPs) and three insertions (23-bp insertion and two single nucleotide insertions). The 
length was generally 458-460 bp, or 481 bp with the 23 bp insertion. Different C. felis 
ITS1 sequences were often found from a single cat. The most common ITS1 sequence 
matched a C. felis ITS1 sequence (GenBank accession number EU450802) from a 
domestic cat that survived an infection in Georgia. This ITS1 sequence shared 100% 
identity with 56 total cloned sequences (Table 18) representing 32 cloned amplicons 
from 15 domestic cats that succumbed to an acute fatal infection (KR817922-
KR817930, KR817932, KR817933, KR817959, KR817961, KR817962, KR817968- 
Table 17. State of origin and clinical outcome of the cats from which Cytauxzoon felis ITS 
cloned amplicons were derived. 
Clinical Outcome No. of cloned amplicons 
(No. of cats) 
State of Origin 
OK KS AR MO TX 
Acute, fatal 89 (30) 80 (26) 0 0 8 (3) 1 (1) 
Chronic, subclinical 29 (9) 10 (2) 0 17 (6) 2 (1) 0 
Acute, recovered 4 (2) 0 2 (1) 0 0 2 (2) 
gene in GenBank (AY679105). Thirty-five of the 41 (85%) samples yielded C. felis ITS 
KT783524), for a total of 122 cloned sequences (Table 17). 
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KR818009, KR818016, KR818017, KR818020, KR818030- KR818032, and 
KT783524) and 24 clones from 9 cats with subclinical, chronic infections (KR817934-
KR817937, KR817971-KR817980, KR818000, KR818002- KR818006, KR818011, 
KR818012, KR818028, and KR818029). Of the 32 C. felis clones from an acute, fatal 
infection, 27 were from 11 cats in Oklahoma, four were from three Missouri cats, and 
one was from a Texas cat. Of the 24 C. felis cloned amplicons from subclinical, chronic 
infections, seven clones were from two Oklahoma cats, 15 were from six Arkansas cats, 
and two were from one Missouri cat. 
KR817970, KR817981, KR817990, KR817991, KR817995, KR818001, KR818007-
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Table 18. Number and distribution of Cytauxzoon felis cloned ITS1 sequences according to the state of origin and clinical outcome 
that matched sequences previously reported to Genbank GenBank accession no. (GBA) of the previously reported sequence and 
observed differences in this study are listed. The cloned ITS1 sequences from this study are in the GenBank deposited partial-18S-
ITS1-5.8S-ITS2-partial 28S rDNA sequences provided below.  
 
GBA  
and changes 
 
No. of cloned 
amplicons (% of 
total) 
Number of clones according to state of origin Clinical outcome  
OK KS AR MO TX acute, 
fatal 
acute, 
recovered 
chronic, 
subclinical 
EU450802 56 (46) 34 0 15 6 1 32 0 24 
   1 base changea    22 (18) 19 1 2 0 0 18 1 3 
   23-bp insertb         4 (3)  3 0 0 1 0 4 0 0 
   >1 base changec 5 (4) 3 0 1 0 1 3 1 1 
GU581166 6 (5) 6 0 0 0 0 6 0 0 
   1base changed  2 (2) 
1 (1) 
2 
1 
0 
0 
0 
0 
0 
0 
0 
0 
2 
1 
0 
0 
0 
0    >1 base changee        
HQ383820 4 (3) 2 0 0 2 0 4 0 0 
   1 base changef 
   >1 base changeg 
4 (3) 
2 (2) 
4 
2 
0 
0 
0 
0 
0 
0 
0 
0 
4 
2 
0 
0 
0 
0 
HQ383856 3 (2) 3 0 0 0 0 3 0 0 
  1 base changeh 
   >1 base changei 
1 (1) 
1 (1) 
0 
1 
0 
0 
0 
0 
0 
0 
1 
0 
0 
1 
1 
0 
0 
0 
   23-bp insertj 1 (1) 0 0 0 1 0 1 0 0 
JF308498 1 (1) 1 0 0 0 0 1 0 0 
   1 base changek 
>1 base changel 
1 (1) 
3 (2) 
0 
3 
0 
0 
0 
0 
0 
0 
1 
0 
0 
3 
1 
0 
0 
0 
EU450803 1 (1) 1 0 0 0 0 1 0 0 
   >1 base changem 3(2) 3 0 0 0 0 1 0 2 
HQ383867 1 (1) 1 0 0 0 0 1 0 0 
TOTAL                        1 122 (100) 89 1 18 10 4 88 4 30 
Sequences KR817931; KR817940; KR817945-KR817950; KR817955; KR817958; KR817963; KR817965; KR817967; KR817985-KR817989; 
KR817993; KR817996; KR817997; KR818013 from this study. 
b Sequences KT783518; KT783523; KR818035; KR818036 from this study  
c Sequences KR817939; KR817941; KR817942; KR817964; KR817966 from this study.  
d Sequences KR817960; KR817994 from this study.   
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Table 18. Continued. 
e Sequence KT783521 from this study.  
f Sequences KR817953; KR817954; KR818014; KR818015 from this study. 
g Sequences KR817951; KR817952 from this study. 
h Sequence KT783520 from this study.  
i Sequence KR818022 from this study. 
j Sequence KT783522 from this study.  
k Sequence KR817957 from this study. 
l Sequences KR817944; KR817956; KR818027 from this study.  
m Sequences KR818025; KR818026; KT783519 from this study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
81 
The second most common ITS1 sequence found in this study matched that of 
C. felis from a Florida bobcat, GenBank accession number GU581166. This sequence 
was detected in six clones from three fatally infected Oklahoma cats (Table 18) 
(KR817938, KR817982- KR817984, KR817992, and KR818010). KR818021 was 
identical to GenBank accession numbers EU450803 (fatal C. felis infection of an 
Arkansas domestic cat), and KR818024 was identical to previously reported and 
JF308498 (C. felis from an Oklahoma bobcat). The ITS1 sequence of KR817943 was 
identical to the 455-bp submitted for GenBank accession number HQ383867 (Oklahoma 
bobcat C. felis). ITS1 sequences of KR818018, KR818019, KR817998, and KR817999 
were a 100% match with the 455-bp of archived HQ383820 (Kansas bobcat C. felis); 
ITS1 sequences of KR818023, KR818033, and KR818034 identically matched the 
456-bp submitted for GenBank accession number HQ38385 (C. felis from Kansas and 
North Carolina bobcats) (Table 19). Of the three insertions found in ITS1 in this study 
(Table 19), the two single nucleotide insertions were previously reported, and the 23-bp 
insert was novel as it was not reported prior to this study. The 23-bp insert was detected 
with both polymerases utilized in this study. Five C. felis cloned amplicons in this study 
from Missouri (GenBank accession numbers KR818035 and KT783522) and Oklahoma 
(GenBank accession numbers KR818036, KT783518, and KT783523) contained the 23-
bp insert. These five clones were obtained from three domestic cats with acute, fatal 
cases. The insert contained a repeat of AACCT within the sequence, and in the absence 
of the 23-bp insert, three of these five clones (KR818035, KT783518, and KR818036) 
would be identical to previously submitted GenBank accession number EU450802. Two 
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of these three clones had identical sequences (KT783518 and KR818036) while the third 
clone (KR818035) had a SNP inside the 23-bp insert. This exact SNP was shared by one 
of the two remaining clones with 23-bp insert, KT783522, which also had a single 
nucleotide insertion and a SNP outside the insert region. Without the 23-bp insert, 
KT783522 would match the 256-bp of previously submitted GenBank accession number 
HQ383856 (C. felis from Kansas and North Carolina bobcats) with 100%. The other 
remaining clone had a SNP outside of the insert region (KT78523; Fig. 1). 
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Table 19. Maximum identity to prior GenBank accession numbers (GenBank match) and nucleotide variation of cloned Cytauxzoon felis ITS1 amplicons. Sequence position numbering is based on GenBank accession number EU450803. Insertions, single 
nucleotide polymorphisms, and miscellaneous mismatches are shown as INS, SNP, and Misc., respectively.  
 
No. GenBank 
match 
Max. 
identity 
Animal-Clone GenBank accession number Polymorphisms 
Misc. SNP 
80 
A>G 
SNP 
162 
A>G 
SNP 167 
A>C 
INS 
337 
A 
SNP 
338 G>A 
SNP 
344 
T>C 
SNP 
397 
T>C 
SNP 
415 
T>C 
SNP 
444 
A>G 
INS 
457 
C 
23-BP 
INS 
- - - - EU450802             
1.  EU450802 100% 1 Cl 2 KR817922             
2.  EU450802 100% 1 Cl 6 KR817923             
3.  EU450802 100% 1 Cl 8 KR817924             
4.  EU450802 100% 1 Cl 9 KR817925             
5.  EU450802 100% 1 Cl 11 KR817926             
6.  EU450802 100% 3 Cl 2 KR817961             
7.  EU450802 100% 3 Cl 3 KR817962             
8.  EU450802 100% 4 Cl 1 KR817927             
9.  EU450802 100% 4 Cl 3 KR817928             
10.  EU450802 100% 4 Cl 6 KR817929             
11.  EU450802 100% 4 Cl 9 KR817930             
12.  EU450802 100% 19 Cl 1 KR818011             
13.  EU450802 100% 19 Cl 9 KR818012             
14.  EU450802 100% 23 Cl 1 KR818017             
15.  EU450802 100% 27 Cl 1 KR818016             
16.  EU450802 100% 28 Cl 2 KT783524             
17.  EU450802 100% 28 Cl 3 KR817932             
18.  EU450802 100% 28 Cl 5 KR817933             
19.  EU450802 100% 28 Cl 6 KR817959             
20.  EU450802 100% 32 Cl 4 KR818028             
21.  EU450802 100% 34 Cl 2 KR817934             
22.  EU450802 100% 35 Cl 1 KR817935             
23.  EU450802 100% 35 Cl 2 KR817936             
24.  EU450802 100% 36 Cl 1 KR817937             
25.  EU450802 100% 36 Cl 2 KR818029             
26.  EU450802 100% 39 Cl 3 KR818030             
27.  EU450802 100% 42 Cl 10 KR818020             
28.  EU450802 100% 16 Cl 2 KR817990             
29.  EU450802 100% 12 Cl 3 KR818002             
30.  EU450802 100% 12 Cl 7 KR818003             
31.  EU450802 100% 12 Cl 9 KR818004             
32.  EU450802 100% 12 Cl 10 KR818005             
33.  EU450802 100% 12 Cl 12 KR818006             
34.  EU450802 100% 14 Cl 7 KR817991             
35.  EU450802 100% 18 Cl 1 KR817968             
36.  EU450802 100% 18 Cl 2 KR817969             
37.  EU450802 100% 18 Cl 3 KR818031             
38.  EU450802 100% 18 Cl 4 KR818032             
39.  EU450802 100% 20 Cl 2 KR818007             
40.  EU450802 100% 20 Cl 4 KR818008             
41.  EU450802 100% 20 Cl 5 KR818009             
42.  EU450802 100% 21 Cl 8 KR817970             
43.  EU450802 100% 29 Cl 1 KR817971             
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Table 19. Continued.  
 
No. GenBank 
match 
Max. 
identity 
Animal-Clone GenBank accession number Polymorphisms 
Misc. SNP 
80 
A>G 
SNP 
162 
A>G 
SNP 167 
A>C 
INS 
337 
A 
SNP 
338 G>A 
SNP 
344 
T>C 
SNP 
397 
T>C 
SNP 
415 
T>C 
SNP 
444 
A>G 
INS 
457 
C 
23-BP 
INS 
44.  EU450802 100% 29 Cl 4 KR817972             
45.  EU450802 100% 29 Cl 5 KR817973             
46.  EU450802 100% 29 Cl 6 KR817974             
47.  EU450802 100% 30 Cl 2 KR818000             
48.  EU450802 100% 30 Cl 5 KR817975             
49.  EU450802 100% 31 Cl 6 KR817976             
50.  EU450802 100% 31 Cl 8 KR817977             
51.  EU450802 100% 31 Cl 9 KR817978             
52.  EU450802 100% 31 Cl 10 KR817979             
53.  EU450802 100% 31 Cl 11 KR817980             
54.  EU450802 100% 40 Cl 6 KR817995             
55.  EU450802 100% 41 Cl 2 KR818001             
56.  EU450802 100% 41  Cl 5 KR817981             
57.  EU450802 99% 6 Cl 1 KR817955  X           
58.  EU450802 99% 6 Cl 5 KR817958  X           
59.  EU450802 95% 10 Cl 6 KT783523    X        X 
60.  EU450802 99% 15 Cl 7 KR817931 398 A>G            
61.  EU450802 99% 15 Cl 9 KR817940 398 A>G            
62.  EU450802 99% 15 Cl 8 KR817939 350 T>C 
398 A>G 
           
63.  EU450802 99% 15 Cl 12 KR817941 96 T>C 
398 A>G 
 X          
64.  EU450802 99% 17 Cl 12 KR817942 183 T>C 
329 T>C 
           
65.  EU450802 99% 19 Cl 4 KR818013 94 C>T            
66.  EU450802 99% 25 Cl 11 KR817945 93 A>G            
67.  EU450802 99% 26 Cl 1 KR817946 208 A>G            
68.  EU450802 99% 26 Cl 5 KR817948 208 A>G            
69.  EU450802 99% 26 Cl 4 KR817947 221 T>C            
70.  EU450802 99% 32 Cl 5 KR817963 37 A>G            
71.  EU450802 99% 33 Cl 1 KR817965 198 A>G            
72.  EU450802 99% 33 Cl 2 KR817966 217 T>C 
323 T>C 
           
73.  EU450802 99% 34 Cl 1 KR817967 238 T>C            
74.  EU450802 99% 43 Cl 4 KR817964 153 A>G 
161 A>G 
           
75.  EU450802 95% 5 Cl 1 KT783518            X 
76.  EU450802 95% 5 Cl 2 KR818036            X 
77.  EU450802 99% 16 Cl 4 KR817986 140 G>T            
78.  EU450802 99% 16 Cl 5 KR817987 140 G>T            
79.  EU450802 99% 16 Cl 6 KR817988 140 G>T            
80.  EU450802 99% 18 Cl 5 KR817993 75 A>G            
81.  EU450802 99% 20 Cl 1 KR817996 451 T>C            
82.  EU450802 99% 20 Cl 3 KR817997 451 T>C            
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Table 19. Continued. 
 
No. GenBank 
match 
Max. 
identity 
Animal-Clone GenBank accession number Polymorphisms 
Misc. SNP 
80 
A>G 
SNP 
162 
A>G 
SNP 167 
A>C 
INS 
337 
A 
SNP 
338 G>A 
SNP 
344 
T>C 
SNP 
397 
T>C 
SNP 
415 
T>C 
SNP 
444 
A>G 
INS 
457 
C 
23-BP 
INS 
83.  EU450802 99% 23 Cl 3 KR817950         X    
84.  EU450802 95% 40 Cl 2 KR818035 199 (inside INS) 
A>C 
          X 
85.  EU450802 99% 27 Cl 4 KR817949         X    
86.  EU450802 99% 21 Cl 12 KR817985         X    
87.  EU450802 99% 16 Cl 1 KR817989 342 A>G            
- - - - JF308498        X     
88.  JF308498 100% 25 Cl 12 KR818024        X     
89.  JF308498 99% 6 Cl 4 KR817957 61 G>A       X     
90.  JF308498 99% 10 Cl 1 KR818027 37 A>G 
406 T>C 
      X     
91.  JF308498 99% 25 Cl 6 KR817944 84 A>G 
262 A>C 
      X     
92.  JF308498 99% 6 Cl 2 KR817956 284 T>C X      X     
- - - - GU581166      X       
93.  GU581166 100% 9 Cl 3 KR817938      X       
94.  GU581166 100% 5 Cl 5 KR818010      X       
95.  GU581166 100% 13 Cl 1 KR817982      X       
96.  GU581166 100% 13 Cl 3 KR817983      X       
97.  GU581166 100% 13 Cl 4 KR817984      X       
98.  GU581166 100% 13 Cl 5 KR817992      X       
99.  GU581166 99% 9 Cl 5 KR817960 126 A>G     X       
100. GU581166 99% 25 Cl 9 KT783521 93A>G 
312 A>G 
451 T>C 
   X        
101. GU581166 99% 13 Cl 2 KR817994 273 G>A     X       
- - - - HQ383867  X       X    
102. HQ383867 100% 25 Cl 4 KR817943  X       X    
- - - - HQ383856     X  X      
103. HQ383856 100% 4 Cl 11 KR818023     X  X      
104. HQ383856 100% 5 Cl 3 KR818033     X  X      
105. HQ383856 100% 5 Cl 4 KR818034     X  X      
106. HQ383856 99% 6 Cl 3 KR818022 180 A>G   X X  X      
107. HQ383856 99% 43 Cl 1 KT783520 11 A>G    X  X      
108. HQ383856 95% 40 Cl 5 KT783522     X  X     X 
- - - - HQ383820    X         
109. HQ383820 100% 23 Cl 4 KR818019    X         
110. HQ383820 100% 27 Cl 3 KR818018    X         
111. HQ383820 100% 41 Cl 1 KR817998    X         
112. HQ383820 100% 41 Cl 3 KR817999    X         
113. HQ383820 99% 9 Cl 8 KR817951 110 T>C 
176 A>C 
182T>G 
211A>G 
283T>C 
  X         
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Table 19. Continued.  
 
    
No. GenBank 
match 
Max. 
identity 
Animal-Clone GenBank accession number Polymorphisms 
Misc. SNP 
80 
A>G 
SNP 
162 
A>G 
SNP 167 
A>C 
INS 
337 
A 
SNP 
338 G>A 
SNP 
344 
T>C 
SNP 
397 
T>C 
SNP 
415 
T>C 
SNP 
444 
A>G 
INS 
457 
C 
23-BP 
INS 
114. HQ383820 99% 9 Cl 9 KR817952 110 T>C 
176 A>C 
182T>G 
211A>G 
283T>C 
  X         
115. HQ383820 99% 23 Cl 2 KR818015 250 T>C   X         
116. HQ383820 99% 27 Cl 2 KR818014 250 T>C   X         
117. HQ383820 99% 23 Cl 5 KR817954    X     X    
118.                 
119.                 
120. HQ383820 99% 27 Cl 5 KR817953    X     X    
-  - - - EU450803   X  X  X  X X   
121. EU450803 100% 15 Cl 1 KR818021   X  X  X  X X   
122. EU450803 99% 19 Cl 3 KR818026     X  X  X X X  
123. EU450803 99% 19 Cl 6 KT783519     X  X  X X X  
124. EU450803 99% 26 Cl 2 KR818025 267 T>C    X  X  X X X  
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KT783522      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR818026      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR818025      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KT783521      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR818021      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
EU450803      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR818022      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KT783520      ACATGAAATAGTTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR818023      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
HQ383856      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR818035      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KT783523      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KT783518      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR817951      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR817964      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR817966      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR817944      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR817942      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR817941      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR818027      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAGTGACGAAGTCAGTGACGCAGAGC 60 
KR817957      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR818024      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
JF308498      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR817956      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR818015      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR818019      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
HQ383820      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
              ********** ************************* *********************** 
 
Fig. 1. Clustal Omega alignment of Cytauxzoon felis ITS1 sequence representatives of all sequences from this study that identically 
matched (100% identity) or had 1 or more base differences from the C. felis ITS1 sequences previously submitted to GenBank. 
Alignment also includes the previously reported C. felis ITS1 sequences in GenBank (EU450802, EU450803, HQ383820, HQ383856, 
HQ383867, GU531166, and JF308498), in which the ITS1 sequences of this study were most similar. Nucleotide position number 
indicated at the right. Matching nucleotides in all sequences are shown by *. Mismatch nucleotides are shown in bold. Gaps (deletions) 
are indicated by a dash (-).  
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KR817996      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR817993      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR817986      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR817989      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR817994      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR817967      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR817965      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR817963      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAGTGACGAAGTCAGTGACGCAGAGC 60 
KR817947      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR817946      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR817945      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR817943      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR817954      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR817950      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR818013      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR817939      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR817931      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR817940      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR817960      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR817938      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
GU581166      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR817922      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
EU450802      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
KR817955      ACATGAAATAATTATTTACATGAGTGAGGGAAGTCAATGACGAAGTCAGTGACGCAGAGC 60 
              ********** ************************* *********************** 
 
KT783522      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR818026      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR818025      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KT783521      GAAGCGAAGTTATGAAATCACTGATGTCAGAGGCGTAGTCAATGACTGATGTGATGAATG 120 
KR818021      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
EU450803      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR818022      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
               ************* **** *** ********  * ************* ********** 
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KT783520      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR818023      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
HQ383856      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR818035      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KT783523      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KT783518      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR817951      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGACGTGATGAATG 120 
KR817964      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR817966      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR817944      GAAGCGAAGTTATGAAATCACTGGTGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR817942      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR817941      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGCAGTCAATGACTGATGTGATGAATG 120 
KR818027      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR817957      AAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR818024      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
JF308498      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR817956      GAAGCGAAGTTATGAAATCGCTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR818015      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR818019      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
HQ383820      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR817996      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR817993      GAAGCGAAGTTATGGAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR817986      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR817989      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR817994      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR817967      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR817965      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR817963      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR817947      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR817946      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR817945      GAAGCGAAGTTATGAAATCACTGATGTCAGAGGCGTAGTCAATGACTGATGTGATGAATG 120 
KR817943      GAAGCGAAGTTATGAAATCGCTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR817954      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR817950      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR818013      GAAGCGAAGTTATGAAATCACTGATGTCAGAGATGTAGTCAATGACTGATGTGATGAATG 120 
               ************* **** *** ********  * ************* ********** 
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KR817939      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR817931      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR817940      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR817960      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR817938      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
GU581166      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR817922      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
EU450802      GAAGCGAAGTTATGAAATCACTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
KR817955      GAAGCGAAGTTATGAAATCGCTGATGTCAGAGACGTAGTCAATGACTGATGTGATGAATG 120 
               ************* **** *** ********  * ************* ********** 
 
KT783522      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR818026      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR818025      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KT783521      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR818021      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAGTAACATACTTCAAACTAA 180 
EU450803      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAGTAACATACTTCAAACTAA 180 
KR818022      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACCTACTTCAAACTAG 180 
KT783520      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR818023      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
HQ383856      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR818035      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KT783523      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACCTACTTCAAACTAA 180 
KT783518      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR817951      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACCTACTTCAACCTAA 180 
KR817964      AAGTAACGACCGAGGTCGTGATTGTCTTCATAGCTGAGGTGATAACATACTTCAAACTAA 180 
KR817966      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR817944      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR817942      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR817941      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAGTAACATACTTCAAACTAA 180 
KR818027      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR817957      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR818024      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
JF308498      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR817956      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
              ***** ************* ************ *******  **** ******** ***  
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KR818015      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACCTACTTCAAACTAA 180 
KR818019      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACCTACTTCAAACTAA 180 
HQ383820      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACCTACTTCAAACTAA 180 
KR817996      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR817993      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR817986      AAGTAACGACCGAGGTCGTTATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR817989      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR817994      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR817967      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR817965      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR817963      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR817947      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR817946      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR817945      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR817943      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR817954      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACCTACTTCAAACTAA 180 
KR817950      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR818013      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR817939      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR817931      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR817940      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR817960      AAGTAGCGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR817938      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
GU581166      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR817922      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
EU450802      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
KR817955      AAGTAACGACCGAGGTCGTGATTGTCTTCATAACTGAGGTAATAACATACTTCAAACTAA 180 
              ***** ************* ************ *******  **** ******** ***  
 
KT783522      CTTCATAACCTACTTCAACCTAACTTCATAACCTACTTCAACCTAACGTCATAACTATCT 240 
KR818026      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR818025      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KT783521      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR818021      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
EU450803      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
              *  ***                       *********** ********* ** *****  
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KR818022      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KT783520      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR818023      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
HQ383856      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR818035      CTTCATAACCTACTTCAACCTAACTTCATAACCTACTTCAACCTAACGTCATAACTATCT 240 
KT783523      CTTCATAACCTACTTCAAACTAACTTCATAACCTACTTCAACCTAACGTCATAACTATCT 240 
KT783518      CTTCATAACCTACTTCAAACTAACTTCATAACCTACTTCAACCTAACGTCATAACTATCT 240 
KR817951      CGTCAT-----------------------AACCTACTTCAACCTAACGTCATAGCTATCT 217 
KR817964      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR817966      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCC 217 
KR817944      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR817942      CTCCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR817941      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR818027      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR817957      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR818024      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
JF308498      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR817956      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR818015      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR818019      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
HQ383820      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR817996      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR817993      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR817986      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR817989      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR817994      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR817967      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR817965      CTTCAT-----------------------AACCTACTTCAGCCTAACGTCATAACTATCT 217 
KR817963      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR817947      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR817946      CTTCAT-----------------------AACCTACTTCAACCTAACGTCGTAACTATCT 217 
KR817945      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR817943      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR817954      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR817950      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
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KR818013      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR817939      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR817931      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR817940      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR817960      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR817938      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
GU581166      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR817922      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
EU450802      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
KR817955      CTTCAT-----------------------AACCTACTTCAACCTAACGTCATAACTATCT 217 
              *  ***                       *********** ********* ** *****  
 
KT783522      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 300 
KR818026      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR818025      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTCCCTTCGGGAA 277 
KT783521      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR818021      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
EU450803      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR818022      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KT783520      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR818023      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
HQ383856      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR818035      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 300 
KT783523      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 300 
KT783518      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 300 
KR817951      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR817964      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR817966      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR817944      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAACCGCTTCCTTCGGGAA 277 
KR817942      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR817941      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR818027      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR817957      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR818024      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
JF308498      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
              *** **************** *********** *********** **** ***** **** 
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KR817956      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR818015      CCCTTCATCCTGTAATTTCGTAACGTTGTTTACTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR818019      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
HQ383820      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR817996      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR817993      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR817986      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR817989      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR817994      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCAGGAA 277 
KR817967      CCCTTCATCCTGTAATTTCGCAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR817965      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR817963      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR817947      CCCCTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR817946      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR817945      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR817943      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR817954      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR817950      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR818013      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR817939      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR817931      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR817940      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR817960      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR817938      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
GU581166      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR817922      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
EU450802      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277 
KR817955      CCCTTCATCCTGTAATTTCGTAACGTTGTTTATTCATAGAGTAAACGCTTCCTTCGGGAA 277  
              *** **************** *********** *********** **** ***** **** 
 
KT783522      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGAA 360 
KR818026      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGAA 337 
KR818025      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGAA 337 
KT783521      AAACGTTACATTACCACCCCTCCATGTGATTTTAGATCACTTGGGTTATGTTGCAGTGAA 337 
KR818021      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGAA 337 
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EU450803      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGAA 337 
KR818022      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGAA 337 
KT783520      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGAA 337 
KR818023      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGAA 337 
HQ383856      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGAA 337 
KR818035      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 359 
KT783523      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 359 
KT783518      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 359 
KR817951      AAACGCTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR817964      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR817966      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGCTATGTTGCAGTGA- 336 
KR817944      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR817942      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTCGCAGTGA- 336 
KR817941      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR818027      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR817957      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR818024      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
JF308498      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR817956      AAACGTCACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR818015      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR818019      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
HQ383820      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR817996      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR817993      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR817986      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR817989      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR817994      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR817967      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR817965      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR817963      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR817947      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR817946      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR817945      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR817943      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR817954      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
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KR817950      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR818013      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR817939      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR817931      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR817940      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR817960      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR817938      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
GU581166      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR817922      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
EU450802      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
KR817955      AAACGTTACATTACCACCCCTCCATGTGATTTTAAATCACTTGGGTTATGTTGCAGTGA- 336 
              *****  *************************** ********** ***** *******  
 
KT783522      GATTCACTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 420 
KR818026      GATTCACTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 397 
KR818025      GATTCACTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 397 
KT783521      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 397 
KR818021      GATTCACTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 397 
EU450803      GATTCACTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 397 
KR818022      GATTCACTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 397 
KT783520      GATTCACTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 397 
KR818023      GATTCACTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 397 
HQ383856      GATTCACTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 397 
KR818035      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 419 
KT783523      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 419 
KT783518      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 419 
KR817951      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR817964      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR817966      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR817944      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATC 396 
KR817942      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR817941      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR818027      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATC 396 
KR817957      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATC 396 
KR818024      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATC 396 
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JF308498      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATC 396 
KR817956      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATC 396 
JF308498      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATC 396 
KR817956      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATC 396 
KR818015      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR818019      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
HQ383820      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR817996      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR817993      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR817986      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR817989      GATTCGTTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR817994      AATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR817967      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR817965      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR817963      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR817947      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR817946      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR817945      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR817943      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR817954      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR817950      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR818013      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR817939      GATTCATTGCAAACGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR817931      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR817940      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR817960      AATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR817938      AATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
GU581166      AATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR817922      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
EU450802      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
KR817955      GATTCATTGCAAATGTAATTAATAGAGTAATTGCTAATTCTCTATTAGTTGCTGGATATT 396 
               ****  ****** ********************************************* 
 
KT783522      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 480 
KR818026      AATTATCCTTCTTTCTTCCATACAACTACATGAGATGTTTCATCTCGACACATTTATTTC 457 
              * ****** ******** **************************** ******  ****  
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KR818025      AATTATCCTTCTTTCTTCCATACAACTACATGAGATGTTTCATCTCGACACATTTATTTC 457 
EU450803      AATTATCCTTCTTTCTTCCATACAACTACATGAGATGTTTCATCTCGACACATTTATTT- 457 
KT783521      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATCTATTT- 457 
KR818021      AATTATCCTTCTTTCTTCCATACAACTACATGAGATGTTTCATCTCGACACATTTATTT- 457 
KR818022      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 457 
KT783520      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 457 
KR818023      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 457 
HQ383856      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR818035      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 479 
KT783523      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 479 
KT783518      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 479 
KR817951      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR817964      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR817966      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR817944      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR817942      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR817941      AGTTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR818027      AATTATCCCTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR817957      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR818024      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
JF308498      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR817956      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR818015      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR818019      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
HQ383820      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 455 
KR817996      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTCATTT- 456 
KR817993      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR817986      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR817989      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR817994      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR817967      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR817965      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR817963      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR817947      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR817946      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
              * ****** ******** **************************** ******  ****  
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KR817945      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR817950      AATTATCCTTCTTTCTTCCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR817943      AATTATCCTTCTTTCTTCCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR817954      AATTATCCTTCTTTCTTCCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR818013      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR817939      AGTTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR817931      AGTTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR817940      AGTTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR817960      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR817938      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
GU581166      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR817922      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
EU450802      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
KR817955      AATTATCCTTCTTTCTTTCATACAACTACATGAGATGTTTCATCTCAACACATTTATTT- 456 
              * ****** ******** **************************** ******  ****  
 
KT783522      ATC 482 
KR818026      ATC 460 
KR818025      ATC 460 
KT783521      ATC 459 
KR818021      ATC 459 
EU450803      ATC 459 
KR818022      ATC 459 
KT783520      ATC 459 
KR818023      ATC 459 
HQ383856      --- 456a 
KR818035      ATC 481 
KT783523      ATC 481 
KT783518      ATC 481 
KR817951      ATC 458 
KR817964      ATC 458 
KR817966      ATC 458 
KR817944      ATC 458 
KR817942      ATC 458 
KR817941      ATC 458 
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KR818027      ATC 458 
JF308498      ATC 458 
KR817957      ATC 458 
KR818024      ATC 458 
KR817956      ATC 458 
KR818015      ATC 458 
KR818019      ATC 458 
HQ383820      --- 455b 
KR817996      ATC 458 
KR817993      ATC 458 
KR817986      ATC 458 
KR817989      ATC 458 
KR817994      ATC 458 
KR817967      ATC 458 
KR817965      ATC 458 
KR817963      ATC 458 
KR817947      ATC 458 
KR817946      ATC 458 
KR817945      ATC 458 
KR817943      ATC 458 
KR817954      ATC 458 
KR817950      ATC 458 
KR818013      ATC 458 
KR817939      ATC 458 
KR817931      ATC 458 
KR817940      ATC 458 
KR817960      ATC 458 
KR817938      ATC 458 
GU581166      ATC 458 
KR817922      ATC 458 
EU450802      ATC 458 
KR817955      ATC 458 
a  Only 456-bp submitted to GenBank for HQ383856.  
b Only 455-bp submitted to GenBank for HQ383820.  
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The remaining 45 ITS1 sequences varied from archived C. felis ITS1 sequences 
by one or more nucleotide substitution(s). Thirty had a single substitution that occurred, 
and of these, 22 clones (KR817931, KR817940, KR817945-KR817950, KR817955, 
KR817958, KR817963, KR817965, KR817967, KR817985-KR817989, KR817993, 
KR817996, KR817997, and KR818013) differed from prior GenBank accession number 
EU450802; two (KR817960 and KR817994) from deposited GenBank accession number 
GU581166; one (KR817957) from prior GenBank accession number JF308498; four 
(KR818015, KR818014, KR817953, and KR817954) from prior GenBank accession 
number HQ383820; and one (KT783520) from previously submitted GenBank accession 
number HQ383856 (Table 19). Fifteen C. felis ITS1 clones (KR817939; KR817941; 
KR817942; KR817944; KR817951; KR817952; KR817956; KR817964; KR817966; 
KR818022; KR818025; KR818026; KR818027; KT783519; KT783521) from 10 cats 
had two or more bases that varied from GenBank deposited sequences EU450802, 
HQ383820, GU581166, EU450803, and JF308498 (Table 18). 
The alignment of the sequence data from 122 C. felis ITS2 region clones 
revealed nine SNPs, one insertion, and one deletion (Fig. 2; Table 20), which resulted in 
a length of 264-265 bp, or 305 bp with the insert. Different C. felis ITS2 sequences were 
often found from a single cat. The most common ITS2 sequence (63 clones) matched a 
C. felis infection survived by a domestic cat in Georgia, EU450804, and was found in 47 
cloned amplicons from 16 domestic cats with acute, fatal C. felis infections (KR817922-
KR817933, KR817939-KR817941, KR817943, KR817944, KR817946, KR817953, 
 102 
 
KR817954, KR817956, KR817959, KR817968-KR817970, KR817986-KR817990, 
KR817993, KR817996-KR817999, KR818001, KR818010, KR818021-KR818024, 
KR818033-KR818035, KT783522, KT783524) and 16 cloned amplicons from seven 
cats with subclinical, chronic C. felis infections (KR817934- KR817937, KR817963, 
KR817967, KR817971- KR817980, KR818036) (Table 21). Of the 47 cloned C. felis 
amplicons from an acute, fatal infection, 42 clones were from 14 domestic cats from 
Oklahoma, and the five others were clones from two domestic cats from Missouri. The 
16 cloned C. felis amplicons from a subclinical, chronic infection were from one 
domestic cat (one clone) from Missouri and six domestic cats (15 clones) from 
Arkansas. 
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KT783518      TAAAATCCTAAAAGTACAACTTTTGTTGTTCTTTTGTGAGTAGAGGTGATTTACAATCCC 60 
EU450806      TAAAATCCTAAAAGTACAACTTTTGTTGTTCTTTTGTGAGTAGAGGTGATTTACAATCCC 60 
KR818028      TAAAATCCTAAAAGTACAACTTTTGTTGTTCTTTTGTGAGTAGAGGTGATTTACAATCCC 60 
KR818027      TAAAATCCTAAAAGTACAACTTTTGTTGTTCTTTTGTGAGTAGAGGTGATTTACAATCCC 60 
KR818011      TAAAATCCTAAAAGTACAACTTTTGTTGTTCTTTTGTGAGTAGAGGTGATTTACAATCCC 60 
KR818017      TAAAATCCTAAAAGTACAACTTTTGTTGTTCTTTTGTGAGTAGAGGTGATTTACAATCCC 60 
KT783523      TAAAATCCTAAAAGTACAACTTTTGTTGTTCTTTTGTGAGTAGAGGTGATTTACAATCCC 60 
KR817958      TAAAATCCTAAAAGTACAACTTTTGTTGTTCTTTTGTGAGTAGAGGTGATTTACAATCCC 60 
KR817957      TAAAATCCTAAAAGTACAACTTTTGTTGTTCTTTTGTGAGTAGAGGTGATTTGCAATCCC 60 
KR817948      TAAAATCCTAAAAGTACAACTTTTGCTGTTCTTTTGTGAGTAGAGGTGATTTACAATCCC 60 
KR817947      TAAAGTCCTAAAAGTACAACTTTTGTTGTTCTTTTGTGAGTAGAGGTGATTTACAATCCC 60 
KR817945      TAAAATCCTAAAAGTACAACTTTTGTTGTTCTTTTGTGAGTAGAGGTGATTTACAATCCC 60 
KR817950      TAAAATCCTAAAAGTACAACTTTTGTTGTTCTTTTGTGAGTAGAGGTGATTTACAATCCC 60 
KR818026      TAAAATCCTAAAAGTACAACTTTTGTTGTTCTTTTGTGAGTAGAGGTGATTTACAATCCC 60 
JF308506      TAAAATCCTAAAAGTACAACTTTTGTTGTTCTTTTGTGAGTAGAGGTGATTTACAATCCC 60 
KR817942      TAAAATCCTAAAAGTACAACTTTTGTTGTTCTTTTGTGAGTAGAGGTGATTTACAATCCC 60 
KR817951      TAAAATCCTAAAAGTACAACTTTTGTTGTTCTTTTGTGAGTAGAGGTGATTTACAATCCC 60 
KR817960      TAAAATCCTAAAAGTACAACTTTTGTTGTTCTTTTGCGAGTAGAGGTGATTTACAATCCC 60 
KR817938      TAAAATCCTAAAAGTACAACTTTTGTTGTTCTTTTGTGAGTAGAGGTGATTTACAATCCC 60 
EU450805      TAAAATCCTAAAAGTACAACTTTTGTTGTTCTTTTGTGAGTAGAGGTGATTTACAATCCC 60 
KR817955      TAAAATCCTAAAAGTACAACTTTTGTTGTTCTTTTGTGAGTAGAGGTGATTTACAATCCC 60 
KR817961      TAAAATCCTAAAAGTACAACTTTTGTTGTTCTTTTGTGAGTAGAGGTGATTTACAATCCC 60 
KR817922      TAAAATCCTAAAAGTACAACTTTTGTTGTTCTTTTGTGAGTAGAGGTGATTTACAATCCC 60 
EU450804      TAAAATCCTAAAAGTACAACTTTTGTTGTTCTTTTGTGAGTAGAGGTGATTTACAATCCC 60 
KR817962      TAAAATCCTAAAAGTACAACTTTTGTTGTTCTTTTGTGAGTAGAGGTGATTTACAATCCC 60 
              **** ******************** ********** *************** ******* 
 
KT783518      TCTATATCTACATTCTAGAGATTCACTACCTCGCATCTCGAAACTCTATTGTATTTTATA 120 
EU450806      TCTATATCTACATTCTAGAGATTCACTACCTCGCATCTCGAAACTCTATTGTATTTTATA 120 
KR818028      TCTATATCTACATTCTAGAGATTCACTACCTCGCATCTCGAAACTCTATTGTATTTTATA 120 
KR818027      TCTATATCTACATTCTAGAGATTCACTACCTCGCATCTCGAAACTCTATTGTATTTTATA 120 
KR818011      TCTATATCTACATTCTAGAGATTCACTACCTCGCATCTCGAAACTCTATTGTATTTT-AA 119 
KR818017      TCTATATCTACATTCTAGAGATTCACTACCTCGCATCTCGAAACTCTATTGTATTTT-AA 119 
KT783523      TCTATATCTACATTCTAGAGATTCACTACCTCGCATCTCGAAACTCTATTGTATTTTATA 120 
 
Fig. 2. Clustal Omega alignment of Cytauxzoon felis ITS2 sequence representatives of all sequences from this study that identically 
matched (100% identity) or had 1 or more base differences from the C. felis ITS2 sequences previously submitted to GenBank. 
Alignment also includes the previously reported C. felis ITS2 sequences in GenBank (EU450804, EU450805, EU450806, and JF308506), 
in which the ITS2 sequences of this study were most similar. Nucleotide position number indicated at the right. Matching nucleotides in 
all sequences are shown by *. Mismatch nucleotides are shown in bold. Gaps (deletions) are indicated by a dash (-).  
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KR817958      TCTATATCTACATTCTAGAGATTCACTACCTCGCATCTCGAAACTCTATTGTATTTTATA 120 
KR817957      TCTATATCTACATTCTAGAGATTCACTACCTCGCATCTCGAAACTCTATTGTATTTTATA 120 
KR817948      TCTATATCTACATTCTAGAGATTCACTACCTCGCATCTCGAAACTCTATTGTATTTTATA 120 
KR817947      TCTATATCTACATTCTAGAGATTCACTACCTCGCATCTCGAAACTCTATTGTATTTTATA 120 
KR817945      TCTATATCTACATTCTAGAGATTCACTACCTCGCATCTCGAAACTCTATTGTATTTTATA 120 
KR817950      TCTATATCTACATTCTAGAGACTCACTACCTCGCATCTCGAAACTCTATTGTATTTTATA 120 
KR818026      TCTATATCTACATTCTAGAGATTCACTACCTCGCATCTCGAAACTCTATTGTATTTTATA 120 
JF308506      TCTATATCTACATTCTAGAGATTCACTACCTCGCATCTCGAAACTCTATTGTATTTTATA 120 
KR817942      TCTATATCTACATTCTAGAGATTCACTACCTCGCATCTCGAAGCTCTATTGTATTTTATA 120 
KR817951      TCTATATCTACATTCTAGAGATTCACTACCTCGCATCTCGAAACTCTATTGTATTTTACA 120 
KR817960      TCTATATCTACATTCTAGAGATTCACTACCTCGCATCTCGAAACTCTATTGTATTTTATA 120 
KR817938      TCTATATCTACATTCTAGAGATTCACTACCTCGCATCTCGAAACTCTATTGTATTTTATA 120 
EU450805      TCTATATCTACATTCTAGAGATTCACTACCTCGCATCTCGAAACTCTATTGTATTTTATA 120 
KR817955      TCTATATCTACATTCTAGAGATTCACTACCTCGCATCTCGAAACTCTATTGTATTTTATA 120 
KR817961      TCTATATCTACATTCTAGAGATTCACTACCTCGCATCTCGAAACTCTATTGTATTTTATA 120 
KR817922      TCTATATCTACATTCTAGAGATTCACTACCTCGCATCTCGAAACTCTATTGTATTTTATA 120 
EU450804      TCTATATCTACATTCTAGAGATTCACTACCTCGCATCTCGAAACTCTATTGTATTTTATA 120 
KR817962      TCTATATCTACATTCTAGAGATTCACTACCTCGCATCTCGAAACTCTATTGTATTTTATA 120 
              ********************* ******************** **************  * 
 
KT783518      TACTCTACGTTTTGAGTGAGGGACATGAATTTCATTATTGAATGACGTGAGGAAGATCCG 180 
EU450806      TACTCTACGTTTTGAGTGAGGGACATGAATTTCATTATTGAATGACGTGAGGAAGATCCG 180 
KR818028      TACTATACGTTTTGAGTGAGGGACATGAATTTCATTATTGAATGACGTGAGGAAGATCCG 180 
KR818027      TACTCTACGTTTTGAGTGAGGGACATGAATTTCATTATTGAATGACGTGAGGAAGATCCG 180 
KR818011      TACTCTACGTTTTGAGTGAGGGACATGAATTTCATTATTGAATGACGTGAGGAAGATCCG 179 
KR818017      TACTCTACGTTTTGAGTGAGGGACATGAATTTCATTATTGAATGACGTGAGGAAGATCCG 179 
KT783523      TACTCTACGTTTTGAGTGAGGGACATGAATTTCCTTATTGAATGACGTGAGGAAGATCCG 180 
KR817958      TACTCTACGTTTTGAGTGAGGGACATGAATTTCATTATTGAATGACGTGAGGAAGATCCG 180 
KR817957      TACTCTACGTTTTGAGTGAGGGACATGAATTTCATTATTGAATGACGTGAGGAAGATCCG 180 
KR817948      TACTCTACGTTTTGAGTGAGGGACATGAATTTCATTATTGAATGACGTGAGGAAGATCCG 180 
KR817947      TACTCTACGTTTTGAGTGAGGGACATGAATTTCATTATTGAATGACGTGAGGAAGATCCG 180 
KR817945      TACTCTACGTTTTGAGTGAGGGACATGAACTTCATTATTGAATGACGTGAGGAAGATCCG 180 
KR817950      TACTCTACGTTTTGAGTGAGGGACATGAATTTCATTATTGAATGACGTGAGGAAGATCCG 180 
KR818026      TACTCTACGTTTTGAGTGAGGGACATGAATTTCATTATTGAATGACGTGAGGAAGATCCG 180 
JF308506      TACTCTACGTTTTGAGTGAGGGACATGAATTTCATTATTGAATGACGTGAGGAAGATCCG 180 
KR817942      TACTCTACGTTTTGAGTGAGGGACATGAATTTCATTATTGAATGACGTGAGGAAGATCCG 180 
KR817951      TACTCTACGTTTTGAGTGAGGGACATGAATTTCATTATTGAATGACGTGAGGAAGATCCT 180 
KR817960      TACTCTACGTTTTGAGTGAGGGACATGAATTTCATTATTGAATGACGTGAGGAAGATCCT 180 
KR817938      TACTCTACGTTTTGAGTGAGGGACATGAATTTCATTATTGAATGACGTGAGGAAGATCCT 180 
EU450805      TACTCTACGTTTTGAGTGAGGGACATGAATTTCATTATTGAATGACGTGAGGAAGATCCT 180 
              **** **** ******************* *** *************************  
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KR817955      TACTCTACGTTTTGAGTGAGGGACATGAATTTCATTATTGAATGACGTGAGGAAGATCCG 180 
KR817961      TACTCTACGCTTTGAGTGAGGGACATGAATTTCATTATTGAATGACGTGAGGAAGATCCG 180 
KR817922      TACTCTACGTTTTGAGTGAGGGACATGAATTTCATTATTGAATGACGTGAGGAAGATCCG 180 
EU450804      TACTCTACGTTTTGAGTGAGGGACATGAATTTCATTATTGAATGACGTGAGGAAGATCCG 180 
KR817962      TACTCTACGTTTTGAGTGAGGGACATGAATTTCATTATTGAATGACGTGAGGAAGATCCG 180 
              **** **** ******************* *** *************************  
 
KT783518      AACGGAGTGAGGAAGTGTGGGATGTACCGACGTGTGAGGATTATCACAGTATTCCTCAAT 240 
EU450806      AACGGAGTGAGGAAGTGTGGGATGTACCGACGTGTGAGGATTATCACAGTATTCCTCAAT 240 
KR818028      AACGGAGTGAGGAAGTGTGGGATGTACCGACGTGTGAGGATTATCACAGTATTCCTCAAT 240 
KR818027      AACGGAGTGAGGAAGTGTGGGATGTACCGACGTGTGAGGATTATCACAGTATTCCTCAAT 240 
KR818011      AACGGAGTGAGGAAGTGTGTGATGTACCGACGTGTGAGGATTATCACAGTATTCCTCAAT 239 
KR818017      AACGGAGTGAGGAAGTGTGGGATGTACCGACGTGTGAGGATTATCACAGTATTCCTCAAT 239 
KT783523      AACGGAGTGAGGAAGTGTGGGATGTACCGACGTGTGAGGATTATCACAGTATTCCTCGAT 240 
KR817958      AACGGAGTGAGGGAGTGTGGGATGTAACGACGTGTGAGGATTATCACAGTATTCCTCAAT 240 
KR817957      AACGGAGTGAGGAAGTGTGGGATGTACCGACGTGTGAGGATTATCACAGTATTCCTCAAT 240 
KR817948      AACGGAGTGAGGAAGTGTGGGATGTACCGACGTGTGAGGATTATCACAGTATTCCTCAAT 240 
KR817947      AACGGAGTGAGGAAGTGTGGGATGTACCGACGTGTGAGGATTATCACAGTATTCCTCAAT 240 
KR817945      AACGGAGTGAGGAAGTGTGGGATGTACCGACGTGTGAGGATTATCACAGTATTCCTCAAT 240 
KR817950      AACGGAGTGAGGAAGTGTGGGATGTACCGACGTGTGAGGATTATCACAGTATTCCTCAAT 240 
KR818026      AACGGAGTGAGGAAGTGTGGGATGTACCGACGTGTGAGGATTATCACAGTATTCCTCAAT 240 
JF308506      AACGGAGTGAGGAAGTGTGGGATGTACCGACGTGTGAGGATTATCACAGTATTCCTCAAT 240 
KR817942      AACGGAGTGAGGAAGTGTGGGATGTACCGACGTGTGAGGATTATCACAGTATTCCTCAAT 240 
KR817951      AACGGAGTGAGGAAGTGTGGGATGTACCGACGTGTGAGGATTATCACAGTATTCCTCAAT 240 
KR817960      AACGGAGTGAGGAAGTGTGGGATGTACCGACGTGTGAGGATTATCACAGTATTCCTCAAT 240 
KR817938      AACGGAGTGAGGAAGTGTGGGATGTACCGACGTGTGAGGATTATCACAGTATTCCTCAAT 240 
EU450805      AACGGAGTGAGGAAGTGTGGGATGTACCGACGTGTGAGGATTATCACAGTATTCCTCAAT 240 
KR817955      AACGGAGTGAGGAAGTGTGGGATGTACCGACGTGTGAGGATTATCACAGTATTCCTCAAT 240 
KR817961      AACGGAGTGAGGAAGTGTGGGATGTACCGACGTGTGAGGATTATCACAGTATTCCTCAAT 240 
KR817922      AACGGAGTGAGGAAGTGTGGGATGTACCGACGTGTGAGGATTATCACAGTATTCCTCAAT 240 
EU450804      AACGGAGTGAGGAAGTGTGGGATGTACCGACGTGTGAGGATTATCACAGTATTCCTCAAT 240 
KR817962      AACGGAGTGAGGAAGTGTGGGATGTACCGACGTGTGAGGATTATCACAGTATTCCTCAAT 240 
              ************ ****** ****** ****************************** ** 
 
KT783518      ACATCGATATATCTCAACATCTCCATCAATACATCAACATACGTCGATGTATCGATCTAC 300 
EU450806      ACATCGATNTATCTCAACATCTCCATCAATACATCAACATACGTCGATGTATCGATCTTC 300 
KR818028      ACATCGATGTATCTCAACATCTCCATCAATACATCAACATACGTCGATGTATCGATCTTC 300 
KR818027      ACATCGATGTATCTCAACATCTCCATCAATACATCAACATACGTCGATGTATCGATCTTC 300 
KR818011      ACATCGATGTATC----------------------------------------GATCTTC 259 
              ** * *** ****                                        ******* 
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KR818017      ACATCGATGTATC----------------------------------------GATCTTC 259 
KT783523      ACATCGATGTATC----------------------------------------GATCTTC 260 
KR817958      ACATCGATGTATC----------------------------------------GATCTTC 260 
KR817957      ACGTTGATGTATC----------------------------------------GATCTTC 260 
KR817948      ACATCGATGTATC----------------------------------------GATCTTC 260 
KR817947      ACGTCGATGTATC----------------------------------------GATCTTC 260 
KR817945      ACATCGATGTATC----------------------------------------GATCTTC 260 
KR817950      ACATCGATGTATC----------------------------------------GATCTTC 260 
KR818026      ACGTCGATGTATC----------------------------------------GATCTTC 260 
JF308506      ACGTCGATGTATC----------------------------------------GATCTTC 260 
KR817942      ACATCGATGTATC----------------------------------------GATCTTC 260 
KR817951      ACATCGATGTATC----------------------------------------GATCTTC 260 
KR817960      ACATCGATGTATC----------------------------------------GATCTTC 260 
KR817938      ACATCGATGTATC----------------------------------------GATCTTC 260 
EU450805      ACATCGATGTATC----------------------------------------GATCTTC 260 
KR817955      ACATTGATGTATC----------------------------------------GATCTTC 260 
KR817961      ACATCGATGTATC----------------------------------------GATCTTC 260 
KR817922      ACATCGATGTATC----------------------------------------GATCTTC 260 
EU450804      ACATCGATGTATC----------------------------------------GATCTTC 260 
KR817962      ACATCGATGTATC----------------------------------------GATCTTC 260 
              ** * *** ****                                        ******* 
 
KT783518      CTTCA 305 
EU450806      CTTCA 305 
KR818028      CTTCA 305 
KR818027      CTTCA 305 
KR818011      CTTCA 264 
KR818017      CTTCA 264 
KT783523      CTTCA 265 
KR817958      CTTCA 265 
KR817957      CTTCA 265 
KR817948      CTTCA 265 
KR817947      CTTCA 265 
KR817945      CTTCA 265 
KR817950      CTTCA 265 
KR818026      CTTCA 265 
JF308506      CTTCA 265 
KR817942      TTTCA 265 
KR817951      CTTCA 265 
KR817960      CTTCA 265 
         **** 
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KR817938      CTTCA 265 
EU450805      CTTCA 265 
KR817955      CTTCA 265 
KR817961      TTTCA 265 
KR817922      CTTCA 265 
EU450804      CTTCA 265 
KR817962      TTTCA 265 
         **** 
Fig. 2. Continued.  
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Table 20. Maximum identity to prior GenBank accession numbers (GenBank match) and nucleotide variation of cloned Cytauxzoon felis 
ITS2 amplicons. Sequence position numbering is based on GenBank accession number EU450804. Insertions, single nucleotide 
polymorphisms, miscellaneous mismatches, and deletions are shown as INS, SNP, Misc., and DEL, respectively.  
 
No. GenBank 
match 
Max 
identity 
Animal-Clone GenBank accession number Polymorphisms 
Misc. SNP 
80 
T>C 
119 
DEL 
T 
SNP 
180 
G>T 
SNP 
243 
A>G 
SNP 
249 
G>A 
254 
40-
BP 
INS 
SNP 
261 
C>T 
- - - - EU450804         
1 EU450804 100% 1 Cl 2 KR817922         
2 EU450804 100% 1 Cl 6 KR817923         
3 EU450804 100% 1 Cl 8 KR817924         
4 EU450804 100% 1 Cl 9 KR817925         
5 EU450804 100% 1 Cl 11 KR817926         
6 EU450804 100% 4 Cl 1 KR817927         
7 EU450804 100% 4 Cl 3 KR817928         
8 EU450804 100% 4 Cl 6 KR817929         
9 EU450804 100% 4 Cl 9 KR817930         
10 EU450804 100% 4 Cl 11 KR818023         
11 EU450804 100% 6 Cl 2 KR817956         
12 EU450804 100% 6 Cl 3 KR818022         
13 EU450804 100% 15 Cl 1 KR818021         
14 EU450804 100% 15 Cl 7 KR817931         
15 EU450804 100% 15 Cl 8 KR817939         
16 EU450804 100% 15 Cl 9 KR817940         
17 EU450804 100% 15 Cl 12 KR817941         
18 EU450804 100% 23 Cl 5 KR817954         
19 EU450804 100% 25 Cl 4 KR817943         
20 EU450804 100% 25 Cl 6 KR817944         
21 EU450804 100% 25 Cl 12 KR818024         
22 EU450804 100% 26 Cl 1 KR817946         
23 EU450804 100% 27 Cl 5 KR817953         
24 EU450804 100% 28 Cl 2 KT783524         
25 EU450804 100% 28 Cl 3 KR817932         
26 EU450804 100% 28 Cl 5 KR817933         
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No. GenBank 
match 
Max 
identity 
Animal-Clone GenBank accession number Polymorphisms 
Misc. SNP 
80 
T>C 
119 
DEL 
T 
SNP 
180 
G>T 
SNP 
243 
A>G 
SNP 
249 
G>A 
254 
40-
BP 
INS 
SNP 
261 
C>T 
27 EU450804 100% 28 Cl 6 KR817959         
28 EU450804 100% 34 Cl 1 KR817967         
29 EU450804 100% 34 Cl 2 KR817934         
30 EU450804 100% 35 Cl 1 KR817935         
31 EU450804 100% 35 Cl 2 KR817936         
32 EU450804 100% 36 Cl 1 KR817937         
33 EU450804 100% 5 Cl 2 KR818036         
34 EU450804 100% 5 Cl 3 KR818033         
35 EU450804 100% 5 Cl 4 KR818034         
36 EU450804 100% 32 Cl 5 KR817963         
37 EU450804 100% 16 Cl 1 KR817989         
38 EU450804 100% 16 Cl 2 KR817990         
39 EU450804 100% 16 Cl 4 KR817986         
40 EU450804 100% 16 Cl 5 KR817987         
41 EU450804 100% 16 Cl 6 KR817988         
42 EU450804 100% 18 Cl 1 KR817968         
43 EU450804 100% 18 Cl 2 KR817969         
44 EU450804 100% 18 Cl 5 KR817993         
45 EU450804 100% 20 Cl 1 KR817996         
46 EU450804 100% 20 Cl 3 KR817997         
47 EU450804 100% 21 Cl 8 KR817970         
48 EU450804 100% 29 Cl 1 KR817971         
49 EU450804 100% 29 Cl 4 KR817972         
50 EU450804 100% 29 Cl 5 KR817973         
51 EU450804 100% 29 Cl 6 KR817974         
52 EU450804 100% 30 Cl 5 KR817975         
53 EU450804 100% 31 Cl 6 KR817976         
54 EU450804 100% 31 Cl 8 KR817977         
55 EU450804 100% 31 Cl 9 KR817978         
56 EU450804 100% 31 Cl 10 KR817979         
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No. GenBank 
match 
Max 
identity 
Animal-Clone GenBank accession number Polymorphisms 
Misc. SNP 
80 
T>C 
119 
DEL 
T 
SNP 
180 
G>T 
SNP 
243 
A>G 
SNP 
249 
G>A 
254 
40-
BP 
INS 
SNP 
261 
C>T 
57 EU450804 100% 31 Cl 11 KR817980         
58 EU450804 100% 40 Cl 2 KR818035         
59 EU450804 100% 40 Cl 5 KT783522         
60 EU450804 100% 41 Cl 1 KR817998         
61 EU450804 100% 41 Cl 3 KR818001         
62 EU450804 100% 41 Cl 5 KR817999         
63 EU450804 100% 5 Cl 5 KR818010         
64 EU450804 99% 27 Cl 1 KR818016   X      
65 EU450804 99% 27 Cl 2 KR818014   X      
66 EU450804 99% 27 Cl 3 KR818018   X      
67 EU450804 99% 42 Cl 10 KR818020   X      
68 EU450804 99% 18 Cl 3 KR818031   X      
69 EU450804 99% 18 Cl 4 KR818032   X      
70 EU450804 99% 23 Cl 1 KR818017   X      
71 EU450804 99% 23 Cl 2 KR818015   X      
72 EU450804 99% 23 Cl 4 KR818019   X      
73 EU450804 99% 33 Cl 1 KR817965        X 
74 EU450804 99% 33 Cl 2 KR817966        X 
75 EU450804 99% 43 Cl 4 KR817964        X 
76 EU450804 99% 40 Cl 6 KR817995        X 
77 EU450804 99% 3 Cl 3 KR817962        X 
78 EU450804 99% 19 Cl 1 KR818011 200 T>G  X      
79 EU450804 99% 19 Cl 4 KR818026 200 T>G  X      
80 EU450804 99% 19 Cl 6 KR818013 200 T>G  X      
81 EU450804 99% 19 Cl 9 KT783519 200 T>G  X      
82 EU450804 99% 27 Cl 4 KR817949  X       
83 EU450804 99% 21 Cl 12 KR817985  X       
84 EU450804 99% 23 Cl 3 KR817950  X       
85 EU450804 99% 25 Cl 11 KR817945 150 T>C        
86 EU450804 99% 26 Cl 5 KR817948 26 T>C        
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No. GenBank 
match 
Max 
identity 
Animal-Clone GenBank accession number Polymorphisms 
Misc. SNP 
80 
T>C 
119 
DEL 
T 
SNP 
180 
G>T 
SNP 
243 
A>G 
SNP 
249 
G>A 
254 
40-
BP 
INS 
SNP 
261 
C>T 
87 EU450804 99% 6 Cl 5 KR817958 193 A>G 
207 C>A 
       
88 EU450804 99% 10 Cl 6 KT783523 154 A>C 
238 A>G 
       
            
89 EU450804 99% 3 Cl 2 KR817961 130 T>C      X 
91 EU450804 99% 17 Cl 12 KR817942 103 A>G      X  
- - - - EU450805   X      
92 EU450805 100% 9 Cl 3 KR817938   X      
93 EU450805 100% 13 Cl 1 KR817982   X      
94 EU450805 100% 13 Cl 2 KR817994   X      
95 EU450805 100% 13 Cl 3 KR817983   X      
96 EU450805 100% 13 Cl 4 KR817984   X      
97 EU450805 100% 13 Cl 5 KR817992   X      
98 EU450805 99% 9 Cl 5 KR817960 37 T>C  X      
99 EU450805 99% 9 Cl 8 KR817951 119 T>C  X      
100 EU450805 99% 9 Cl 9 KR817952 119 T>C  X      
- - - - EU450806a   X   X   
101 EU450806 100% 12 Cl 3 KR818002   X  X X   
102 EU450806 100% 12 Cl 7 KR818003   X  X X   
103 EU450806 100% 12 Cl 9 KR818004   X  X X   
104 EU450806 100% 12 Cl 10 KR818005   X  X X   
105 EU450806 100% 12 Cl 12 KR818006   X  X X   
106 EU450806 100% 14 Cl 7 KR817991   X  X X   
107 EU450806 100% 20 Cl 4 KR818008   X  X X   
108 EU450806 100% 20 Cl 5 KR818009   X  X X   
109 EU450806 100% 30 Cl 2 KR818000   X   X   
110 EU450806 100% 43 Cl 1 KT783520   X   X   
111 EU450806 100% 20 Cl 2 KR818007   X  X X   
112 EU450806 100% 25 Cl 9 KT783521   X   X   
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Table 20. Continued. 
 
No. GenBank 
match 
Max 
identity 
Animal-Clone GenBank accession number Polymorphisms 
Misc. SNP 
80 
T>C 
119 
DEL 
T 
SNP 
180 
G>T 
SNP 
243 
A>G 
SNP 
249 
G>A 
254 
40-
BP 
INS 
SNP 
261 
C>T 
113 EU450806 100% 10 Cl 1 KR818027   X   X   
114 EU450806 100% 41 Cl 2 KR818001    X   X  
115 EU450806 99% 36 Cl 2 KR818029 125 C>A   X   X  
116 EU450806 99% 39 Cl 3 KR818030 125 C>A   X   X  
117 EU450806 99% 32 Cl 4 KR818028 125 C>A   X   X  
118 EU450806 99% 5 Cl 1 KT783518 299 T>A   X  X X  
- - - - JF308506     X    
119 JF308506 100% 26 Cl 2 KR818025     X    
120 JF308506 100% 19 Cl 3 KR818026     X    
121 JF308506 99% 26 Cl 4 KR817947 5 A>G    X    
122 JF308506 99% 6 Cl 4 KR817957 53 A>G 
243 C>T 
   X    
a Sequence contained a polymorphic site depicted as N at position 249.
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Table 21. Number and distribution of Cytauxzoon felis cloned ITS2 sequences according to the state 
of origin and clinical outcome that matched sequences previously reported to GenBank. GenBank 
accession no. (GBA) of the previously reported sequence and observed differences in this study are 
listed. The cloned ITS2 sequences from this study are in the GenBank deposited partial-18S-ITS1-
5.8S-ITS2-partial 28S rDNA sequences provided below. 
 
GBA  
and changes 
 
No. of 
cloned 
amplicons 
(% of 
total) 
Number of genetic types 
according to state of origin 
Clinical outcome  
OK KS AR MO TX acute, 
fatal 
acute, 
recovered 
chronic, 
subclinical 
EU450804 63 (52) 42 0 15 6 0 47 0 16 
   1 base changea    20 (16) 15 2 0 1 2 17 3 0 
   >1 base changeb 8 (7) 8 0 0 0 0 4 0 4 
EU450806 14 (11) 11 0 0 2 1 8 1 5 
   1 base changec 4 (3) 1 1 1 1 0 2 1 1 
EU450805 6 (5) 6 0 0 0 0 6 0 0 
   1 base changed 3 (2) 3 0 0 0 0 3 0 0 
JF308506  2 (2) 2 0 0 0 0 1 0 1 
   1 base changee                             1 (1) 1 0 0 0 0 1 0 0 
   >1 base changef 1 (1) 1 0 0 0 0 1 0 0 
a Sequences KR817945; KR817948-KR817950; KR817955; KR817962; KR817964-KR817966; 
KR817985; KR817995; KR818014-KR818020; KR818031; KR818032 from this study.  
b Sequences KR817942; KR817958; KR817961; KR818011; KR818013; KR818026;  
KT783519; KT783523 from this study. 
c Sequences KR818028-KR818030; KT783518 from this study. 
d Sequences KR817951; KR817952; KR817960 from this study. 
e Sequence KR817947 from this study. 
f Sequence KR817957 from this study.  
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The second most common ITS2 sequence matched a C. felis ITS2 sequence from 
a fatally infected cat from Arkansas, EU450806, which had a 40-bp insertion. A similar 
sequence with a 40-bp insert was found in three ITS2 sequences (HQ383878, 
HQ383880, HQ383881) of C. felis from Florida pumas (Shock et al., 2012). A 41-bp 
insert in the same location as the C. felis ITS2 sequences of the Florida pumas and 
EU450806 was detected in C. felis of a bobcat from Missouri (HQ383897) (Shock et al., 
2012). In this study, this 40-bp insert was detected in 14 C. felis cloned amplicons from 
Oklahoma (11 clones), Missouri (two clones), and Texas (one clone) in eight domestic 
cats that either recovered, survived, or died from cytauxzoonosis (Table 21) (KR817991, 
KR818000-KR818009, KR818027, KT783520, and KT783521). Of the 11 cloned 
C. felis amplicons from Oklahoma, six clones were from four domestic cats that 
succumbed to acute, fatal infection, and five clones were from one cat with a subclinical, 
chronic infection. Two clones from Missouri came from two domestic cats with acute, 
fatal infections. The one C. felis clone from a domestic cat in Texas was from an acute, 
recovery case.  
The ITS2 sequences of three additional clones (KR818028-KR818030) contained 
this 40-bp insert as well as the same SNP at position 125 of the non-insert region (Table 
20). These clones were from three domestic cats (two subclinical, chronic carriers from 
Arkansas and one acute, fatal infection from Missouri). One other C. felis ITS2 clone, 
KT783518, from a domestic cat from Oklahoma with an acute, fatal infection had the 
40-bp insert, which contained a single nucleotide change inside the 40-bp insert region 
(Fig. 2).  
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Additionally, two C. felis ITS2 clones (KR818025 and KR818026) from two 
domestic cats (one acute, fatal and one subclinical, chronic) from Oklahoma matched 
GenBank accession number JF308506 (C. felis from a bobcat from Missouri) and six 
clones (KR817938, KR817982- KR817984, KR817992, and KR817994) from two 
domestic cats with acute, fatal infections from Oklahoma matched GenBank accession 
number EU450805 (C. felis infected domestic cat from Georgia) (Table 21).  
The remaining 33 ITS2 sequences differed from the C. felis ITS2 sequences 
deposited in GenBank by one or more nucleotide substitution(s). Twenty-four had a 
single substitution, and of these, 20 clones (KR817945, KR817948-KR817950, 
KR817955, KR817962, KR817964-KR817966, KR817985, KR817995, KR818014-
KR818020, KR818031, and KR818032) varied from prior GenBank accession number 
EU450804 and one (KR817947) from previously submitted GenBank accession number 
JF308506, and three (KR817951, KR817952, and KR817960) from prior GenBank 
accession number EU450805 (Table 20). Nine C. felis ITS2 clones (KR817942, 
KR817957, KR817958, KR817961, KR818011, KR818013, KR818026, KT783519, and 
KT783523) from six cats had two or more bases that varied from GenBank deposited 
sequences EU450804 and JF308506 (Table 20).  
The ITS1 and ITS2 sequences for each clone were joined together for genotyping 
as previously described (Brown et al., 2009a). When ITS1 and ITS2 sequences were 
combined, 72 C. felis clones from 27 domestic cats had previously described genotypes 
(Brown et al., 2009a, 2009b, 2010; Shock et al., 2012). This entailed clones that had 
exact matches and one nucleotide difference with the sequences of the prior genotypes 
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(Table 22). Due to multiple variances of a previous genotype or not having a genotype 
that was previously designated, 50 clones did not have prior genotypes. An observation 
of variances of multiple C. felis ITS genotypes infecting the same animal was seen with 
25 domestic cats. The other 10 cats produced 42 clones of the same C. felis ITS 
genotypes.  
The most common genotype, ITSa (GenBank accession numbers EU450802 and 
EU450804 for ITS1 and ITS2, respectively) (Brown et al., 2009a), was found in 51 
C. felis clones of 22 domestic cats. Clones with one random nucleotide substitution in 
the ITS1 or ITS2 sequence of the ITSa genotype were included, and these clones were 
represented by GenBank accession number KR817962 (Table 22). There were 14 clones 
of eight domestic cats with the ITSn genotype (GenBank accession numbers EU450802 
and EU450806) (Shock et al., 2012), and this included the clones with a single random 
base substitution in either one of the ITS sequences of this genotype. These clones were 
represented by GenBank accession number KR818029 (Table 22). Six clones of two 
domestic cats were the ITSd genotype (GenBank accession numbers GU581166 and 
EU450805) (Brown et al., 2010). These six clones consisted of clones with one random 
nucleotide substitution in their ITS1 or ITS2 sequences in this genotype, and these 
clones were represented by GenBank accession number KR818029. There was only one 
clone from one domestic cat with the ITSc genotype (GenBank accession numbers 
EU450803 and EU450804) (Brown et al., 2009a).  
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Table 22. Number of C. felis isolates (N) assigned a particular ITS genotype in this 
study.  Genotypes include previously reported ITSa, ITSc, ITSd, and ITSn (100% match 
or one base difference), ITSaa and ITSbb which match ITSa and ITSn except for a 23-bp 
insert in ITS1, ITScc-ITShh which represent newly identified combinations of 
previously reported ITS1 and ITS2 sequences, and ITSii-ITStt which show the highest 
identity to the ITS1 and ITS2 shown but are considered variances.  The reference or 
source and the total number of cloned amplicons for each genotype are shown. 
 
N Genotype 
 
Previously Reported 
GBA 
Reference/source GBA this 
study 
Total of 
cloned 
amplicons ITS1 ITS 2   
22 ITSa EU450802 EU450804 Brown et al., 
2009a 
KR817922 51a 
1 ITSc EU450803 EU450804 Brown et al., 
2009a 
KR818021 1a 
2 ITSd GU581166 EU450805 Brown et al., 2010 KR817938 6a 
8 ITSn EU450802 EU450806 Shock et al., 2012 KR818002 14a 
3 ITSaa EU450802 EU450804 This study KR818036 4b 
1 ITSbb EU450802 EU450806 This study KT783518  1b 
1 ITScc JF308498 EU450804 This study KR818024 1 
2 ITSdd  HQ383856 EU450804 This study KR818023 3 
3 ITSee HQ383820 EU450804 This study KR818018  6 
1 ITSff GU581166 EU450804 This study KR818010 1 
1 ITSgg HQ383867 EU450804 This study KR817943 1 
1 ITShh HQ383856 EU450806 This study KT783520 1 
12 ITSii EU450802 EU450804 This study KR818013 17 
1 ITSjj EU450802 JF308506 This study KR817947 1 
2 ITSkk EU450803 JF308506 This study KR818025 2 
1 ITSll EU450803 EU450804 This study KT783519 1 
2 ITSmm HQ383820 EU450804 This study KR818014 2 
1 ITSnn HQ383856 EU450804 This study KR818022 1 
2 ITSoo JF308498 EU450804 This study KR817944 2 
1 ITSpp JF308498 JF308506 This study KR817957 1 
1 ITSqq JF308498 EU450806 This study KR818027 1 
1 ITSrr GU581166 EU450806 This study KT783521 1 
1 ITSss GU581166 EU450805 This study KR817960 1 
1 ITStt HQ383820 EU450805 This study KR817951 2 
       
a Includes genotypes and sequences with one base difference in ITS1 and/or ITS2 from 
the previously reported genotype sequence. 
b Includes clones with the 23-bp insert in ITS1. 
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The remaining 50 clones did not correspond to these previously described 
genotypes. These clones either had multiple variances of a prior genotype or had a 
genotype that was not previously described. Five of these clones contained the novel 23-
bp insert in their ITS1 sequence and therefore had novel genotypes (genotypes ITSaa 
and ITSbb). The ITS1 sequence of three of these clones had a 95% identity to the 
previously submitted GenBank accession number EU450802. GenBank accession 
number KR818036 from this study represents these three clones (Table 22). With the 
previously reported GenBank accession number EU450804 as their ITS2 sequence, these 
clones were designated ITSaa for their genotype. Another clone from this study, 
KT783522, had an additional one base insert but was still considered as the ITSaa 
genotype. One clone contained both the 23-bp insert in the ITS1 sequence and the 40-bp 
insert in the ITS2 sequence in this study (KT783518) and was designated ITSbb as the 
genotype.  
Thirteen clones either exactly matched or had a single base substitution from 
exactly matching sequences previously submitted to GenBank, but their combined ITS1 
and ITS2 sequences had no prior genotype designations. In the current study, these 
sequence combinations were designated a genotype. One clone in this study (GenBank 
accession number KR818024) had previously submitted GenBank accession numbers 
JF308498 and EU450804 for the ITS1 and ITS2 sequences, respectively. This sequence 
combination was denoted as genotype ITScc in this study (Table 22). Combined 
sequences of previously submitted GenBank accession numbers HQ383856 and 
EU450804 were found in three clones in this study. GenBank accession number 
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KR818023 from this study represented these clones, and they were referred to as having 
an ITSdd genotype (Table 22). Six clones in this study had genotype ITSee as they had a 
combination of previously submitted GenBank accession numbers HQ383820 and 
EU450804. GenBank accession number of KR817998 from this study represented the 
two clones with the exact matches, and sequences of four clones, such as GenBank 
accession number of KR818018, had a one base substitution. One clone (GenBank 
accession number KR818010) had prior sequences of GU581166 and EU450804 and 
was referred to as genotype ITSff. Another clone (GenBank accession number 
KR817943) had prior sequences of HQ383867 and EU450804 and was denoted as 
ITSgg. The clone with GenBank accession number KT783520 in this study was one 
nucleotide substitution from being identical to archived sequences HQ383856 and 
EU450806, and it was referred to ITShh.  
Thirty-two clones had more than one nucleotide substitution in the sequence(s) of 
ITS1, ITS2, or both (Table 22). The previously reported sequences with the highest 
identities were used to designate the genotypes. Despite these multiple differences, these 
sequences still shared a 99% identity to the sequences reported from prior studies.  
The one clone that had the ITSc genotype was from a cat with a fatal C. felis 
infection, and the ITSd genotype was found in six clones from two cats with a fatal 
C. felis infection. (Table 23). Of the 51 C. felis clones with the ITSa genotype, 35 of the 
51 clones (69%) were from acute, fatal cases of 15 domestic cats and 16 of 51 clones 
(31%) from subclinical, chronic cases of seven domestic cats (Table 23). Of the 14 
C. felis clones of the ITSn genotype, found in this study, eight out of 14 clones (57%) 
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were from subclinical, chronic cases of four domestic cats, and the other six out of 14 
clones (43%) were from acute, fatal cases of four domestic cats (Table 23). The four 
clones with the ITSaa genotype from three cats and the one clone with the ITSbb 
genotype from a single cat were all from acute, fatal cases. The 13 clones with ITScc, 
ITSdd, ITSee, ITSff, and ITSgg were all from cats with a fatal C. felis infection, and the 
clone with the ITShh was found in a cat with an acute, recovered case (Table 23). There 
was no association found with the previously described genotypes in this study and 
clinical outcome of C. felis infection (P > 0.05). The remaining 32 clones were from all 
clinical outcomes.
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Table 23. Clinical outcome and state of origin for cat samples (N) for derivation of 122 Cytauxzoon felis cloned amplicons and their matches to 
previously described genotype (ITSa, ITSc, ITSd, and ITSn) or to new genotype designated in this study (ITSaa-ITStt). 
 
Genotype N No. of cloned amplicons for state No. of cloned amplicons per clinical 
outcome 
Total of cloned 
amplicons 
OK KS AR MO TX fatal recovered chronic 
ITSa 22 32 0 15 3 1 35 0 16 51 
ITSc 1 1 0 0 0 0 1 0 0 1 
ITSd 2 6 0 0 0 0 6 0 0 6 
ITSn 8 9 0 2 3 0 6 0 8 14 
ITSaa 3 2 0 0 2 0 4 0 0 4 
ITSbb 1 1 0 0 0 0 1 0 0 1 
ITScc 1 1 0 0 0 0 1 0 0 1 
ITSdd 2 3 0 0 0 0 3 0 0 3 
ITSee 3 4 0 0 2 0 6 0 0 6 
ITSff 1 1 0 0 0 0 1 0 0 1 
ITSgg 1 1 0 0 0 0 1 0 0 1 
ITShh 1 0 0 0 0 1 0 1 0 1 
ITSii 12 14 2 0 0 1 11 3 3 17 
ITSjj 1 1 0 0 0 0 1 0 0 1 
ITSkk 2 2 0 0 0 0 1 0 1 2 
ITSll 1 1 0 0 0 0 0 0 1 1 
ITSmm 2 2 0 0 0 0 2 0 0 2 
ITSnn 1 1 0 0 0 0 1 0 0 1 
ITSoo 2 2 0 0 0 0 2 0 0 2 
ITSpp 1 1 0 0 0 0 1 0 0 1 
ITSqq 1 1 0 0 0 0 1 0 0 1 
ITSrr 1 1 0 0 0 0 1 0 0 1 
ITSss 1 1 0 0 0 0 1 0 0 1 
ITStt 1 2 0 0 0 0 2 0 0 2 
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The one C. felis clone with the ITSc genotype was from a cat in Oklahoma, and the six 
clones with the ITSd genotype were from two cats from Oklahoma. The ITSn and ITSa 
genotypes were detected in clones from this state as well. Of the 14 C. felis clones of the 
ITSn genotype, nine clones (64%) were from three cats from Oklahoma, two clones 
(14%) from two cats from Arkansas, and three clones (21%) from three cats from 
Missouri (Table 23). Thirty-two of the 51 total ITSa clones (63%) were from 12 cats 
from Oklahoma, 15 clones (29%) from six cats from Arkansas, three clones (6%) from 
three cats from Missouri, and one clone (2%) from one cat from Texas (Table 23). Two 
of the four clones with the ITSaa genotype were from two cats from Oklahoma, and the 
other two clones were from a cat in Missouri. The clone with the ITSbb genotype was 
from a cat from Oklahoma. The six clones with ITScc, ITSdd, ITSff, and ITSgg were 
from cats from Oklahoma. Four clones with ITSee were from two cats from Oklahoma, 
and the other two clones were from one cat from Missouri. ITShh was found in a clone 
from a cat from Texas. There was no association found with the previously described 
genotypes in this study and geography (P > 0.05). The remaining 32 clones were from 
cats from Oklahoma, Kansas, and Texas. 
There were 49 and 73 amplicons from nested and primary amplifications for the 
ITS region, respectively. Fourteen of 49 nested PCR amplicons contained variance(s), in 
which nine (64%) contained one variance and five (36%) had multiple variances. Fifty-
one of 73 primary amplicons contained variance(s), in which 19 (37%) had one variance 
and 32 (63%) contained multiple variances. There was no correlation between the single 
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or multiple variance(s) in the genotypes and PCR amplifications (primary or nested) (P > 
0.05).  
The High Fidelity Platinum® Taq DNA Polymerase and the Phusion High-Fidelity 
DNA Polymerase were used for amplifying the ITS region in 57 and 65 PCR assays, 
respectively. Of the 28 PCRs with a single variance, 18 (64%) and 10 (36%) utilized the 
Phusion High-Fidelity DNA Polymerase and High Fidelity Platinum® Taq DNA 
Polymerase, respectively. Of the 37 PCRs with multiple variances, eight (22%) and 29 
(78%) were synthesized with Phusion High-Fidelity DNA Polymerase and High Fidelity 
Platinum® Taq DNA Polymerase, respectively. There were more single variances in the 
PCRs with the Phusion High-Fidelity DNA Polymerase and more multiple variances in 
PCRs with the High Fidelity Platinum® Taq DNA Polymerase, in which there was a 
correlation between variance(s) and type of polymerase used (P < 0.05). 
DISCUSSION   
In this study, the 18S rRNA gene was the molecular marker used to confirm the 
identity of C. felis. The C. felis genotypes were further investigated based on rRNA ITS1 
and ITS2 regions amplified and cloned from infected blood samples from domestic cats 
in Arkansas, Kansas, Oklahoma, Missouri, and Texas. Genotypes previously were 
assigned based on directly sequenced PCR products (Brown et al., 2009a, 2009b, 2010; 
Cohn et al., 2011; MacNeill et al., 2015). This study was undertaken to genotype C. felis 
through use of cloning and higher fidelity polymerases than previously employed. 
Additional genotypes were observed in the current study compared to the previous 
studies. Moreover, this study detected for the first time the same C. felis ITS1 and ITS2 
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sequences in domestic cats previously only found in C. felis isolates from wild felids 
(Shock et al. 2012).  
Sequence analysis in previous studies revealed the incorporation of two 
nucleotides at single, variable positions in the ITS1 and ITS2 of samples (Brown et al., 
2009a, 2009b, 2010; Cohn et al., 2011; Shock et al., 2012; MacNeill et al., 2015). A 
coinfection with multiple strains of C. felis or the presence of multiple rRNA copies in 
the genome may have led to these ambiguous sequences. However, since no previous 
study utilized a high-fidelity DNA polymerase, it is possible that some of the 
polymorphisms may have been incorporated during amplification. This study was the 
first to use high-fidelity DNA polymerases in conjunction with cloning amplicons prior 
to sequencing, and with their utilization, polymorphic sites, as depicted as double peaks 
in chromatograms in previous studies, were resolved to a single nucleotide. The Phusion 
High-Fidelity DNA Polymerase and Platinum® Taq DNA Polymerase, High Fidelity 
have 50X and 6X higher fidelity, respectively, than the Taq DNA polymerases used in 
the previous studies.  Single and multiple variance(s) in genotypes were found in both 
nested and primary PCR amplifications, and that variance(s) occurred independently of 
the type of PCR. 
Cloning is a very useful in vivo technique that can be used to copy DNA 
fragments (Strachan and Read, 1999). Cloning does involve the selection for a single 
DNA molecule, and this could lessen the chance of obtaining ambiguous sequence data 
as noted with two peaks in chromatogram. This way cloning can be helpful in quickly 
identifying and dismissing any spuriously amplified DNA (Carr et al., 2007). Cloning 
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also has the capability of detecting polymorphisms (whether caused by Taq DNA 
polymerase error or a heterogeneous sequence mixture) at a low frequency, which 
otherwise could be overwhelmed by the sequence in abundance (Ruecker et al., 2011) 
and missed with direct sequencing. Because of this ability, cloning could lead to an even 
greater sequence diversity (Ruecker et al., 2011). More costs and time expended can 
come with cloning as well. Both direct sequencing of PCR products and cloning into a 
vector prior to sequencing have their benefits and drawbacks. In order to obtain the 
correct, consensus sequence both approaches should be evaluated and possibly used, 
especially in the case of any amplification from a highly heterogenetic pool of 
molecules.  
The most common ITS1 sequence found in this study matched Genbank 
accession number EU450802, an ITS1 sequence from a domestic cat that survived an 
infection in Georgia. This ITS1 sequence was only found in C. felis clones from acute, 
fatal and subclinical, chronic cases. This ITS1 sequence was found in cloned amplicons 
from every state included in this study, except Kansas. This could possibly be due to the 
usage of only one C. felis infected cat from Kansas in this study, and it was one of the 
samples that only yielded two amplicons for analysis. ITS1 sequence EU450802 was 
also the most commonly found in previous studies in domestic cats (Brown et al., 2009a, 
2009b, 2010; Cohn et al., 2011; MacNeill et al., 2015), bobcats (Brown et al., 2010), and 
wild felids (Shock et al., 2012). 
In this study, a novel 23-bp insertion was detected within the ITS1 region. This 
insertion contained a repeated sequence, and repeats are dispersed throughout coding 
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and non-coding regions of genomes, particularly eukaryotes (Tóth et al., 2000; Viguera 
et al., 2001a). However, anomalous DNA fragments containing insertions or deletions of 
repeats may result from polymerase slippage during the extension step of PCR (Litt and 
Luty, 1989). In previous studies with the C. felis ITS regions, an insert was regarded as a 
finding in the C. felis genome, and attributing the inserts to DNA polymerase slippage 
during PCR was not mentioned (Brown et al., 2009a, 2009b, 2010; Cohn et al., 2011; 
Shock et al., 2012). Slippage is a misalignment of DNA strands during replication of 
repeated sequences (Castillo-Lizardo et al., 2014). Certain polymerases may undergo 
slippage more so than others (Viguera et al., 2001b), and the increased processivity 
polymerases do have a lesser occurrence of slippage (McInerney et al., 2014).   
The processivity of a DNA polymerase refers to the number of nucleotides 
incorporated per binding event (McDougal and Guarino, 1999). A Taq DNA polymerase 
was used in the previous studies (Brown et al., 2009a, 2009b, 2010; Cohn et al., 2011; 
Shock et al., 2012), and this DNA polymerase has relatively low processivity in PCR 
(Shinde et al., 2003). In the current study, the High Fidelity Platinum® Taq DNA 
Polymerase and the Phusion High-Fidelity DNA Polymerase were used. The High 
Fidelity Platinum® Taq DNA Polymerase (a blend of Taq DNA polymerase and a lesser 
amount of a proofreading DNA polymerase) is more known for its fidelity (Barnes, 
1994) and less for its processivity. However, the fusion of a DNA binding domain to an 
archaeal polymerase increased the processivity of the Phusion High-Fidelity DNA 
Polymerase and improved its overall performance (Wang et al., 2004). The 23-bp insert 
was detected with use of both the Phusion and the Platinum® Taq High Fidelity DNA 
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polymerases, indicating that it was not an artifact introduced by PCR. It could be 
speculated that the 23-bp insert occurs at a very low frequency, which may be why it 
was not detected by direct sequencing in previous studies but able to be revealed by 
cloning in this study. 
The most common C. felis ITS2 sequence found in this study matched Genbank 
accession number EU480504, an ITS2 sequence from a C. felis infection survived by a 
domestic cat in Georgia. This sequence was only found in acute, fatal and subclinical, 
chronic cases from the states of Oklahoma, Missouri, and Arkansas in this study. This 
ITS2 sequence was also the most common in previous C. felis studies with domestic cats 
(Brown et al., 2009a, 2010; Cohn et al., 2011), bobcats (Brown et al., 2010), and wild 
felids (Shock et al., 2012). In a previous study, there was an incorporation of two 
nucleotides, thymine or cytosine, at position 76 in the sequence of two C. felis samples. 
Therefore, the ITS2 sequences of the C. felis were either the same as GenBank accession 
numbers EU450804 (thymine at this position) or HQ383890 (cytosine at this position) 
(MacNeill et al., 2015). This would mean that the GenBank accession number 
EU480504 sequence may have been detected in C. felis from two domestic cats from 
southern Illinois, and this further exemplifies the presence of multiple rRNA 
transcriptional units in an isolate or coinfection with multiple C. felis strains.  
 Genotypes were a compilation of ITS1 and ITS2 sequences (Brown et al., 
2009a). The initial study to analyze the intergenic regions of C. felis from a large sample 
size used domestic cats from Georgia and Arkansas (Brown et al., 2009a). This study 
found an association with C. felis ITS genotype and geographic location and clinical 
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outcome of cytauxzoonosis. The most common genotype found in this previous study 
was ITSa, and it was associated with survival as well as C. felis infection of cats from 
Arkansas (Brown et al., 2009a). However, the subsequent studies on the ITS regions of 
C. felis did not find an association of ITS genotype with clinical outcome or geographic 
region (Brown et al., 2009b, 2010; Cohn et al., 2011; Shock et al., 2012). The ITSa 
genotype was also the most common genotype found in bobcats (Brown et al., 2010), 
wild felids (Shock et al., 2012) as well as domestic cats (Cohn et al., 2011) over greater 
locations. In the current study, ITSa was the genotype that was most commonly found, 
and it was found in both acute, fatal and subclinical, chronic cases. It was found in the 
states of Oklahoma, Arkansas, and Missouri.  
 The second most commonly found C. felis ITS genotype in this study was ITSn. 
This genotype was only found in one domestic cat in one previous study (Brown et al., 
2009a). This genotype is comprised of Genbank accession numbers EU450802 and 
EU450806 for ITS1 and ITS2, respectively. The 40-bp insert is found within the ITS2 
sequence.  
 The other previously described genotypes found in this study were ITSc and 
ITSd. The ITSc genotype was previously found only in domestic cats from Arkansas that 
either died from acute cytauxzoonosis (Brown et al., 2009a) or had a subclinical C. felis 
infection (Brown et al., 2010). In this study, this genotype was found in one C. felis 
cloned amplicon of a cat from Missouri that had an acute, fatal infection. The ITSd 
genotype was previously found in a bobcat from Florida (Brown et al., 2010). In the 
current study, this genotype was found in five C. felis cloned amplicons of cats from 
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Oklahoma that died from acute cytauxzoonosis. This is the first study to report this 
genotype in domestic cats.  
Some genotypes were recategorized since their original designation (Brown et 
al., 2009b, 2010), and due to discrepancies in these genotypes, they were consolidated 
(Shock et al., 2012). Shock et al., 2012 obtained all of the respective ITS1 and ITS2 
sequences of these genotypes and condensed them into 22 genotypes in order to use 
them for comparison. Only four of the 22 previously described genotypes were found in 
the current study. It could be that these C. felis genotypes dominated the sampled 
population of cats. Only a limited number of ITS1 and ITS2 combinations were 
designated a genotype, and this possibly restricted the detection of more prior genotypes. 
For instance, one C. felis clone from this study matched 100% with HQ383856 and 
EU450804 for the ITS1 and ITS2 sequences, respectively, and there is no genotype 
designated for this ITS1 and ITS2 combination before this study. The ITS1 sequence of 
GenBank HQ383856 was from C. felis in bobcats from Kansas and North Carolina 
(Shock et al., 2012). This sequence was not detected prior to the study conducted by 
Shock et al., 2012, in which no newly discovered ITS1 and ITS2 sequences were 
designated genotypes. Also, some of the newly designated genotypes in this study 
contained only one clone. If the ITS1 and ITS2 sequences of prior studies were all 
resolved to a single base, then it is possible that the C. felis from those cats could have 
been designated these genotypes as well.  
In view of the polymorphism observed in cloned ITS sequences, it would appear 
that more than one difference in the nucleotide sequence should be considered when 
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designating genotypes. In prior studies, at base position 180 in ITS2 a guanine 
substitution differentiated ITSa from ITSb, which had thymine at that position. 
Similarly, genotypes ITSa and ITSo only differed by a single nucleotide within the ITS2 
sequence. The one nucleotide that differed between genotypes of a number of amplicons 
could have been a true SNP. Since sequencing errors can result in a wrongfully 
identified SNP (Yu and Sun, 2013), there is a chance the variable base may have been a 
false positive SNP. A single nucleotide, which was polymorphic, distinguished three 
additional previously described genotypes from one another. Due to a false-positive SNP 
or a two nucleotide incorporation at one position, genotyping based on more than one 
nucleotide difference would have been more practical.  
Previously, polymerase errors were taken into account, and the identity of 
nucleotides was determined for each position from at least two independent PCR 
reactions in a study of the subspecies of Babesia canis (Zahler et al., 1998). Cloning was 
employed in that study, and ten clones from ten independent PCR amplifications from 
each of three subspecies were sequenced. Mutations detected in only one clone were 
considered an error of the Taq DNA polymerase (Zahler et al., 1998). A similar 
interpretation was taken in the current study in which a variable base found in a clone or 
clones of only a single isolate was regarded as an error. In this study, the sequenced 
clones were derived from a single PCR amplification. Sequencing each additional clone 
from an independent amplification might have clarified whether the variation seen in this 
study was reproducible.  
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Taq DNA polymerase errors led to false 16S rRNA gene sequence diversity in a 
complex bacterioplankton sample, and a 99% similarity was proposed as a cutoff in 
order to accommodate Taq DNA polymerase errors (Acinas et al., 2005). Genotype 
designation should take the possible DNA polymerase errors into account and adjusted 
accordingly. These observations were taken into consideration for the current study. The 
approach, therefore, was to accommodate for PCR and/or sequencing induced errors by 
including the clones with a single base change with the genotype of closest match.  
The C. felis ITS region, although diverse, did not associate a particular genotype 
with geography or clinical outcome in this study. However, there seemed to be a trend 
with the novel 23-bp insert (ITS1) linked with a fatal outcome. Other genetic markers or 
findings have been associated with outcome and geography in related hemoparasites 
(i.e., Babesia and Theileria), and potential homologues of these genes may be beneficial 
in classification of C. felis.  
Using the 18S rRNA gene, Babesia gibsoni and the three subtypes of Babesia 
canis (B. canis vogeli, B. canis canis, and B. canis rossi) have been classified according 
to differences in vector specificity and pathogenicity, and in order to enhance the 
phylogenetic analysis, sequences of additional genes were used (Yamasaki et al., 2007). 
Heat shock protein 70 (hsp70) is found in virtually all organisms, and it may contribute 
to the survival of protozoa in the host (Kaufman, 1990). Hsp70 was used to classify 
piroplasms, and the phylogenetic analysis of the nucleotide and predicted amino acid 
sequences revealed that when compared to other Babesia and Theileria spp., Babesia 
gibsoni, B. canis vogeli, B. canis canis, and B. canis rossi were closely related to each 
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other and formed one cluster (Yamasaki et al., 2007). Also, the nucleotide sequences of 
this gene were more diverse than the 18S rDNA sequences. A similar study may be 
useful in classifying C. felis, especially with subclinical, chronic infections. 
Since C. felis has a schizogonous stage in its life cycle, studying a potential 
homologue of a gene during this phase may be helpful in understanding its 
pathogenecity as well. The polymorphic immunodominant molecule (PIM) is localized 
on the schizont surface (Shapiro et al., 1987), and Geysen et al., 2004 found differences 
(i.e., short repeated sequences and duplicated or deleted long sequence runs) in the PIM 
gene of Theileria parva (a hemoparasite with a schizogonous phase like C. felis) from 
different epidemiological environments. The polymorphisms may indicate that PIM is an 
important surface antigen in T. parva, and establishing the mechanisms responsible for 
the polymorphisms may be essential for further understanding the host-parasite 
relationship (Geysen et al., 2004). Use of possible gene homologues like these as well as 
others may be useful for identifying markers related to pathogenicity in C. felis. The 
annotation of a complete C. felis genome (Tarigo et al., 2013) provides additional 
information on potential genes, which would advance genome wide association research 
for studying the pathogenicity of C. felis.  
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CHAPTER IV 
MOLECULAR DETECTION OF HEMOPLASMAS IN DOMESTIC CATS 
WITH CYTAUXZOON FELIS INFECTION 
 
INTRODUCTION 
 Cytauxzoon felis is the causative agent of the emerging infectious disease, feline 
cytauxzoonosis, in the United States. Cytauxzoon felis infection was first reported in 
1976 in fatally infected domestic cats in Missouri (Wagner, 1976). Originally, 
cytauxzoonosis had a nearly 100% grave prognosis, but over time there are now 
numerous reports of survival (Motzel and Wagner, 1990; Greene et al., 1999; Meinkoth 
et al., 2000; Haber et al., 2007; Brown et al., 2008; Brown et al., 2009; Brown et al., 
2010; Cohn et al., 2011). A coinfection with another blood parasite may contribute to a 
difference in pathogenicity, clinical manifestations, or response to treatment (Shaw et al., 
2001). 
One concurrent infection with C. felis may be with a feline hemotrophic 
mycoplasma (hemoplasma). The most common feline hemoplasmas are Mycoplasma 
haemofelis, Candidatus Mycoplasma turicensis, and Candidatus Mycoplasma 
haemominutum (Sykes, 2010). Occasionally a fourth Mycoplasma, a Candidatus 
Mycoplasma haematoparvum-like organism, may be found infecting felines as well 
(Sykes et al., 2007).  
The primary mode of dissemination of feline hemoplasmas is by hematophagous 
ectoparasites (Willi et al., 2007). The more time cats spend outdoors in temperate and 
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tropical regions, the more they may be exposed to infected ectoparasites, such as fleas 
and ticks (Loyd et al., 2013), thus potentially creating a C. felis and feline hemoplasma 
coinfection (Allison et al., 2010). If in a close proximity, these infected domestic cats 
can pose a threat to endangered felids in the wild, as well as felids in a zoo.  
In the U.S., a domestic shorthair cat that went from healthy and appearing normal 
to markedly lethargic with icterus within a 24-hour period was diagnosed with a M. 
haemofelis and C. felis coinfection (Allison et al., 2010). It was purported that the cat 
had a latent M. haemofelis infection, and the presence of the C. felis infection reactivated 
the mycoplasma (Allison et al., 2010). Similarly in Brazil, there was a report of a 
naturally acquired C. felis and Candidatus M. haemominutum coinfection in a domestic 
cat that exhibited neutrophilia, lymphocytopenia, and thrombocytopenia as well as 
increased blood urea nitrogen, concentration and alanine aminotransferase, and aspartate 
aminotransferase activities (Maia et al., 2013). It was speculated that the coinfection of 
these two pathogens may have caused the exacerbation in the hematological and clinical 
alterations, which led to the cat’s demise (Maia et al., 2013).  
The objective of this study was to molecularly survey C. felis positive cats for 
Mycoplasma spp. using PCR assay targeting the 16S rRNA gene and to determine if an 
antagonistic or synergistic relationship exists with the coinfection of the two pathogens.  
MATERIALS AND METHODS 
The genomic DNA from 41 cats previously identified as positive for C. felis was 
provided for this study. A primary PCR assay using primers Hbart250F and Hbart1250R 
was employed in order to amplify the 16S rRNA gene of mycoplasmas (Table 24). All 
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samples underwent primary amplification using High Fidelity Platinum® Taq DNA 
Polymerase (Invitrogen™, Carlsbad, CA) following manufacturer’s recommendations. A 
plasmid containing part of the 16S rRNA gene of a mycoplasma served as the positive 
control and water as the negative. Primary reactions underwent a 2 min denaturation at 
94°C followed by 45 cycles of 94°C for 30s, 55.5°C for 30s, 68°C for 2 min, with a final 
extension at 68°C for 7 min, and followed by a hold at 4°C (Labnet MultiGene™ 
Thermal Cycler, Labnet International, Inc., Woodbridge, NJ). EconoTaq® Plus Green 
2X Master Mix (Lucigen, Middleton, WI) was used in repeated primary amplifications 
according to the above protocol, except the extension temperature was 72°C. The PCR 
products were electrophoresed through TBE buffered 1% agarose gel alongside a 100bp 
DNA marker (Invitrogen), stained with ethidium bromide and visualized by ultraviolet 
transillumination (FluorChem 8000, Alpha Innotech Corporation, San Leandro, CA).  
 
 
 
 
 
 
Table 24.  Oligonucleotide primers used in amplifying the 16S rRNA gene of feline hemoplasmas. 
 
Primer Name, sense PCR Sequence 5'→3' 
Hbart250F, forward Primary 16S TGAACAGCCRCAATGGGATTG 
Hbart1250R, reverse Primary 16S CTGGGAACGKATTCACCC 
Mycofe260F, forward Nested 16S ACAATGGACGAAAGTCTGATG 
Mycofe1220R, reverse Nested 16S GGATTACTAGTGATTCCAACTTCA 
m13F, forward Colony 16S plasmid (pDNA) GTAAAACGACGGCCAG 
m13R, reverse Colony 16S plasmid (pDNA) CAGGAAACAGCTATGAC 
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If a band was not visualized, the primary product was diluted 1:5 and used in a 
nested reaction with primers Mycofe260F and Mycofe1220R (Table 24). The cycling 
parameters were as above, except that the reactions underwent 30 cycles with an 
annealing temperature of 50°C and extension temperature of 72°C. The PCR products 
were gel electrophoresed, stained, and visualized as above.  
A PCR using a polymerase with higher fidelity (Phusion DNA Polymerase, 
Thermo Fisher Scientific Inc., Waltham, MA) was employed according to the 
manufacturer’s recommendations for additional confirmation. Primary PCR utilized 
primers Hbart250F and Hbart1250R and cycling parameters of one cycle at 98°C for 1 
min, 45 cycles at 98°C for 10 s, 55.5°C for 30 s, and 72°C 1 min, and 72°C final 
extension for 7 min. This was followed by electrophoresis as described above. If no band 
visualized, then 1:5 diluted products underwent nested PCR for 30 cycles with same 
parameters as stated, except with a 30 s denaturation, a 50°C annealing temperature, and 
a 45 s extension step.  
 Appropriately-sized 16S rDNA amplicons synthesized by High Fidelity Platinum 
® Taq DNA Polymerase were ligated into pCR®2.1-TOPO® (Invitrogen, Life 
Technologies, Grand Island, NY) cloning vector. Those amplified using EconoTaq DNA 
Polymerase or the Phusion DNA Polymerase were cloned into the pJET1.2/blunt cloning 
vector (Thermo Fisher Scientific Inc., Waltham, MA). TOP10 E. coli were transformed 
according to manufacturer’s instructions. Colonies were verified to contain the cloned 
insert by colony PCR using primers specific for mycoplasma or primers appropriate for 
the plasmid vector (Table 24). Verified colonies were expanded overnight in broth 
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cultures, and plasmid DNA was prepared (Bio Basic, Inc.). The plasmid DNA 
concentration was determined by spectrophotometry (NanoDrop ND-1000 
Spectrophotometer, NanoDrop Technologies, Wilmington, DE). Bidirectional 
sequencing of the inserts was conducted by Davis Sequencing (Davis, CA) or Eton 
Biosciences, Inc. (San Diego, CA). Forward and reverse sequence data were trimmed to 
exclude primer regions and unreadable data, aligned, and analyzed for contiguous 
sequences using Sequencher 4.2 software (Gene Codes Corporation, Inc., Ann Arbor, 
MI). Using the NCBI Basic Local Alignment Search Tool (BLAST) (Altschul et al., 
1990), the sequences were compared to sequences in GenBank. With the chi-square test 
for independence, detected Mycoplasma spp. were evaluated for associations with the 
clinical outcomes of cytauxzoonosis (fatal, recovered, or chronic) (JMP®, Version Pro 
11. SAS Institute Inc., Cary, NC, 1989-2007).   
RESULTS 
 The primary PCR showed three out of 41 (7%) cats as PCR-positive for the 16S 
rRNA gene of Mycoplasma spp. The three positive samples were from cats representing 
the three clinical outcomes of cytauxzoonosis - recovered, chronic, or fatal (Table 25). 
Each positive sample successfully yielded at least one cloned amplicon with five clones 
in total. Sequencing revealed 1,020-bp inserts in all five. One clone had 100% identity to 
Candidatus M. haemominutum (GenBank accession number AF271154) and four clones 
shared a 99% identity with Candidatus Mycoplasma haemominutum (GenBank 
accession numbers AF271154, DQ825456, or FJ004275) (Table 25).  
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 When the 38 cat samples that were negative in the primary PCR underwent a 
nested PCR, 10 (26%) were PCR-positive. Eight when cloned yielded sequences (N=16) 
913-bp in length that matched Candidatus M. haemominutum (GenBank accession 
numbers DQ825456, FJ004275, or AF271154) with 99% identity. These cloned samples 
were from cats that had either a recovered, chronic, or fatal C. felis infection. The two 
clones from the ninth cat sample matched Candidatus Mycoplasma kahanei (GenBank 
accession number AF338269) with 99% identity (Table 25). Six additional clones from 
that sample were sequenced. One clone matched Candidatus M. kahanei (GenBank 
accession number AF338269) with 99% identity. Four clones matched numerous 
Rhodococcus spp. 16S rRNA sequences reported in the GenBank database with 97-
100% identity and the remaining clone matched an uncultured bacterium (GenBank 
accession number KJ013390) with 93% identity. The two cloned amplicons from the 
10th sample also matched numerous Rhodococcus spp. with 99% identity.  
An association between the Mycoplasma sp. and clinical outcome of C. felis 
infection was evaluated. Eleven of the 12 cats positive for Mycoplasma spp. were 
identified as positive for Candidatus M. haemominutum. The C. felis-infected cats 
coinfected with Candidatus M. haemominutum exhibited all outcomes of 
cytauxzoonosis, therefore there was no association between degree of cytauxzoonosis 
and hemoplasma coinfection. The cat sample identified with Candidatus Mycoplasma 
kahanei was from a cat that died, but since it was the only sample matching this 
particular hemoplasma, no conclusion regarding an association between severity of 
cytauxzoonosis and mycoplasma coinfection could be determined
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Table 25. Identification of cloned samples by animal and clone number, sequence length in base pairs, the  
Mycoplasma spp. and GenBank Accession Number with closest percent identity, and clinical outcome of C. felis-infected cats.   
 
Animal-
Clone 
Size 
(bp) 
NCBI BLAST highest identity (%) Clinical 
Outcome 
32 Clone 3 1,020 Candidatus Mycoplasma haemominutum AF271154 (99%) Chronic 
32 Clone 4 1,020 Candidatus Mycoplasma haemominutum AF271154 (99%) Chronic 
32 Clone 5 1,020 Candidatus Mycoplasma haemominutum AF271154 (100%) Chronic 
33 Clone 3 1,020 Candidatus Mycoplasma haemominutum DQ825456 (99%) Recovered 
23 Clone 2 1,020 Candidatus Mycoplasma haemominutum FJ004275 (99%) Fatal 
1 Clone 3 913 Candidatus Mycoplasma haemominutum DQ825456 (99%) Fatal 
1 Clone 4 913 Candidatus Mycoplasma haemominutum DQ825456 (99%) Fatal 
13 Clone 1 913 Candidatus Mycoplasma haemominutum FJ004275 (99%) Fatal 
13 Clone 2 913 Candidatus Mycoplasma haemominutum FJ004275 (99%) Fatal 
14 Clone 11 913 Candidatus Mycoplasma haemominutum AF271154 (99%) Fatal 
14 Clone 12 913 Candidatus Mycoplasma haemominutum AF271154 (99%) Fatal 
19 Clone 7 913 Candidatus Mycoplasma haemominutum AF271154 (99%) Chronic 
19 Clone 8 913 Candidatus Mycoplasma haemominutum AF271154 (99%) Chronic 
21 Clone 4 913 Candidatus Mycoplasma haemominutum AF271154 (99%) Fatal 
21 Clone 5 913 Candidatus Mycoplasma haemominutum AF271154 (99%) Fatal 
34 Clone 14 913 Candidatus Mycoplasma haemominutum AF271154 (99%) Chronic 
34 Clone 15 913 Candidatus Mycoplasma haemominutum AF271154 (99%) Chronic 
43 Clone 4 913 Candidatus Mycoplasma haemominutum AF271154 (99%) Recovered 
43 Clone 8 913 Candidatus Mycoplasma haemominutum AF271154 (99%) Recovered 
22 Clone A1 464 Candidatus Mycoplasma kahanei AF338269 (99%) Fatal 
22 Clone A2 911 Candidatus Mycoplasma kahanei AF338269 (99%) Fatal 
22 Clone B1 911 Candidatus Mycoplasma kahanei AF338269 (99%) Fatal 
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DISCUSSION 
 Domestic cats, especially those that are frequently outdoors, are likely to be 
infected by Mycoplasma spp. and/or piroplasms, and they may not exhibit any outward 
signs. These cats can transport pathogens, which can subsequently infect other naïve 
felids.  
 In a 2014 study, blood samples from 260 stray cats in a capture-neuter-release 
program in northern Italy were screened for C. felis or Babesia microti infection by PCR 
(Spada et al., 2014). No samples were positive for C. felis (0.0%), but two cats were 
positive for B. microti (0.08%). Both cats were in good clinical condition. One was 
identified as being positive for B. microti, Candidatus Myocplasma haemominutum, and 
Anaplasma phagocytophilum. These particular blood-borne pathogens do not seem to be 
a serious concern to cats in northern Italy (Spada et al., 2014).  
Higher infection rates of arthropod-borne pathogens were detected in a smaller 
sample size of 37 free-roaming cats in a Brazilian zoo (Andre et al., 2014). Blood was 
screened for the presence of Anaplasmataceae agents, piroplasms, hemoplasmas, 
Bartonella spp., and Hepatozoon spp. by PCR.  Three (8%) cats were positive for 
Anaplasma spp. (closely related to Anaplasma phagocytophilum), 12 (32%) cats for 
hemoplasmas [two (5%) for Mycoplasma haemofelis, five (13.5%) for Candidatus M. 
haemominutum, and five (13.5%) for Candidatus Mycoplasma turicensis], 11 (30%) for 
Bartonella spp., six (16%) for Babesia vogeli, and one (3%) for Theileria sp. (Andre et 
al., 2014). Some of the sampled cats were positive for multiple vector-borne pathogens, 
but no cats were positive for Hepatozoon spp., Cytauxzoon spp., or Ehrlichia spp. This 
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study emphasized the need to control the free-roaming cat population as a way to 
prevent infections of zoo-housed felids (Andre et al., 2014).  
      In another study from Brazil, an urban colony of 75 free-roaming cats were 
molecularly surveyed for the presence of various infectious agents (Mendes-de-Almeida 
et al., 2007). Cats were shown to be infected with feline immunodeficiency virus, feline 
leukemia virus (FeLV), C. felis, T. gondii, and ectoparasites such as lice (Felicola 
subrostratus) and fleas (Ctenocephalides felis). There was also a significant association 
made between cats infected with FeLV and infected with Mycoplasma spp.  
       Since the known vectors of C. felis are AmbylommA. americanum and Dermacentor 
variabilis, which are not known to occur in South America, the authors suggest there are 
other competent vectors in Rio de Janeiro, Brazil (Mendes-de-Almeida et al., 2007). A 
likely candidate is Rhipicephalus sanguineus since this was the only tick species found 
infesting the cats in this study (Mendes-de-Almeida et al., 2007). This study illustrated 
the need to identify competent vectors outside of the U.S. for non-native pathogens.  
In the current study, cats were molecularly assessed for coinfections with 
Mycoplasma spp. and C. felis because of the possibility that an underlying coinfection 
could affect the course of disease. Previously, a coinfection with Plasmodium falciparum 
and a mycoplasma was evaluated in squirrel monkeys (Saimiri sciureus) (Contamin and 
Michel, 1999). It was observed that a latent mycoplasma infection that occurred prior to 
a P. falciparum infection remained latent and did not influence the course of the 
P. falciparum infection. If the P. falciparum infection occurred before the patent 
mycoplasma infection, then the P. falciparum infection persisted longer as the host 
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resisted longer or was able to clear P. falciparum infection. When intact P. falciparum-
infected monkeys were splenectomized at different times, then the patent mycoplasma 
infection was prolonged. It was demonstrated that a mycoplasma infection activated 
after splenectomy may have an effect on parasitemia of P. falciparum (Contamin and 
Michel, 1999). In another P. falciparum study with splenectomized squirrel monkeys as 
hosts, it was shown that the splenectomy caused an activation in a patent infection with a 
hemotrophic mycoplasma (Neimark et al., 2002). 
 In this study, more than one-fourth of the cats with known C. felis infections 
were coinfected with Candidatus M. haemominutum. Determining whether this is a 
significant finding necessitates screening of another population of clinically normal cats 
that are C. felis negative and are from the same geographic regions.     
Interestingly, one cat in the current study was positive for Candidatus 
Mycoplasma kahanei. The cat had a fatal C. felis infection and was from Oklahoma, but 
the history of the cat is unknown. Candidatus Mycoplasma kahanei has been found in 
the blood of colony-reared squirrel monkeys (S. sciureus) (Contamin and Michel, 1999; 
Neimark et al., 2002). To our knowledge, there has been no report of Candidatus M. 
kahanei in domestic cats. The potential host range is unknown, but it may be possible 
that other animals (including cats) can be suitable hosts (Neimark et al., 2002).  
 A 16S rRNA gene fragment of Rhodococcus spp., was detected in six clones 
from the blood of two cats in this study. Rhodococcus spp. are generally found in the soil 
and usually are non-pathogenic. However, they have the potential to cause disease in 
humans, plants, and animals (Baba et al., 2009).  
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Rhodococcus erythropolis has been shown to be infective to ticks (Tveten and 
Sjastad, 2011), and this bacterium was identified in the skin lesions of a cat from a case 
of feline leprosy syndrome in the U.S. (Davies et al., 2006). Rhodococcus erythropolis 
has been found on the surface of a healthy human eye (Graham et al., 2007) and in the 
bloodstream of a human (Baba et al., 2009), although the exact source of the latter is not 
known. However, to our knowledge this bacterium has not been reported in the blood of 
domestic cats. As a skin contaminant, it is possible that the blood samples were exposed 
to Rhodococcus spp. during the blood draw. 
It is also not unusual to find Rhodococcus spp. DNA contaminating laboratories 
and reagents, especially DNA extraction kits (Salter et al., 2014). Although this can 
occur, the DNA of many other organisms has been extracted in this laboratory using the 
same reagents, then amplified, cloned, and sequenced. To date no sequenced clones from 
other samples have been found to contain Rhodococcus DNA. 
There was no association found with the species of Mycoplasma and outcome of 
C. felis infection. Using molecular techniques, Maia et al. (2013) described the first 
detection of a natural C. felis infection in a Brazilian cat that was also coinfected with 
Candidatus M. haemominutum in South America. It was suggested that the cat may have 
succumbed due to the association with these two vector-borne pathogens. More 
extensive studies employing molecular detection of pathogens in coinfections should be 
conducted because the presence of both pathogens may cause changes in clinical 
manifestations, response to treatment, or pathogenicity (Shaw et al., 2001). An 
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undetected coinfection could ultimately affect the results of studies focusing on a sole 
pathogen.  
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CHAPTER V 
MOLECULAR SURVEY FOR CYTAUXZOON FELIS AND BABESIA SPP. IN 
TICKS INFESTING WHITE-TAILED DEER IN TEXAS  
 
INTRODUCTION 
 Due to their ability to harbor and transmit pathogens, ticks are the most important 
vectors of disease in wild mammals (Forrester, 1992)., including wild-tailed deer (WTD; 
Odocoileus virginianus) Ticks that commonly parasitize WTD are hard ticks of the 
genera Ixodes, Amblyomma, Dermacentor, and Rhipicephalus (Boophilus) (Davidson, 
2006). Boophilus ticks (now renamed Rhipicephalus subgenus Boophilus) vector 
Babesia bovis and Babesia bigemina, the causative agents of bovine babesiosis. After its 
eradication from the U.S., this tick can occasionally be seen in California and the buffer 
quarantine zone along the Mexican border in southern Texas (Allan, 2001). 
Data from molecular and serological studies have indicated the presence of 
Babesia spp. in WTD in counties of south Texas (LaSalle and Webb) (Ramos et al., 
2010), central Texas (Tom Green) (Holman et al., 2011) and northern states of Mexico 
that border Texas (Cantu et al., 2007; Cantu et al., 2009) suggesting a role for WTD as 
reservoirs of bovine babesiosis agents. With WTD potentially serving as additional 
reservoir hosts, this could pose a challenge in maintaining the Cattle Tick Fever-free 
status for the U.S. (Holman et al., 2011). 
 White-tailed deer also have a role in maintaining infected ticks and serving as 
reservoirs for other protozoal and bacterial pathogens. The Lyme disease bacterium, 
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Borrelia burgdorferi, is transmitted by Ixodes scapularis ticks, for which WTD are the 
primary reproductive hosts for the adult ticks (Tillett, 2010). The WTD have a greater 
role in maintaining and transporting the infected ticks than harboring the pathogen (Lane 
et al., 1991). 
Amblyomma americanum adults feed on WTD, and these WTD serve as 
reservoirs of pathogens carried by this tick (Kollars et al., 2000; Childs and Paddock, 
2003; Allan et al., 2010). White-tailed deer naturally infected with Ehrlichia chaffeensis 
(Allan et al., 2010), Ehrlichia ewingii (Yabsley et al., 2002), and Borrelia lonestari 
(Moore et al., 2003) have been reported, and all of these bacteria are transmitted by 
A. americanum. Amblyomma americanum is the primary vector of Cytauxzoon felis, and 
wild felids serve as the reservoirs for this pathogen. With A. americanum being a 3-host 
this could possibly lead to WTD as additional hosts in the sylvatic cycle of C. felis.  
In the current study, actively feeding ticks on WTD were collected in Gus 
Engeling Wildlife Management Area (Anderson County, East Texas), Aggieland 
Humane Society (formerly Brazos Animal Shelter) (Brazos County, central Texas), 
Uvalde and Maverick Counties (south Texas), and Las Palomas Wildlife Management 
Area (Cameron County, south Texas). Polymerase chain reaction (PCR) targeting the 
hemoparasite 18S ribosomal RNA gene was utilized to survey ticks for the presence of 
B. bovis, B. bigemina, C. felis, and other closely related piroplasm DNA.  
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MATERIALS AND METHODS 
 Extracted DNA from 161 Ixodid ticks were provided for this study by Texas 
A&M University in College Station, TX (Table 26). To target the full-length 18S rRNA 
gene of C. felis or Babesia spp., a primary PCR assay utilized primers A and B (Sogin, 
1990) (Table 27). The reactions contained 50-100 ng DNA and primers A and B 
according to manufacturer’s instructions (Accustart™ PCR SuperMix, Quanta 
BioSciences, Inc., Gaithersburg, MD). Molecular biology grade water served as a 
negative control and B. bovis genomic DNA served as the positive control. The primary 
reactions underwent a 2 min denaturation at 94°C followed by 45 cycles of 94°C for 30s, 
60°C for 30s, 72°C for 2 min, with a final extension at 72°C for 5 min, and then were 
held at 4°C (Eppendorf® Thermal Cycler, Hauppauge, NY). The PCR products were 
resolved by electrophoresis through TBE buffered 1% agarose gel alongside a 1-kb 
DNA marker (New England Biolabs, Ipswich, Massachusetts), stained with ethidium 
bromide, and visualized by ultraviolet light transillumination (FluorChem 8000, Alpha 
Innotech Corporation, San Leandro, CA).  
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Table 26. Species identification and collection locales of ticks (N=161) from infested deer molecularly tested for piroplasm DNA 
  
Tick species 
 
Location County Samples 
Ixodes scapularis Aggieland Humane Society Brazos BAS-11 
Amblyomma americanum Gus Engeling Wildlife Management Area Anderson GEWMA-1 – GEWMA-3 
Ixodes scapularis Gus Engeling Wildlife Management Area Anderson GEWMA-4 – GEWMA-9 
Amblyomma americanum Gus Engeling Wildlife Management Area Anderson GEWMA-10 – GEWMA-11 
Ixodes scapularis Gus Engeling Wildlife Management Area Anderson GEWMA-12 – GEWMA-26 
Amblyomma americanum Gus Engeling Wildlife Management Area Anderson GEWMA-27 – GEWMA-30 
Amblyomma inornatum Gus Engeling Wildlife Management Area Anderson GEWMA-31 
Ixodes scapularis Gus Engeling Wildlife Management Area Anderson GEWMA-32 – GEWMA-33 
Amblyomma americanum Gus Engeling Wildlife Management Area Anderson GEWMA-34 – GEWMA-36 
Ixodes scapularis Gus Engeling Wildlife Management Area Anderson GEWMA-37 
Amblyomma americanum Gus Engeling Wildlife Management Area Anderson GEWMA-38 – GEWMA-50 
Amblyomma inornatum Gus Engeling Wildlife Management Area Anderson GEWMA-51 
Amblyomma americanum Gus Engeling Wildlife Management Area Anderson GEWMA-52 – GEWMA-64 
Amblyomma cajennense Las Palomas Wildlife Management Area Cameron LPWMA-10 – LPWMA-13 
Ixodes scapularis Las Palomas Wildlife Management Area Cameron LPWMA-14 – LPWMA-16 
Dermacentor albipictus Uvalde Uvalde UMTX-1 
Dermacentor albipictus Maverick Maverick UMTX-2 – UMTX-7 
Dermacentor albipictus Uvalde Uvalde UMTX-8 
Dermacentor albipictus Maverick Maverick UMTX-9 - UMTX-90 
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Table 27. Oligonucleotide primers used in amplifying the 18S rRNA gene region of Cytauxzoon felis and Babesia spp.  
Primer name, sense PCR Sequence 5'→3' Annealing 
temperature 
A, forward Primary 18S AACCTGGTTGATCCTGCCAG 60°C 
B, reverse 
 
GATCCTTCTGCAGGTTCACCTAC  
 
Bbov680F, forward Nested 18S ACCTTGTATGACCCTGTC 51.5°C 
Bbov1270R, reverse  TGCCTTAAACCTCACCG  
 
Bbov660F, forward Nested 18S GCCTGTATAATTGAGCATGG 50°C 
Bbov1330R, reverse 
 
CAAGCATCAGTGTAGCG 
 
 
srBoFN, forward Nested 18S CACCGTATTTTGACTTTTGTCGACTGTCGG 55°C 
srBoRN, reverse  CCCGTAACGGACGAACCTTCTCACGGG  
 
Piro1F, forward Nested 18S CCATGCATGTCTWAGTAYAARCTTTT 52°C 
Piro5.5R, reverse  CCTYTAAGTGATAAGGTTCACAAAAC  
 
Cfelis170F, forward Nested 18S GCTAATACATGTTGGAGACC 50°C 
Cfelis1330R, reverse  AGAAGCGATGCTGAGAC  
 
989A, forward Nested 18S GGTAGGGTATTGGCCTACCGT 55°C 
990A, reverse  CSCAAAGTCCCTCTAAGAAGC  
 
m13F, forward Colony 18S plasmid (pDNA) GTAAAACGACGGCCAG 50°C 
m13R, reverse 
 
CAGGAAACAGCTATGAC  
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The primary products underwent a 1:5 dilution and were used in nested reactions 
with primers Bbovis 660F/Bbovis1330R, Bbovis 680F/Bbovis1270R, Piro 1F/Piro 5.5R, 
srBoFN/srBoRN (Ramos, et al., 2010), 989A/990A (Aktas et al., 2007), or 
Cfelisspec170F/Cfelisspec1300R (Table 27). The cycling parameters were as above, 
except a 30s initial denaturation, 30 cycles, and 1-1.5 min extension step were used. In 
order to improve specificity, higher annealing temperatures (55°C and 56°C) were 
utilized with the Bbov660F/Bbov1330R primers as well. The PCR products were 
resolved by agarose gel electrophoresis as above. 
Appropriately-sized 18S rDNA amplicons were directly ligated into pPrime (5 
Prime, Inc., Gaithersburg, MD) or pCR®2.1-TOPO® (Invitrogen, Life Technologies, 
Grand Island, NY) cloning vector. TOP10 E. coli were transformed according to 
manufacturer’s instructions. Colonies were verified to contain the cloned insert by 
colony PCR using primers appropriate for the plasmid vector (Table 27). Selected 
colonies containing the correct size insert were expanded overnight in broth cultures and 
plasmid DNA was prepared (EZ-10 Spin Column Plasmid DNA Kit, Bio Basic, Inc., 
Amherst, NY). The plasmid DNA concentration was determined using 
spectrophotometry (NanoDrop ND-1000 Spectrophotometer, NanoDrop Technologies, 
Wilmington, DE). Bidirectional DNA sequencing of the inserts was conducted by Davis 
Sequencing (Davis, CA). Sequence and chromatogram data were analyzed and forward 
and reverse sequence data were trimmed to exclude primer sequences and unreadable 
data, aligned, and analyzed for contiguous sequences using Sequencher 4.2 software 
(Gene Codes Corporation, Inc., Ann Arbor, MI).  The sequences were compared to 
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sequences in GenBank using the NCBI Basic Local Alignment Search Tool (BLAST) 
(Altschul et al., 1990). Using obtained tick rDNA sequences, two restriction enzymes 
(SacI and EcoRI) were selected for their capability to cleave tick rDNA. According to 
protocol (New England BioLabs, Inc. Ipswich, MA), a dual digestion with these 
enzymes was used with PCR products that underwent a repeated PCR with an increased 
annealing temperature in order to discriminate tick from putative parasite rDNA.  
RESULTS 
 Amplification for the 18S rRNA gene showed 105/161 (65%) positive by PCR. 
Eighty-four PCR-positive samples underwent nested PCR with Bbov660F/Bbov1330R 
primers, and 62 of these 84 samples (74%) were PCR-positive for B. bovis, producing 
the expected size band of 688 bp. Ten B. bovis PCR-positive amplicons were cloned, 
producing 19 clones. Fourteen clones were sequenced, and results were that 18S rDNA 
sequences of four clones matched Ixodes scapularis GenBank (GU318898) with 99% 
identity. Four other clones matched Xiphocephalus ellisi GenBank (FJ459762) with 
97-98% identity, and the six remaining clones matched Dermacentor nitens GenBank 
(KC76962) with 99-100%.  
 All samples underwent nested PCR using Bbov680F/Bbov 1270R primers. All 
samples were negative with none producing the expected 600bp B. bovis product.  
 The diluted primary PCR products of the 84 samples underwent nested PCR 
using Piro1F/Piro5.5R primers. This PCR resulted in 43 positive samples (51%). Three 
positive amplicons were cloned, and two clones were sequenced. The sequencing 
revealed that one clone matched the 18S rRNA gene of Dermacentor andersoni 
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GenBank (L76340) with 99% identity, and the other clone matched D. nitens GenBank 
(KC76962) with 98% identity.  
 Using srBoFN/srBoRN primers (Ramos et al., 2010), all 161 tick samples 
underwent a nested PCR in order to amplify the 18S rRNA gene of Babesia odocoilei. 
This amplification should result in 688bp of this organism. No samples were positive for 
B. odocoilei by PCR. An additional nested PCR using these same primers was conducted 
on the 28 I. scapularis ticks, in which all failed to yield a positive amplification for 
B. odocoilei.  
 The 161 tick samples underwent a nested PCR using 989A/990A primers (Aktas 
et al., 2007). These primers should amplify 1,000 to 1,050bp of Theileria spp. as well as 
closely related hemoparasites. This PCR resulted in 18 (11%) PCR-positive samples. 
Four positives were cloned with two being sequenced. The results of the sequencing 
matched the amplification of 18S rRNA gene of an uncultured eukaryote GenBank 
(GQ462637) with 98% identity and of an uncultured stramenopile (GU823482) with 
97% identity.  
 All 161 tick samples underwent a nested PCR with 
Cfelisspec170F/Cfelisspec1300R primers. The amplification should result in 1,200bp of 
the 18S rRNA gene of C. felis. Once the PCR assay was complete, no samples were 
positive.  
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DISCUSSION 
 The role of WTD in the expansion of certain hemoparasites, especially bovine 
Babesia spp., raises concern in the southern U.S. Due to the increased rate of vector tick 
outbreaks in south Texas, especially in areas not in the quarantine buffer zone, WTD are 
seemingly a crucial factor in the epizootiology of bovine babesiosis (Perez de Leon et 
al., 2010). Although outbreaks in the Cattle Fever Ticks, Rhipicephalus (Boophilus) spp. 
have not been linked to disease, the resurgence of babesiosis is still a risk to the southern 
U.S.  
 It has been shown molecularly and serologically that WTD of central and south 
Texas and north Mexico may host bovine Babesia spp. (Cantu et al., 2007; Cantu et al., 
2009; Ramos et al., 2010; Holman et al., 2011). Cantu et al., 2007 was able to detect 
B. bovis in 11 WTD samples and B. bigemina in four WTD from the states of Nuevo 
Leon and Tamaulipas, Mexico by nested PCR assay. In addition, indirect fluorescence 
antibody test (IFAT) revealed antibodies against both hemoparasites in serum samples 
(Cantu et al., 2007). 
 Another study used nested PCR to detect 19 WTD positive for B. bigemina and 
six WTD positive for B. bovis out of a total of 457 WTD. Results of IFAT showed 274 
samples showed antibodies to B. bovis and 25 for B. bigemina (Cantu et al., 2009). 
Ramos et al., 2010 found eight of 49 WTD samples from LaSalle County, Texas and two 
of 47 WTD samples from Webb County, Texas as B. bovis-PCR positive. Sequence 
analysis of subsequent cloning revealed 99% identity with B. bovis 18S rRNA gene, and 
phylogenetic analysis showed a well-supported group with the bovine B. bovis and 
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B. bovis-like 18S rDNA sequences. There was poor seroreactivity to B. bovis with the 
IFAT (Ramos et al., 2010). In another study, out of 25 WTD blood samples from Tom 
Green county three were positive for B. bovis by amplification and analysis of the 
internal transcribed spacer (ITS) region. Three samples were PCR-positive for 
B. bigemina, but sequencing revealed only one as positive for B. bigemina. There was no 
difference between the cervine B. bigemina or B. bovis 18S rDNA or cervine B. bovis 
ITS regions sequences from bovine sequences as depicted in a neighbor-joining 
phylogenetic tree (Holman et al., 2011). 
 Despite the numerous accounts of nested PCR detection of hemoparasites such as 
bovine Babesia spp. in WTD, this was not as successful in this study. Unlike the 
previous studies, this study focused more on the actively feeding ticks rather than the 
whole blood of the WTD. Despite the source, detection of parasite DNA should have 
still been feasible.  
 Increased annealing temperatures and different primer sets were utilized in order 
to improve specificity. After the initial PCR with the Bbov660F/Bbov1330R primers and 
subsequent sequencing, it was shown that only tick rDNA was being amplified. To 
alleviate amplification of tick rDNA, a gradient PCR was employed in order to find the 
most optimal annealing temperature. The original annealing temperature of 50°C was 
increased to 55°C and then 56°C to improve specificity. Unfortunately, the increased 
annealing temperatures still resulted in the amplification of tick rDNA.  
 Different primer sets were utilized for better specificity. Since the 
Bbov660F/Bbov1330R primers were able to amplify tick DNA in addition to targeting 
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B. bovis, another primer set (Bbov680F/Bbov1270R) was used. These primers were 
more specific for B. bovis, and once they were included in the PCR reaction, tick rDNA 
was no longer amplified. Also, the generic primer sets of Piro1F/Piro5.5R and 
989A/990A (Aktas et al., 2007) were used to amplify the DNA of similar hemoparasites. 
The Piro1F/Piro5.5R primers can be used to amplify part of the 18S rRNA gene of 
Babesia microti, B. bigemina, Theileria cervi, C. felis, and Theileria equi. The 
989A/990A primers can target part of the 18S rRNA gene of different species of 
Theileria as well as C. felis, B. microti, and Babesia divergens.  
 Even though Babesia spp. and other closely related protozoa were not detected in 
this study, WTD have previously shown to be exposed to B. bovis and B. bigemina. The 
exact position of WTD in bovine babesiosis still warrants further clarification. It has 
been demonstrated that a virulent strain of B. bovis failed to establish infection in WTD 
via larval extract supernatant containing sporozoites from infected Rhipicephalus 
microplus or a B. bovis infected blood stabilate (Ueti et al., 2015). More research is still 
warranted in order to confirm if WTD are affected or not by bovine babesiosis and 
whether WTD are competent hosts for completion of the transmission cycle of 
Babesia spp. and other similar hemoparasites.  
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CHAPTER VI 
CONCLUSION 
 
 The research for this dissertation focused on Cytauxzoon felis, feline hemotrophic 
mycoplasmas, and Babesia spp. in the U.S. Historically, it has been believed that 
bobcats serve as reservoirs of C. felis and domestic cats as aberrant hosts, in which the 
infection was ultimately fatal. However, as years passed, it was observed that cats were 
surviving infections with and without treatment. It was speculated that survival was due 
to development of different strains of C. felis that possibly varied geographically.  
 One study used the genotypes of C. felis internal transcribed spacer (ITS) regions   
in order to determine if there was an association with the varying clinical outcomes 
(fatal, recovery, and chronic) and geographical regions (Arkansas, Missouri, Texas, 
Oklahoma, and Kansas) of C. felis-infected cats. Amplification of the C. felis 18S 
ribosomal RNA (rRNA) gene was used to positively identify cats as infected.  The 
C. felis ITS regions showed genetic diversity within the domestic cats, but there was no 
association with the ITS genotypes and clinical outcome or geography. These ITS 
genotypes in conjunction with other C. felis genes or other associations may provide 
more insight to them.  
 These same C. felis-infected cats were molecularly surveyed for feline 
Mycoplasma spp. to see if the presence of a mycoplasma might have an effect on the 
clinical outcome of C. felis infection. After amplification of the 16S rRNA gene of 
Mycoplasma spp., it was revealed that nearly a quarter of the cats had a coinfection with 
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C. felis and Candidatus Mycoplasma haemominutum. All of the cats were from different 
clinical outcomes. Thus it appears the outcome of disease is independent of the presence 
of this Mycoplasma sp. More studies should be conducted in order to confirm if an 
association of a C. felis coinfection with Candidatus M. haemominutum and other feline 
hemotrophic mycoplasmas does exist. Also, Rhodococcus spp. were detected in this 
study. In addition, Candidatus Mycoplasma kahanei was identified in one cat that did 
died. This identification has not previously been reported in domestic cats, and more 
studies would need to be done in order to confirm this result and understand its 
implication.  
 Using a microaerophilous stationary phase system (Levy and Ristic, 1980) the 
continuous in vitro cultivation of C. felis was attempted. This would lead to an abundant 
source of this parasite, which could be used to recognize antigenic proteins for vaccine 
development and diagnostic improvement. Although the indefinite propagation of 
C. felis was not achieved, the cultures did provide insight. It was demonstrated that HL-1 
medium, cat serum or fetal bovine serum, hypoxanthine, and the source of C. felis-
infected blood had involvement in some of the best culture conditions. These conditions, 
along with the supplementation of antibiotics-antimycotic should be investigated more 
and further modified for optimization in order to establish a continuous culture.  
 In studying transmission of C. felis as well as similar hemoparasites, 161 ticks 
actively feeding on white-tailed deer (WTD) were molecularly surveyed for the 18S 
rRNA gene of these protozoans. Although there were PCR positive samples, sequencing 
revealed that the positive amplicons were tick rDNA sequences. Modifications such as 
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raising the annealing temperature and utilization of more specific primers for 
hemoparasites also resulted in the amplification of tick rDNA. Despite not detecting 
hemoparasites in these WTD ticks, there have been other molecular and serological 
evidence of bovine Babesia spp. in WTD. Further studies should be conducted in order 
detect protozoal parasites and determine the role of these WTD in their transmission 
cycle.  
 Since its initial report in 1976 (Wagner, 1976), our knowledge of C. felis has 
progressed with microscopy and molecular research. Without the establishment of a 
culture system, C. felis research relies on either naturally infected cats or infecting 
healthy cats with a fatal disease. Until a continuous C. felis culture is achieved, 
comparative genomics (Tarigo et al., 2013) and molecular technologies (i.e., high 
resolution melt analysis) (Schreeg et al., 2015) have been able to add to the vast growing 
knowledge of C. felis, especially with finding means of control and aiding in faster 
diagnoses.  
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